Reference list concerning peripheral neuropathy · 19238 Herron LD, Kissel P, Smilovitz D (1997)....

of 53

PERIPHERAL NEUROPATHY

RMA ID Number Reference List for RMA292-3 as at August 2014

3722

American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, (Fourth edition),. Washington: American Psychiatric Association.

12368

Schilling CJ (1997). Effects of acute exposure to ultrahigh radiofrequency radiation on three antenna engineers. Occupational and Environmental Medicine, 54: 281-84.

12468

Scott RS, Clay L, Storey KV, Johnson RJR (1985). Transient microwave induced neurosensory reactions during superficial hyperthermia treatment. Radiation, Oncology, Biology, Physics, 11: 561-66.

15957 Frumkin H (1998). Multiple system atrophy following chronic carbon disulfide exposure. Environmental Health Perspectives, 106(9) pp 611-613.

18243

Zober A, Ott MG, Messerer P (1994). Morbidity follow up study of BASF employees exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) after a 1953 chemical reactor incident. Occupational and Environmental Medicine, 51(7): 479-86.

18978 Paulson GW (2000). Restless Legs Syndrome: how to provide symptom relief with drug and nondrug therapies. Neurology, 55(4) pp 35-48.

18979

Fernandez-Obregon AC, Forconi RJ (1988). Neurologic symptoms posing as Dapsone-induced polyneuropathy in two patients with dermatitis herpetiformis. CUTIS, 41: 347-50.

18980 Daneshmend TK, Homeida M (1981). [LETTER] Dapsone-induced optic atrophy and motor neuropathy. British Medical Journal, Vol 283 pp 311.

18981 Homeida M, Babikr A, Daneshmend TK (1980). Dapsone-induced optic atrophy and motor neuropathy. British Medical Journal, Vol 281 pp 1180.

18982 Gutmann L, Martin JD, Welton W (1976). Dapsone motor neuropathy - an axonal disease. Neurology, 26: 514-16.

18983 Rapoport AM, Guss SB (1972). Dapsone-induced peripheral neuropathy. Arch Neur, 27: 184-85.

18984 Taburet A-M, Singlas E (1996). Drug interactions with antiviral drugs. Clin Pharmacokinet, 30(5): 385-401.

18985

Rhodes LE, Coleman MD, Lewis-Jones MS (1995). Dapsone-induced motor peripheral neuropathy in pemphigus foliaceus. Clinical and Experimental Dermatology, Vol 20 pp 155-156.

18986

Sirsat AM, Lalitha VS, Pandya SS (1987). Dapsone neuropathy - report of three cases and pathologic features of a motor nerve. International Journal of Leprosy, 55(1) pp 23-29.

18987 Ahrens EM, Meckler RJ, Callen JP (1986). Dapsone-induced peripheral neuropathy. International Journal of Dermatology, 25(5) pp 314-316.

18989 Koller WC, Gehlmann LK, Malkinson FD, Davis FA (1977). Dapsone-induced peripheral neuropathy. Archives of Neurology, Vol 34 pp 644-646.

of 53

18998

Southgate HJ, Masterson R (1999). Lessons to be learned: a case approach: Prolonged methaemoglobinaemia due to inadvertent dapsone poisoning; treatment with methylene blue and exchange transfusion. The journal of the Royal Society for the Promotion of Health, 119(1): 52-5.

19133 Hales TR, Bernard BP (1996). Epidemiology of work-related musculoskeletal disorders. Orthopedic Clinics of North America, Vol 27 pp 679-709.

19134 Allos BM (1998). Campylobacter jejuni infection as a cause of the Guillain-Barre syndrome. Infectious Disease Clinics of North America, 12: 173-84.

19135 Alter M (1990). The epidemiology of Guillain-Barre syndrome. Ann Neurol, 27(suppl) pp S7-S12.

19136 Harati Y (1996). Diabetes and the nervous system. Endocrinology and Metabolism Clinics of North America, Vol 25 pp 325-359.

19137

Dimopoulos MA, Papadimitriou C, Sakarellou N, Athanassiades P (1995). Complications and supportive therapy of multiple myeloma. Bailliere's Clinical Haematology, 8: 845-52.

19138 Ross MA (1993). Neuropathies associated with diabetes. Medical Clinics of North America, Vol 77 pp 111-124.

19139 Zenz T, Zenz M, Tryba M (1996). Treatment of postherpetic neuralgia. NEJM, 335(23) pp 1768-9.

19140 Kost RG, Straus SE (1996). Postherpetic neuralgia - pathogenesis, treatment, and prevention. NEJM, Vol 335 pp 32-42.

19141 Allos BM (1997). Association between Campylobacter infection and Guillain-Barre syndrome. J Infect Dis, 176(s2): s125-8.

19142 Blaser MJ (1997). Epidemiologic and clinical features of Campylobacter jejuni infections. Journal of Infectious Disease, Vol 176(S2) pp S103-5.

19143 Hughes RAC, Rees JH (1997). Clinical and epidemiological features of Guillain-Barre syndrome. Journal of Infectious Disease, 176(S2) pp S92-8.

19144

Tuttle J, Chen RT, Rantala H, et al (1997). The risk of Guillain-Barre syndrome after tetanus-toxoid-containing vaccines in adults and children in the United States. American Journal of Public Health, 87(12): 2045-48.

19145 Chaudhuri KR (1997). The neurology of diabetes. British Journal of Hospital Medicine, Vol 58 pp 343-347.

19146 Warner MA (1998). Perioperative neuropathies. Mayo Clin Proc, Vol 73 pp 567-574.

19147 Dvorak J (1998). Epidemiology, physical examination, and neurodiagnostics. Spine, Vol 23 pp 2663-2673.

19148 Kyle RA, Gertz MA, Greipp PR, et al (1999). Long-term survival (10 years or more) in 30 patients with primary amyloidosis. Blood, Vol 93 pp 1062-1066.

19149

Allen G, Galer BS, Schwartz L (1999). Epidemiology of complex regional pain syndrome: a retrospective chart review of 134 patients. Pain, Vol 80 pp 539-544.

19150 Greene DA, Stevens MJ, Feldman EL (1999). Diabetic neuropathy: Scope of the syndrome. Am J Med, 107(2B) pp 2S-8S.

19151 Melgaard B (1993). Chronic encephalopathy and peripheral neuropathy associated with alcoholism. Danish Medical Bulletin, Vol 40 pp 31-38.

19152 Latov N (1995). Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies. Ann Neurol, 37(s1) pp S32-S42.

19153 Gaster B (1998). The effects of improved glycemic control on complications in Type 2 diabetes. Arch Intern Med, Vol 158 pp 134-140.

19154 Wrenn K. (1991). Immersion foot: a problem of the homeless in the 1990's. Arch Intern Med, Vol 151 pp 785-788.

19161

Sweeney MH, Fingerhut MA, Arezzo JC, Hornung RW, Connally LB (1993). Peripheral neuropathy after occupational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). American Journal of Industrial Medicine, Vol 23 pp 845-858.

of 53

19162

Bejjani FJ, Kaye GM, Benham M (1996). Musculoskeletal and neuromuscular conditions of instrumental musicians. Arch Phys Med Rehabil, Vol 77 pp 406-13.

19163 Hughes RAC (1995). Epidemiology of peripheral neuropathy. Current Opinion in Neurology, Vol 8 pp 335-8.

19164

Awong IE, Dandurand KR, Keeys CA, Khin M-G FA (1996). Drug-associated Guillain-Barre Syndrome: a literature review. Neurology, Ann Pharmacother, Vol 30 pp 173-80.

19165

Grieco A, Molteni G, deVito G, Sias N (1998). Epidemiology of musculoskeletal disorders due to biomechanical overload. Ergonomics, Vol 41(9) pp 1253-1260.

19166 Waldinger TP, Siegle RJ, Weber W, Voorhees JJ (1984). Dapsone-induced peripheral neuropathy. Arch Dermatol, 120(3) pp 356-9.

19167 Wyatt EH, Stevens JC (1972). Dapsone induced peripheral neuropathy. British Journal of Dermatology, 86(5) pp 521-3.

19169 Argov Z, Mastaglia FL (1979). Drug-induced peripheral neuropathies. BMJ, Vol 1 pp 663-666.

19205 Beck MA (2000). Nutritionally induced oxidative stress: effect on viral disease. American Journal of Clinical Nutrition, 71: 1676S-9S.

19206 Novak CB, Mackinnon SE (1998). Nerve injury in repetitive motion disorders. Clinical Orthopaedics and Related Research, 351: 10-20.

19207 Hahn AF (1998). Guillain-Barre syndrome. Lancet, 352(9128): 635-41.

19208 Khoury MJ, Little J (2000). Human genome epidemiologic reviews: the beginning of something HuGE. American Journal of Epidemiology, 151(1): 2-3.

19209 White RF, Proctor SP (1997). Solvents and neurotoxicity. The Lancet, 349: 1239-43.

19210 Oh SJ (1997). Paraneoplastic vasculitis of the peripheral nervous system. Neurologic Clinics, 15(4) pp 849-863.

19211 Brin MF, Koller W (1998). Epidemiology and genetics of essential tremor. Movement Disorders, 13(S3) pp 55-63.

19226 Tittiranonda P, Burastero S, Rempel D (1999). Risk factors for musculoskeletal disorders among computer users. Occupational Medicine, Vol 14(1) pp 17-38.

19227 Chimelli L, Scaravilli F (1997). Trypanosomiasis. Brain Pathology, Vol 7(1) pp 599-611.

19228 Potter GK, Feldman JS (1990). Neoplasms of the peripheral nervous system. Clin Podiatr Med Surg, 7(1) pp 141-9.

19229

Beghi E, Cornelio F, Marconi M, Rizzuto N, et al (1991). The epidemiology of inflammatory polyradiculoneuropathy. A critical review of the distribution, characteristics and outcome of the disease. Italian Journal of Neurologic Science, 12(1) pp 63-73.

19230 Korczyn AD (1991). Creutzfeldt-Jakob disease among Libyan jews. European Journal of Epidemiology, 7(5): 490-3.

19231 Mollman JE (1992). Neuromuscular toxicity of therapy. Current Opinion in Oncology, 4(3) pp 540-6.

19232 Zimmerman NB, Zimmerman SI, Clark GL (1992). Neuropathy in the workplace. Hand Clinic, 8(2) pp 255-62.

19233 Haskell SG, Fiebach NH (1997). Clinical epidemiology of nocturnal leg cramps in male veterans. American Journal of Medical Science, 313(40) pp 210-4.

19234 Saqueton AC, Lorincz AL, Vick NA, Hamer RD (1969). Dapsone and peripheral motor neuropathy. Archives of Dermatology, 100(2) pp 214-7.

19235 Fredericks EJ, Kugelman TP, Kirsch N (1976). Dapsone-induced motor polyneuropathy. Arch Dermatology, 112(8) pp 1158-60.

19236 Epstein FW, Bohm M (1976). Dapsone-induced peripheral neuropathy. Archives of Dermatology, 112(12) pp 1761-2.

19237 Marelich GP (1997). Volatile substance abuse. Clin Rev Allergy Immunol, 15(3) pp 271-89.

of 53

19238 Herron LD, Kissel P, Smilovitz D (1997). Treatment of coccidioidal spinal infection: experience in 16 cases. Journal of Spinal Disorders, 10(3) pp 215-22.

19239 Openshaw H (1997). Peripheral neuropathy after bone marrow transplantation. Biol Blood Marrow Transplantation, 3(4) pp 202-9.

19240 Kiuru S (1998). Gelsolin-related familial amyloidosis, Finnish type (FAF), and its variants found worldwide. Amyloid, 5(1) pp 55-66.

19241 Rosen I, Somas R (1982). Peripheral motor neuropathy caused by excessive intake of dapsone (avlosulfon). , 232(1): 63-9.

19242

Leijten FSS & de Weerd AW (1994). Critical illness polyneuropathy. A review of the literature, definition and pathophysiology. Clin Neurol Neurosurg, 96(1) pp 10-19.

19251

Piligian G, Herbert R, Hearns M, Dropkin J, et al (2000). Evaluation and management of chronic work-related musculoskeletal disorders of the distal upper extremity. American Journal of Industrial Medicine, 37(1) pp 75-93.

19276

Rotta FT, Sussman AT, Bradley WG, Ayyar DR, et al (2000). The spectrum of chronic inflammatory demyelinating polyneuropathy. Journal of Neurological Sciences, 173(2) pp 129-39.

19277 Isaacson M (1998). Guillain-Barre syndrome and campylobacter infection. Journal of Travel Medicine, 5(3) p160.

19278 Rubin M, Lange DJ (1990). Infectious agents and disease of peripheral nerve. Clin Podiatr Med Surg, 7(1) pp 51-70.

19279 Yuki N, Hirata K (1998). Fisher's syndrome and group A streptococcal infection. Journal of Neurological Science, 160(1) pp 64-6.

19280 Hoppmann RA, Reid RR (1995). Musculoskeletal problems of performing artists. Current Opinion in Rheumatology, 7(2) pp 147-50.

19292

Grumbine NA, Radovic PA, Parsons R, Scheinn GS (1990). Tarsal tunnel syndrome. Comprehensive review of 87 cases. Journal of the American Podiatry Medical Association, 80(9) pp 457-61.

19293 Ho T, Griffin J (1999). Guillain-Barre syndrome. Current Opinion in Neurology, 12(4) pp 389-94.

19294

Delzell E, Beall C, Rodu B, Lees PSJ, et al (1999). Case-series investigation of intracranial neoplasms at a petrochemical research facility. American Journal of Industrial medicine, 36(4) pp 450-458.

19303 Forman A (1990). Peripheral neuropathy in cancer patients: incidence, features, and pathophysiology. Oncology (Hunting), 4(1) pp 57-62

19304

Asbury AK, Thomas PK (1995). The clinical approach to neuropathy. In Peripheral Nerve Disorders 2 Edited by Asbury AK & Thomas PK. Chapter 1 pp 1-28.

19305

Hughes RAC (1995). Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculonephropathy. In Peripheral Nerve Disorders 2 eds Asbury AK & Thomas PK. Chapter 0 pp 175-204.

19306

Said G (1995). Neuropathies due to Lyme disease, leprosy and Chagas' disease. In Peripheral Nerve Disorders 2 eds Asbury AK & Thomas PK, Chapter 10 pp 205-222.

19307 Schaumburg HH, Kaplan JG (1995). Toxic peripheral neuropathies. AK Asbury, PK thomas (Eds). Peripheral Nerve Disorders 2, Chapter 12: 238-261. .

19308 Bolton CF (1995). Critical illness polyneuropathy. In Peripheral Nerve Disorders 2 eds Asbury AK & Thomas PK, Chapter 13 pp 262-280.

19309 Donaghy M (1993). Disorders of peripheral nerves. Eds Walton J. In. Brain's Diseases of the Nervous System,, Chapter 18, : 555-624.

19360

Kwasa TO (1995). Neurologiocal manifestations of human immunodeficiency virus infection and acquired immune deficiency syndrome: a review. East Afr Med Journal, 72(10) pp 664-8.

19711 Hughes R, Sharrack B, Rubens R (1996). Carcinoma and the peripheral nervous system. J Neurol, Vol 243 pp 371-6.

of 53

20016 Gehlmann LK, Koller WC, Malkinson FD (1977). Dapsone-induced neuropathy. Archives Dermatology, 113(6): 845-6.

20017 Robinson LR (2000). Traumatic injury to peripheral nerves. Muscle Nerve, 23(6): 863-73.

20350

Various authors (2000). Gulf War and Health: Volume 1 - Depleted Uranium, Pyridostigmine Bromide, Sarin, Vaccines. CE Fulco, CT Liverman, HC Sox [Eds]. Institute of Medicine, . National Academies Press - Washington, DC.

20703 Wartenberg D, Reyner D, Scott CS (2000). Trichloroethylene and cancer: epidemiologic evidence. Environmental Health Perspective, 108(S2): 161-76.

21007

Vergne P, Bertin P, Bonnet C, Scotto C, Treves R. (2000). Drug-induced rheumatic disorders. Incidence, prevention and management. Drug Safety, 23(4): 279-293.

21008

Wulff EA, Wang AK, Simpson DM. (2000). HIV-associated peripheral neuropathy. Epidemiology, pathophysiology and treatment. Drugs, 59(6) pp 1251-1260.

21009

Dworkin RH, Perkins FM, Nagasako EM (2000). Prospects for the prevention of postherpetic neuralgia in herpes zoster patients. The Clinical Journal of Pain, Vol 16 pp S90-S100.

21010 Robinson LR (2000). Traumatic injury to peripheral nerves. Muscle Nerve, Vol 23 pp 863-873.

21011 Grant AC, Cook AA (2000). A prospective study of handcuff neuropathies. Muscle Nerve, Vol 23 pp 933-8.

21012 Van Brakel WH (2000). Peripheral neuropathy in leprosy and its consequences. Leprosy Review, Vol 71 Suppl pp S146-53.

21030 Bromberg MB (2000). Peripheral neurotoxic disorders. Neurologic Clinics, 18(3) pp 681-94.

21108

Ammendola A, Gemini D, Iannaccone S, Argenzio F, et al (2000). Gender and peripheral neuropathy in chronic alcoholism: a clinical-electroneurographic study. Alcohol & Alcoholism, 35(4) pp 368-71.

21155

Lifshitz M, Gavrilov V (2000). Central nervous system toxicity and early peripheral neuropathy following dermal exposure to methyl bromide. Clinical Toxicology, 38(7) pp 799-801.

21156 Jenkins JG (2000). Iatrogenic postoperative peripheral neuropathy is more common than generally realised. Anaesthesia, Vol 55 pp 86-103.

21157 Johnson ME (2000). Potential neurotoxicity of spinal anesthesia with lidocaine. Mayo Clin Proc, 75: 921-32.

21158 Vinik AI, Park TS, Stansberry KB, Pittenger GL. (2000). Diabetic neuropathies. Diabetologia, Vol 43 pp 957-973.

21159 Orth SR. (2000). Smoking - a renal risk factor. Nephron, Vol 86 pp 12-26.

21160

McDermott CJ, White K, Bushby K, Shaw PJ (2000). Hereditary spastic paraparesis: a review of new developments. J Neurol Neurosurg Psychiatry,, 69: 150-60.

21161 Beck MA (2000). Nutritionally induced oxidative stress: effect on viral disease. Am J Clin Nutr, 71(6 s) pp S1676-9.

21172 Postma TJ, Heimans JJ (2000). Grading of chemotherapy-induced peripheral neuropathy. Annals of Oncology, Vol 11 pp 509-513.

21232 Hadler NM (1996). [Editorial] A keyboard for "Daubert". JOEM, 38(5) pp 469-476.

21233 Nathan PA; Franklin G, Silverstein M and Silverstein B; Hadler NM (1996). [Letters] Carpal Tunnel Syndrome. JOEM, 38(11) pp 1080-1084.

21234 Radecki P; Silverstein M, Franklin G and Silverstein B (1997). [Letters]. Work-related musculoskeletal disorders. JOEM, 39(2) pp 99-101.

21244 Cullum DE, Molloy CJ (1994). Occupation and the carpal tunnel syndrome. The Medical Journal of Australia, Vol 161 pp 552-554.

21245 Radecki P (1995). Variability in the median and ulnar nerve latencies: implications for diagnosing entrapment. JOEM, 37(11) pp 1293-1299.

of 53

21246 Hughes RAC (1995). [Editorial Review] Epidemiology of peripheral neuropathy. Current Opinion in Neurology, Vol 8 pp 335-338.

21247

Awong IE, Dandurand KR, Keeys CA, Maung-Gyi FAK (1996). Drug-associated Guillain-Barre Syndrome: a literature review. The Annals of Pharmacotherapy, Vol 30 pp 173-180.

21248 Jacknowitz AL (1997). [Letter] Comment: capsaicin for pain relief in Guillain-Barre syndrome. The Annals of Pharmacotherapy, Vol 31 p 500.

21249

Estruch R, Nicolas JM, Villegas E, Junque A, Urbano-Marquez A (1993). Relationship between ethanol-related diseases and nutritional status in chronically alcoholic men. Alcohol and Alcoholism, 28(5) pp 543-550.

21250

Nicolas JM, Estruch R, Antunez E, Sacanella E, Urbano-Marquez A (1993). Nutritional status in chronically alcoholic men from the middle socioeconomic class and its relation to ethanol intake. Alcoho & Alcoholism, 28(5): 551-58.

21251

Nathan PA, Meadows KD (2000). Neuromusculoskeletal conditions of the upper extremity: are they due to repetitive occupational trauma? Occupational Medicine, 15(4) pp 677-693.

21252

Sarova-Pinhas I, Achiron A, Gilad R, Lampl Y (1995). Peripheral neuropathy in multiple sclerosis: a clinical and electrophysiologic study. Acta Neurol Scand, Vol 91 pp 234-238.

21253 Palliyath S, Schwartz BD (1993). Peripheral nerve functions improve in chronic alcoholic patients on abstinence. J Stud Alcohol, Vol 54 pp 684-686.

21254 Martyn CN, Hughes RAC (1997). Epidemiology of peripheral neuropathy. Journal of Neurology, Neurosurgery, and Psychiatry, Vol 62 pp 310-318.

21255

Wöhrle JC, Spengos K, Steinke W, Goebel HH, Hennerici M (1998). Alcohol-related acute axonal polyneuropathy: a differential diagnosis of Guillain Barré syndrome. Arch Neurol, Vol 55 pp 1329-1334.

21256

Monforte R, Estruch R, Valls-Solé, Nicolás J, et al (1995). Autonomic and peripheral neuropathies in patients with chronic alcoholism. Arch Neurol, Vol 52 pp 45-51.

21257

Sosenko JM, Soto R, Aronson J, Kato M, et al (1991). The prevalence and extent of vibration sensitivity impairment in men with chronic ethanol abuse. Journal of Studies on Alcohol, 52(4) pp 374-376.

21258

Macias-Matos C, Rodriguez-Ojea A, Chi N, Jimenez S, et al (1996). Biochemical evidence of thiamine depletion during the Cuban neuropathy epidemic, 1992-1993. American Journal of Clinical Nutrition, 64(3) pp 347-353.

21259

Gans DA; Bates C, et al; Ascherio A; Bates C, et al (1997). [Letters] Biochemical evidence of thiamine depletion during the Cuban neuropathy epidemic, 1992-1993. American Journal of Clinical Nutrition, 65(4) pp 1090-1093.

21260

Bowman BA, Bern C, Philen RM (1996)[Editorial]. Nothing's simple about malnutrition: complexities raised by epidemic neuropathy in Cuba. American Journal of Clinical Nutrition, 64(3) pp 383-384.

21261

Gill GV, Bell DR (1982). Persisting nutritional neuropathy amongst former war prisoners. Journal of Neurology, Neurosurgery, and Psychiatry, Vol 45 pp 861-865.

21262 Silber E, Reilly M, et al (1999). Brachial plexopathy related to alcohol intoxication. Journal of Neurology, Neurosurgery & Psychiatry, 67(3): 411-2.

21263

Werner RA, Franzblau A, Albers JW, Armstrong TJ (1997). Influence of body mass index and work activity on the prevalence of median mononeuropathy at the wrist. Occupational and Environmental Medicine, Vol 54 pp 268-271.

21264 Lincoff NS, Odel JG, Hirano M (1993). 'Outbreak' of optic and peripheral neuropathy in Cuba? JAMA, Vol 270 pp 511-518.

21265 Salisbury DM (1998). Association between oral poliovaccine and Gullain-Barre? Lancet, 351: 79-80.

21266 Hedges TR et al; Sadun AA, et al; Espinoza A, et al (1994). [LETTERS] Optic and peripheral neuropathy in Cuba. JAMA, Vol 271 pp 662-4.

of 53

21267 Berger AR, Schaumburg HH, et al (1999). Prevalence of peripheral neuropathy in injection drug users. Neurology, Vol 53 pp 592-7.

21268 Morris K, Rylance G. (1994). Guillain-Barre syndrome after measles, mumps, and rubella vaccine. Lancet, Vol 343 pp 60.

21269 Rees J, Hughes R (1994). Guillain-Barre syndrome after measles, mumps, and rubella vaccine. Lancet, Vol 343 pp 733.

21270 Tuck RR, Jackson M (1991). Social, neurological and cognitive disorders in alcoholics. Medicla Journal of Australia, Vol 155 pp 225-229.

21271 Kiroff GK (1995). Occupation and the carpal tunnel syndrome. MJA, Vol 162 pp 166-7.

21272

Panjawi M, Truong LD, Eknoyan G (1996). Membranous glomerulonephritis associated with inflammatory demyelinating peripheral neuropathies. American Journal of Kidney Diseases, Vol 27 pp 279-283.

21273

Viaene MK, Masschelein R, Leenders J, et al (2000). Neurobehavioural effects of occupational exposure to cadmium: a cross sectional epidemiological study. Occup Environ Med, 57: 19-27.

21274

Stokes L, Stark A, et al (1995). Neurotoxicity among pesticide applicators exposed to organophosphates. Occupational and Environmental Medicine, Vol 52 pp 648-653.

21275

Albers JW, Wald JJ, Werner RA ,et al (1999). Absence of polyneuropathy among workers previously diagnosed with solvent-induced toxic encepahalopathy. JOEM, Vol 41 pp 500-509.

21286 Jackson CE, Amato AA, Barohn RJ (1996). Isolated vitamin E deficiency. Muscle and Nerve, Vol 19 pp 1161-1165.

21295

Palmer KT, Griffin MJ, Bendall H, Pannett B, et al (2000). The prevalence of sensorineural symptoms attributable to hand-transmitted vibration in Great Britain: a national postal survey. American Journal of Industrial Medicine, Vol 38 pp 99-107.

21296

Gerr F, Letz R (2000). Epidemiological case definitions of peripheral neuropathy: experience from two neurotoxicity studies. Neuro Toxicology, 21(5) pp 761-768.

21297

Barnouin J, Cristia RP, Chassagne M, Barrios TV, et al (2000). Vitamin and nutritional status in Cuban smokers and nonsmokers in the context of an emerging epidemic neuropathy. International Journal Vitam Nutr Res, 70(3) pp 126-138.

21298

Burns CJ, Cartmill JB, Powers BS, Lee MK (1998). Update of the morbidity experience of employees potentially exposed to chlorpyrifos. Occup Environ Med, Vol 55 pp 65-70.

21299

Ruijten MW, Salle HJA, Verberk MM, Smink M (1994). Effect of chronic mixed pesticide exposure on peripheral and autonomic nerve function. Archives of Environmental Health, 49(3) pp 188-195.

21300 Latov N (1995). Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies. Annals of Neurology, 37(S 1) pp S32-S42.

21301 Orfila C, Lepert JC, Modesto A, Pipy B, Suc JM (1998). IgA nephropathy complicating diabetic glomerulosclerosis. Nephron, Vol 79 pp 279-287.

21302

Gill GV, Bell DR (1982). Persisting nutritional neuropathy amongst former war prisoners. Journal of Neurology, Neurosurgery, and Psychiatry, Vol 45 pp 861-865.

21303

Stricker BH, van der Klauw MM, Ottervanger JP, van der Meche FGA (1994). A case-control study of drugs and other determinants as potential causes of Guillain-Barre syndrome. Journal of Clinical Epidemiology, 47(10) pp 1203-1210.

21304 Saunderson P (2000). The epidemiology of reactions and nerve damage. Leprosy Rev,, 71: S106-S110.

21305 Tocker K, Hedges TR (1993). Food shortages and an epidemic of optic and peripheral neuropathy in Cuba. Nutrition Reviews, 51(12): 349-357.

of 53

21306 Novak CB, Mackinnon SE (1998). Nerve injury in repetitive motion disorders. Clinical Orthopaedics and Related Research, Vol 351 pp 10-20.

21307

Roquelaure Y, Raimbeau G, Dano C, Martin YH, et al (2000). Occupational risk factors for radial tunnel syndrome in industrial workers. Scand J Work Environ Health, 26(6) pp 507-513.

21308

Camerlingo M, Nemni R, Ferraro B, Casto L, et al (1998). Malignancy and sensory neuropathy of unexplained cause: a prospective study of 51 patients. Arch Neurol, Vol 55 pp 981-984.

21309 Martyn CN (1998). Capture-recapture methods in surveys of diseases of the nervous system. J Neurol Neurosurgery Psychiatry, Vol 64 pp 2-3.

21310

Rees JH, Thompson RD, Smeeton NC, Hughes RAC (1998). Epidemiological study of Guillain-Barre syndrome in south east England. J Neurol Neurosurgery Psychiatry, Vol 64 pp 74-77.

21311

Ho TW, Mishu B, Li CY, Gao CY, Cornblath DR, Griffin JW, et al (1995). Guillain-Barre syndrome in northern China: relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain, Vol 118 pp 597-605.

21312

Adler AI, Stensel V, Boyko EJ, Forsberg RC, et al (1997). Risk factors for diabetic peripheral sensory neuropathy: results of the Seattle prospective diabetic foot study. Diabetic Care, 20(7) pp 1162-1167.

21313

Gobba F, Cavalleri F, Bontadi D, Torri P, Dainese R (1995). Peripheral neuropathy in styrene-exposed workers. Scand J Work Environ Health, Vol 21 pp 517-520.

21314

Govoni M, Bajocchi G, Rizzo N, Tola MR, et al (1999). Neurological involvement in primary Sjogren's syndrome: clinical and instrumental evaluation in a cohort of Italian patients. Clinical Rheumatology, Vol 18 pp 299-303.

21315

Nilsson T, Hagberg M, Burstrom L, Kihlberg S (1994). Impaired nerve conduction in the carpal tunnel of platers and truck assemblers exposed to hand-arm vibration. Scad J Work Environ Health, Vol 20 pp 189-199.

21316 Mendes DG, Nawalkar RR, Eldar S (1991). Post-irradiation femoral neuropathy. The Journal of Bone and Joint Surgery, 73A(1) pp 137-140.

21317 Feistner H, Weissenborn K, Munte TF, Heinze HJ, Malin JP (1989). Post-irradiation lesions of the caudal roots. Acta Neurol Scand, Vol 80 pp 277-281.

21318

Haley RW, Hom J, Roland PS, Bryan WW, et al (1997). Evaluation of neurologic function in Gulf War Veterans: a blinded case-control study. JAMA, 277(3) pp 223-230.

21319 Landrigan PJ (1997). Illness in Gulf War Veterans: causes and consequences. JAMA, 277(3) pp 259-261.

21320

Gemignani F, Marbini A, Pavesi G, Di Vittorio S, et al (1994). Peripheral neuropathy associated with primary Sjogren's syndrome. Journal of Neurology, Neurosurgery, and Psychiatry, Vol 57 pp 983-986.

21325

Harper CM, Thomas JE, Cascino TL, Litchy WJ (1989). Distinction between neoplastic and radiation-induced brachial plexopathy, with emphasis on the role of EMG. Neurology, Vol 39 pp 502-506.

21326 Gorson KC, Ropper AH, Palmetshofer AK, Weinstein R (1997). Prevalence of polyclonal gammopathy in polyneuropathy. Neurology, 49(6) p 1747.

21327

Bekkelund SI, Torbergsen T, Husby G, Mellgren SI (1999). Myopathy and neuropathy in rheumatoid arthritis. A quantitative controlled electromyographic study. The Journal of Rheumatology, Vol 26 pp 2348-2351.

21328 Sessa A, Meroni M, Battini G, Vaccari M, et al (1998). IgA nephropathy complicating diabetic glomerulosclerosis. Nephron, Vol 80 pp 488-489.

21329

Gordon V; Schlesinger N; Engel CC et al; Hyams KC et al; Amato AA, et al; Gots RE, et al; Kaires P; Haley RW, et al; Landrigan PJ (1997). [LETTERS] Identification of Gulf War Syndrome: methodological issues and medical illnesses. JAMA, 278(5) pp 383-387.

of 53

21372 Latronico N, Fenzi F, Recupero D, Guarneri B, et al (1996). Critical illness myopathy and neuropathy. The Lancet, Vol 347 pp 1579-82.

21373

Haberal MA, Gurer S, Akman N, Basgoze O (1996). Persistent peripheral nerve pathologies in patients with electric burns. J Burn care Rehabil, Vol 17 pp 147-9.

21374

Dagum AB, Peters WJ, Neligan PC, Douglas LG (1993). Severe multiple mononeuropathy in patients with major thermal burns. J Burn Care Rehabil, Vol 14 pp 440-5.

21399 Hodgson AJ (1994). A proposed etiology for tourniquet-induced neuropathies. Journal of Biomechanical Engineering, Vol 116 pp 224-7.

21400 Khedr EM, Khedr T, El-Oteify MA, Hassan HA (1997). Peripheral neuropathy in burn patients. Burns,23 (7-8) pp 579-583.

21401

McCarthy N, Giesecke J (2001). Incidence of Guillain-Barre Syndrome following infection with campylobacter jejuni. American Journal of Epidemiology, 153(6) pp 610-4.

21402

Kinnunen E, Junttila O, Haukka J, Hovi T (1998). Nationwide oral poliovirus vaccination campaign and the incidence of Guillain-Barre syndrome. American Journal of Epidemiology, 147(1) pp 69-73.

21403

Albers JW, Cole P, Greenberg RS, Mandel JS, et al (1999). Analysis of chlorpyrifos exposure and human health: expert panel report. Journal of Toxicology & Environmental Health, 2(4) pp 301-324.

21432

Marchiori PE, Silva HCA, Hirata MTA, Lino AM, Scaff M (1995). Acute multiple mononeuropathy after accidental exposure to oven microwaves. Occupational Medicine, 45(5) pp 276-77.

21433

Ammendola A, Gemini D, Iannaccone S, Argenzio F, et al (2000). Gender and peripheral neuropathy in chronic alcoholism: a clinical-electroneurographic study. Alcohol & Alcoholism, 35(4) pp 368-371.

21435

Olsen NK, Pfeiffer P, Johannsen L, Schroder H, Rose C (1993). Radiation-induced brachial plexopathy: neurological follow-up in 161 recurrence-free breast cancer patients. Int J Radiation Oncology Biology Physics, Vol 26(1) pp 43-9.

21436

Shaw EG, Gunderson LL, Martin JK, Beart RW et al (1990). Peripheral nerve and ureteral tolerance to intraoperative radiation therapy: clinical and dose-response analysis. Radiotherapy and Oncology, 18: 247-55.

21439 Jortner BS (2000). Mechanisms of toxic injury in the peripheral nervous system: neuropathologic considerations. Toxicology Pathology, 28(1) pp 54-69.

21440

Tanaka S (1996). Re: Prevalence and work relatedness of self-reported carpal tunnel syndrome among U.S. workers. American Journal of Industrial Medicine, Vol 30 pp 500-1.

21441

Tanaka S, Wild DK, Seligman PJ, Halperin WE, et al (1996). Re: prevalence estimate of self-reported carpal tunnel syndrome among US workers by analyzing the 1998 National Health Interview Survey Data. American Journal of Industrial Medicine, Vol 30 pp 502-3.

21442

Freedman DA, Stark PB (1999). The Swine flu vaccine and Guillain-Barre syndrome. A case study in relative risk and specific causation. Evaluation Review, 23(6) pp 619-47.

21443

Bingham RC, Rosecrance JC, Cook TM (1996). Prevalence of abnormal median nerve conduction in applicants for industrial jobs. American Journal of Industrial medicine, 30(3) pp 355-61.

21444 Wadd NJ, Lucraft HH (1998). Brachial plexus neuropathy following mantle radiotherapy. Clinical Oncology (R Coll Radiol), 10(6) pp 399-400.

21445

Yuasa J, Kishi R, Eguchi T, Harabuchi I, et al (1996). Study of urinary mandelic acid concentration and peripheral nerve conduction among styrene workers. American Journal of Industrial medicine, 30(1) pp 41-7.

of 53

21446

Kindstrand E, Nilsson BY, Hovmark A, Pirskanen R, Asbrink E (1997). Peripheral neuropathy in acrodermatitis chronica atrophicans - a late Borrelia manifestation. Acta Neurologica Scandinavica, 95: 338-345.

21455 Meier C, Bischoff A (1977). Polyneuropathy in hypothyroidism: Clinical and nerve biopsy study of 4 cases. J Neurol, Vol 215 pp 103-114.

21457 Woodhouse JIJA (1993). The prevalence of clinical peripheral neuropathies in human chronic Chagas disease. JR Army Med Corps, Vol 139 pp 54-5.

21459 Vanderbulcke M, Janssens J. (1999). Acute axonal polyneuropathy in chronic alcoholism and malnutrition. Acta Neurol Belg, Vol 99 pp 198-201.

21460

Hermosilla E, Lagueny A, Vital C, et al (1996). Peripheral neuropathy associated with Monoclonal IgG of undetermined significance: Clinical, electrophysiologic, pathologic and therapeutic study of 14 cases. Journal of Peripheral Nervous System, Vol 1 pp 139-148.

21461 Chimelli L, Scaravilli F (1997). Trypanosomiasis. Brain Pathology, Vol 7(1) pp 599-611.

21462

Pessione F, Gerchstein JL, Rueff B. (1995). Parental history of alcoholism: a risk factor for alcohol-related peripheral neuropathies. Alcohol & Alcoholism, 30(6) pp 749-754.

21463

Sweeney MH, Fingerhut MA, Arezzo JC, Hornung RW, Connally LB. (1993). Peripheral neuropathy after occupational exposure to 2,3,7,8-tetrachorodibenzo-p-dioxin (TCDD). American Journal of Industrial Medicine, Vol 23 pp 845-858.

21464 Dasgupta AK, Harrison J (1996). Effects of vibration on the hand-arm system of miners in India. Occupational Medicine, 46(1) pp 71-8.

21465

Agelink MW, Malessa R, Weisser U, Lemmer W, et al (1998). Alcoholism, peripheral neuropathy (PNP) and cardiovascular autonomic neuropathy (CAN). Journal of the Neurological Sciences, 161(2) pp 135-42.

21466 LeQuang C (1989). Postirradiation lesions of the brachial plexus. Result of surgical treatment. Hand Clinic, 5(1) pp 23-32.

21467

Martinello F, Fardin P, Ottina M, Ricchieri GL, et al (1998). Supplemental therapy in isolated vitamin E deficiency improves the peripheral neuropathy and prevents the progression of ataxia. Journal of the Neurological Sciences, 156(2): 177-79.

21468

Roman GC (1994). An epidemic in Cuba of optic neuropathy, sensorineural deafness, peripheral sensory neuropathy and dorsolateral myeloneuropathy. Journal of the Neurological Sciences, Vol 127 pp 11-28.

21469

Cole DC, Carpio F, Julian J, Leon N (1998). Assessment of peripheral nerve function in an Ecuadorian rural population exposed to pesticides. Journal of Toxicology & Environmental Health, Part A, Vol 55 pp 77-91.

21486

Graham DG (2000). Neurotoxicity associated with occupational exposure to acetone, methyl Ethyl Ketone, and cyclohexanone. Environmental Research, 82(2) pp 181-185.

21487

Mitran E, Callender T, Orha B, Dragnea P, Botezatu G (1997). Neurotoxicity associated with occupational exposure to acetone, methyl ethyl ketone, and cyclohexanone. Environmental Research, Vol 73 pp 181-8.

21488

Brew BJ (1994). The clinical spectrum and pathogenesis of HIV encephalopathy, myelopathy, and peripheral neuropathy. Current Opinion in Neurology, Vol 7 pp 209-216.

21489

Pedler SJ, Bint AJ (1984). Guillain-Barre syndrome associated with campylobacter jejuni enteritis. Journal of Infection,. Journal of Infection, 8: 85-6.

21490 Roman GC, Spencer PS, Schoenberg BS (1985). Tropical myeloneuropathies. The hidden endemias. Neurology, Vol 35 pp 1158-70.

21491 Low PA, McLeod JG, Turtle JR, Donnelly P, Wright RG (1974). Peripheral neuropathy in acromegaly. Brain, Vol 97 pp 139-152.

of 53

21492

Correale J, Monteverde DA, Bueri JA, Reich EG (1991). Peripheral nervous system and spinal cord involvement in lymphoma. Acta Neurol Scand, Vol 83 pp 45-51.

21493

Orti-Pareja M, Jimenez-Jimenez FJ, Miquel J, Montero E, et al (1996). Reversible myoclonus, tremor, and ataxia in a patient exposed to methyl ethyl ketone. Neurology, Vol 46 p 272.

21494

Sarova-Pinhas I, Achiron A, Gilad R, Lampl Y (1995). Peripheral neuropathy in multiple sclerosis: a clinical and electrophysiologic study. Acta Neurol Scand, Vol 91 pp 234-8.

21495 Gorson KC, Ropper AH, Palmetshofer A-K, Weinstein R (1997). Prevalence of polyclonal gammopathy in polyneuropathy. Neurology, Vol 49 pp 1747.

21496

Bekkelund SI, Torbergsen Y, Omdal R, Husby G, Mellgren SI (1996). Nerve conduction studies in rheumatoid arthritis. Scand J Rheumatol, Vol 25 pp 287-292.

21497

Lang AH, Kalliomaki JL, Puusa A, Halonen J-P (1981). Sensory neuropathy in rheumatoid arthritis: an electroneurographic study. Scand J Rheumatology, Vol 10 pp 81-4.

21498

Bekkelund SI, Mellgren SI, Proven A, Husby G (1996). Quantified neurological examination with emphasis on motor and sensory functions in patients with rheumatoid arthritis and controls. British Journal of Rheumatology, Vol 35 pp 1116-21.

21499 Osuntokun BO (1981). Cassava diet. Chronic cyanide intoxication and neuropathy in the Nigerian Africans. Wld Rev Nutr Diet, Vol 36 pp 141-173.

21516 Scott DGI, Bacon PA , Tribe CR (1981). Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases. Medicine, 60(4) pp 288-297.

`

Yaqoob M, Patrick AW, McClelland P, Stevenson A, et al (1994). Occupational hydrocarbon exposure and diabetic nephropathy. Diabetic Medicine, Vol 11 pp 789-793.

21520

D'Amico G, Napodano P, Ferrario F, Pia Rastaldi M, Arrigo G (2001). Idiopathic IgA nephropathy with segmental necrotizing lesions of the capillary wall. Kidney International, Vol 59 pp 682-692.

21521 Richer C, Mouthon L, Cohen P, Buchet P, et al (1999). Clinical Nephrology, 52(1) pp 47-50.

21522

Pai P, Bone JM, Bell GM. (1998). Hydrocarbon exposure and glomerulonephritis due to systemic vasculitis. Nephrol Dial Transplant, Vol 13 pp 1321-3.

21523 Ponticelli C, Pezzagno G (1994). Hydrocarbons and glomerulonephritis - is the definite answer in? Nephrol Dial Transplant, 9(11) pp 1539-40.

21524

Yaqoob M, King A, McClelland P, McDicken I, Bell GM. (1994). Relationship between hydrocarbon exposure and nephropathology in primary glomerulonephritis. Nephrol Dial Transplant, Vol 9 pp 1575-9.

21525

Sategna-Guidetti C, Ferfoglia G, Bruno M, Pulitano R, et al (1992). Do gA antigliadin and IgA antiendomysium antibodies show there is latent coeliac disease in primary IgA nephropathy? Gut, Vol 33 pp 476-8.

21526

Hotz P, Thielemans N, Bernard A, Gutzwiller F, Lauwerys R (1993). Serum laminin, hydrocarbon exposure, and glomerular damage. British Journal of Industrial medicine, Vol 50 pp 1104-10.

21527

Ravnskov U (2000). Hydrocarbon exposure may cause glomerulonephritis and worsen renal function: evidence based on Hill's criteria for causality. QJM, Vol 93 pp 551-6.

21535

Spahn TW, Lohse AW, Otto G, Tettenborn B, et al (1995). Remission of severe alcoholic polyneuropathy after liver transplantation. Zeitschrift fur Gastroenterologie, 33(12) pp 711-4.

21536

Tepper M, Rakic S, Haas JA, Woittiez AJJ (2000). Incidence and onset of critical illness polyneuropathy in patients with septic shock. The Netherlands Journal of Medicine, 56(6) pp 211-4.

of 53

21544

Vorgerd M, Tegenthoff M, Kiihne D, Malin JP (1996). Spinal MRI in progressive myeloneuropathy associated with vitamin E deficiency,. Neuroradiology, 38: S111-3.

21545

Rotta FT, Sussman AT, Bradley WG, Ayyar DR, et al (2000). The spectrum of chronic inflammatory demyelinating polyneuropathy. Journal of Neurological Sciences, 173(2) pp 129-39.

21546

Bovenzi M, Giannini F, Rossi S (2000). Vibration-induces multifocal neuropathy in forestry workers: electrophysiological findings in relation to vibration exposure and finger circulation. International Archives of Occupational & Environmental Health, 73(8): 519-27.

21547 Krivickas LS, Wilbourn AJ (2000). Peripheral nerve injuries in athletes: a case series of over 200 injuries. Seminars in Neurology, 20(2) pp 225-32.

21548

Johansson S, Svensson H, Larsson L-G, Denekamp J (2000). Brachial plexopathy after postoperative radiotherapy of breast cancer patients. A long-term follow-up. Acta Oncologica, 39(3) pp 373-382.

21560

Sugimoto K, Murakawa Y, Sima AAF (2000). Diabetic neuropathy - a continuing enigma. Diabetes/Metabolism Research & Reviews, Vol 16 pp 408-433.

21568

Skopouli FN, Dafni U, Ioannidis JP, Moutsopoulos HM (2000). Clinical evolution, and morbidity and mortality of primary Sjogren's Syndrome. Seminars in Arthritis and Rheumatism, 29(5) pp 296-304.

21577

Pessione F, Gerchstein JL, Rueff B (1995). Parental history of alcoholism: a risk factor for alcohol-related peripheral neuropathies. Alcohol and Alcoholism, 30(6) pp 749-754.

21578

Hardell L, Holmgren G, Steen L, Fredrikson M, Axelson O (1995). Occupational and other risk factors for clinically overt familial amyloid polyneuropathy. Epidemiology, 6(6) pp 598-601.

21579

Padua L, Paciello N, Aprile I, Valeri S, Tonali P (2000). Damage to peripheral nerves following radiotherapy at the wrist. Journal of Neurology, 247(4) pp 313-314.

21580 Thomas PK (1997). Tropical neuropathies. Journal of Neurology, 244(8) pp 475-482.

21581

White RF, Proctor SP, Echeverria D, Schweikert J, Feldman RG (1995). Neurobehavioral effects of acute and chronic mixed-solvent exposure in the screen printing industry. American Journal of Industrial Medicine, 28(2) pp 221-231.

21582

Sun DH, Zhou HD, Xue SZ (1998). Epidemiologic survey on organophosphate-induced delayed polyneuropathy (OPIDP) among patients recovered from methamidophos poisoning. Med Lav, 89(S 2) pp S123-S128.

21583

Caillette A, Tabakian A, Colon S, Labeeuw M, Zech P (1993). IgA Mesangial Nephropathy in over-75-year-old patients. Contributions to Nephrology, Vol 105 pp 152-156.

21584 Nadkar MY, Agarwal R, Samant RS, et al (2001). Neuropathy in rheumatoid arthritis. Journal of Association of Physicians of India, Vol 49 pp 217-220.

21585 Nemni R, Gerosa E, Piccolo G, Merlini G (1994). Neuropathies associated with monoclonal gammapathies. Haematologica, 79(6) pp 557-566.

21586 Nemni R, Gerosa E, Piccolo G, Merlini G (1995). [LETTER] Neuropathies associated with monoclonal gammapathies. Haematologica, 80(2) p 198.

21698

Viaene MK, Roels HA, Leenders J, De Groof M, et al (1999). Cadmium: a possible etiological factor in peripheral polyneuropathy. Neurotoxicology, 20(1) pp 7-16.

21834 Kril JJ (1996). Neuropathology of thiamine deficiency disorders. Metabolic Brain Disease, Vol 11 pp 9-17.

21836

Perretti A, Gentile S, Balbi P, Persico M, Caruso G (1995). Peripheral neuropathy in liver cirrhosis. A clinical and electrophysiological study. Ital J Gastroenterol, Vol 27 pp 349-354.

of 53

21837 Kissel JT, Mendell JR (1995). Neuropathies associated with monoclonal gammopathies. Neuromusc Disord, Vol 6 pp 3-18.

21838

de Wytt CN, Jackson RV, Hockings GI, Joyner JM, Strakosch CR (1999). Polyneuropathy in Australian outpatients with Type II diabetes mellitus. J Diabetes Complications, Vol 13 pp 74-8.

21839

D'Amour ML, Butterworth RF (1994). Pathogenesis of alcoholic peripheral neuropathy: Direct effect of ethanol or nutritional deficit? Metabolic Brain Disease, Vol 9 pp 133-42.

21964

Perretti A, Gentile S, Balbi P, Persico M, Caruso G. (1995). Peripheral neuropathy in liver cirrhosis. A clinical and electrophysiological study. Ital J Gastroenterol, Vol 27 pp 349-354.

21965

McCarron MO, Russell JC, Metcalfe RA, Deysilva R (1999). Chronic vitamin E deficiency causing spinocerebellar degeneration, peripheral neuropathy, and centro-cecal scotomata. Nutrition, 15(3): 217-9.

22111 Jafari H, Couratier P, Camu W (2001). Motor neuron disease after electric injury. J Neurol Neurosurg & Psychiatry, 71: 265-7.

27799 Winder C, Balouet JC (2002). The toxicity of commercial jet oils. Environmental Research Section A, Vol 89 pp 146-164.

27801 Ullrich SE (1999). Dermal application of JP-8 jet fuel induces immune suppression. Toxicological Sciences, 52: 61-7.

27804

Zeiger E, Smith L (1998). The first international conference on the environmental health and safety of jet fuel. Environmental Health Perspectives, 106(11) pp 763-764.

27854

Schwerzmann M, Seiler C, Lipp E, Guzman R, et al (2001). Relation between directly detected patent foramen ovale and ischemic brain lesions in sport divers. Annals of Internal Medicine, Vol 134 pp 21-4.

27855 Cordes P, Keil R, Bartsch T, Tetzlaff K, et al (2000). Neurologic outcome of controlled compressed-air diving. Neurology, Vol 55 pp 1743-5.

27856 Hutzelmann A, Tetzlaff K, Reuter M, Muller-Hulsbeck S, Heller M (2000). Does diving damage the brain? Acta Radiologica, Vol 41 pp 18-21.

27857

Germonpre P, Dendale P, Unger P, Balestra C (1998). Patent foramen ovale and decompression sickness in sports divers. Journal of Applied Physiology, 84(5) pp 1622-6.

27858

Knauth M, Ries S, Pohimann S, Kerby T, et al (1997). Cohort study of multiple brain lesions in sport divers: role of a patent foramen ovale. BMJ, Vol 314 pp 701-5.

27859 Yates PO; Broome JR, Pitkin AD; Knauth M, Ries S (1997). [LETTERS] Brain damage in divers. BMJ, Vol 314 pp 1761-2.

27860 Wilmshurst P (1997). Brain damage in divers. Diving itself may cause brain damage - but we need more evidence. BMJ, Vol 314 pp 689-90.

27861

Jungreis CA, Kanal E, Hirsch WL, Martinez AJ, Moossy J (1988). Normal perivascular spaces mimicking lacunar infarction: MR imaging. Radiology, Vol 169 pp 101-4.

27862

Staff RT, Gemmell HG, Duff PM, Sharp PF, et al (1996). Decompression illness in sports divers detected with Technetium-99m-HMPAO SPECT and texture analysis. Journal of Nuclear Medicine, Vol 37 pp 1154-8.

27863 Tournebise H, Boucand MH, Landi J, Theobald X (1995). Paraplegia and decompression sickness. Paraplegia, Vol 33 pp 636-9.

27891

Todnem K, Nyland H, Dick APK, Lind O, et al (1989). Immediate neurological effects of diving to a depth of 360 metres. Acta Neurologica Scandanavica, 80(4) pp 333-40.

27892 Peters BH, Levin HS, Kelly PJ (1977). Neurological and psychologic manifestations of decompression illness in divers. Neurology, 27(2) pp 125-7.

27893 Palmer AC, Calder IM, Yates PO (1992). Cerebral vasculopathy in divers. Neuropathology & Applied Neurobiology, Vol 18 pp 113-24.

of 53

28193

Mork SJ, Morild I, Brubakk AO, Eidsvik S, Nyland H (1994). A histopathologic and immunocytochemical study of the spinal cord in amateur and professional divers. Undersea & Hyperbaric Medicine, Vol 21(4) pp 391-402

28220 Edmonds C, Boughton J (1985). Intellectual deterioration with excessive diving (punch drunk divers). Undersea Biomedical Research, 12(3) pp 321-6.

28221

Todnem K, Nyland H, Riise T, Kambestad BK, et al (1990). Analysis of neurologic symptoms in deep diving: implications for selection of divers. Undersea Biomedical Research, 17(2) pp 95-107.

28235

Todnem K, Vaernes R (1993). Acute and chronic effects of deep diving on the nervous system (in Norwegian). Tidsskr Nor Laegeforen, 113(1) pp 36-9. [Abstract Only - in English]

28245

Murrison AW, Glasspool E, Pethybridge RJ, Francis TJR, Sedgwick EM (1994). Neurophysiological assessment of divers with medical histories of neurological decompression illness. Occupational & Environmental Medicine, Vol 51 pp 730-4.

28246

Isakov AP, Broome JR, Dutka AJ (1996). Acute carpal tunnel syndrome in a diver: evidence of peripheral nervous system involvement in decompression illness. Annals of Emergency Medicine, 28(1) pp 90-3.

28247 Fritz R (1987). Scuba diver's thigh or the bends? The Western Journal of Medicine, 146(3) pp 366-7.

28248

Todnem K, Nyland H, Kambestad BK, Aarli JA (1990). Influence of occupational diving upon the nervous system: an epidemiological study. British Journal of Industrial Medicine, Vol 47 pp 708-14.

28249

Yu YL, Chang CM, Lam TH, Ho KM, Mok KY (1990). Cervical spondylotic radiculopathy precipitated by decompression sickness. British Journal of Industrial Med, 47: 785-7.

28310

Ball R, Auker CR, Ford GC, Lawrence D (1998). Decompression sickness presenting as forearm swelling and peripheral neuropathy: a case report. Aviation Space & Environmental Medicine, 69(7) pp 690-2.

28311 Butler FK (1991). Decompression sickness presenting as optic neuropathy. Aviation Space & Environmental Medicine, 62(4) pp 346-50.

29493 Institute of Medicine (2002). Veterans and Agent Orange Update 2002, . National Academy Press, Washington, D.C.

29663

Lundberg I, Michelsen H, Nise G, Hogstedt C, et al (1995). Neuropsychiatric function of housepainters with previous long-term heavy exposure to organic solvents. Scand J Work Environ Health, 21(S 1) pp 1-44.

29664 Rebert CS, Hall TA (1994). The neuroepidemiology of styrene: a critical review of representative literature. Crit Rev Toxicol, 24 Suppl pp S57-106.

29681 Kelafant GA, Berg RA, Schleenbaker R (1994). Toxic encephalopathy due to 1,1,1-trichloroethane exposure. Am J Ind Med, 25(3) pp 439-46.

29723

Albers JW, Wald JJ, Garabrant DH, Trask CL, Berent S (2000). Neurologic evaluation of workers previously diagnosed with solvent-induced toxic encephalopathy. J Occup Environ Med, 42(4) pp 410-423.

29725

Baker EL (1994). A review of recent research on health effects of human occupational exposure to organic solvents. A critical review. J Occup Med, 36(10) pp 1079-92.

29726 Morton WE; Albers JW, et al (2002). [LETTERS] Solvent-induced toxic encephalopathy. J Occup Environ Med, 44(5) pp 393-5.

29740 Liss GM, House RA, Wills MC (1995). Toxic encephalopathy due to 1,1,1-trichloroethane exposure. Am J Ind Med, 27(3) pp 445-146.

29741

Broadwell DK, Darcey DJ, Hudnell HK, Otto DA, Boyes WK. Work-site clinical and neurobehavioral assessment of solvent-exposed microelectronics workers. Am J Ind Med, 27(5) pp 677-98.

29793

IARC Working Group (1995). IARC Monographs on the evaluation of carcinogenic risks to humans - dry cleaning, some chlorinated solvents and other industrial chemicals. IARC Monographs, Vol 63. IARC Press, Lyon.

of 53

29820

Smith LB, Bhattacharya A, et al (1997). Effect of chronic low-level exposure to jet fuel on postural balance of US Air Force personnel. Journal of Occupational and Environmental Medicine, 39(7) pp 623-32.

29858

Bleecker ML, Bolla KI, Agnew J, Schwartz BS, Ford DP (1991). Dose-related subclinical neurobehavioral effects of chronic exposure to low levels of organic solvents. American Journal of Industrial Medicine, 19(6): 715-728.

29859

Gregersen P, Angelso B, Nielsen TE, Norgaard B, Uldal C (1984). Neurotoxic effects of organic solvents in exposed workers: An occupational, neuropsychological, and neurological investigation. American Journal of Industrial Medicine, Vol 5 pp 201-225.

29869

Triebig GB A, Erbguth F, Holl R, Lang C, et al (1992). Neurotoxicity of solvent mixtures in spray painters, II. Neurologic, psychiatric, psychological, and neuroradiologic findings. International Archives of Occupational and Environmental Health, Vol 64 pp 361-372.

29871

Nasterlack M, Dietz MC, Frank KH, Hacke W, et al (1999). A multidisciplinary cross-sectional study on solvent-related health effects in painters compared with construction workers. International Archives of Occupation and Environmental Health, 72(4) pp 205-14.

29872

Baker EL, Letz RE, Eisen EA, Pothier LJ, et al (1988). Neurobehavioral effects of solvents in construction painters. Journal of Occupational Med, 30(2): 116-23.

29876 Graham DG; Mitran E (2000). [LETTERS] Critical analysis of Mitran, et al (1997). Environ Res, 82(2) pp 181-5.

29982

Gregersen P (1988). Neurotoxic effects of organic solvents in exposed workers: two controlled follow-up studies after 5.5 and 10.6 years. Am J Ind Med, 14(6) pp 681-701

29995

Juntunen J, Hernberg S, Eistola P, Hupli V (1980). Exposure to industrial solvents and brain atrophy. A retrospective study of pneumoencephalographic findings among 37 patients with exposure to industrial solvents. Eur Neurol, 19(6) pp 366-75.

30045

Triebig G, Claus D, Csuzda I, Druschky KF, et al (1988). Cross-sectional epidemiological study on neurotoxicity of solvents in paints and lacquers. Int Arch Occup Environ Health, 60(4) pp 233-41.

30047

Juntunen J, Hupli V, Hernberg S, Luisto M (1980). Neurological picture of organic solvent poisoning in industry. A retrospective clinical study of 37 patients. Int Arch Occup Environ Health, 46(3) pp 219-31.

30055

Integrated Risk Information System (EPA) (IRIS), a database of the National Library of Medicine's TOXNET system (http://toxnet.nlm.nih.gov) accessed on April 14, 2004 for - METHYL ETHYL KETONE.

30056

Integrated Risk Information System (EPA) (IRIS), a database of the National Library of Medicine's TOXNET system (http://toxnet.nlm.nih.gov) accessed on April 14, 2004 for - KEROSENE.

30057

Integrated Risk Information System (EPA) (IRIS), a database of the National Library of Medicine's TOXNET system (http://toxnet.nlm.nih.gov) accessed on April 14, 2004 for - ACETONE.

30058

Integrated Risk Information System (IRIS) (2004). National Library of Medicine's TOXNET system - trichloroethylene. . Retrieved 14 April 2004, from http://toxnet.nlm.nih.gov

30059

Integrated Risk Information System (EPA) (IRIS), a database of the National Library of Medicine's TOXNET system (http://toxnet.nlm.nih.gov) accessed on April 14, 2004 for - TRICHLOROETHANE.

30060

Integrated Risk Information System (EPA) (IRIS), a database of the National Library of Medicine's TOXNET system (http://toxnet.nlm.nih.gov) accessed on April 14, 2004 for - METHYL CHLORIDE.

of 53

30062

Integrated Risk Information System (EPA) (IRIS), a database of the National Library of Medicine's TOXNET system (http://toxnet.nlm.nih.gov) accessed on April 14, 2004 for - CARBON TETRACHLORIDE.

30063

Integrated Risk Information System (EPA) (IRIS), a database of the National Library of Medicine's TOXNET system (http://toxnet.nlm.nih.gov) accessed on April 14, 2004 for - GASOLINE.

30064

Integrated Risk Information System (EPA) (IRIS), a database of the National Library of Medicine's TOXNET system (http://toxnet.nlm.nih.gov) accessed on April 14, 2004 for - FUEL OIL NO.2.

30065

Integrated Risk Information System (EPA) (IRIS), a database of the National Library of Medicine's TOXNET system (http://toxnet.nlm.nih.gov) accessed on April 14, 2004 for - TOLUENE.

30067

Integrated Risk Information System (EPA) (IRIS), a database of the National Library of Medicine's TOXNET system (http://toxnet.nlm.nih.gov) accessed on April 14, 2004 for - BENZENE.

30101 Bleecker ML (2000). The role of quantitative neurological examination in clinical neurotoxicology. Neurol Clin, 18(3) pp 563-578.

30106 Tu RH, Mitchell CS, Kay GG, Risby TH (2004) Human exposure to the jet fuel, JP-8. Aviation Space & Environmental Medicine, 75(1) pp 49-59.

30179 White RD (1999). Refining and blending of aviation turbine fuels. Drug Chem Toxicol, 22(1) pp 143-153.

30339

Dick F, Semple S, Chen R, Seaton A (2000). Neurological deficits in solvent-exposed painters: a syndrome including impaired colour vision, cognitive defects, tremor and loss of vibration sensation. Quarterly Journal of Medicine, Vol 93 pp 655-661.

30396 Grasso P (1988). Neurotoxic and neurobehavioral effects of organic solvents on the nervous system. Occupational Medicine, 3(3): 525-39.

30726 Gobba F (2003). Occupational exposure to chemicals and sensory organs: a neglected research field. Neurotoxicology, 24(4-5) pp 675-91.

30728

Filley CM, Halliday W, Kleinschmidt-DeMasters BK (2004). The effects of toluene on the central nervous system. J Neuropathol Exp Neurol, 63(1) pp 1-12.

30772 Bardodej Z, Vyskocil J (1956). The problem of trichloroethylene in occupational medicine. AMA Arch Ind Health, Vol 56 pp 581-592.

31018

Ruijten MW, Hooisma J, Brons JT, Habets CE, Emmen HH, Muijser H (1994). Neurobehavioral effects of long-term exposure to xylene and mixed organic solvents in shipyard spray painters. Neurotoxicology, 15(3) pp 613-20.

31027 Institute of Medicine (IOM) (2003). Insecticides and solvents. Gulf war and health, Vol 2. National Academies Press - Washington, DC.

31402

Knave B, Olson BA, Elofsson S, Gamberale F, et al (1978). Long-term Exposure to Jet Fuel.II. A Cross-sectional Epidemiologic Investigation on Occupationally Exposed Industrial Workers With Special Reference to the Nervous System. Scan J Work Environ Health, Vol 4(1) pp 19-45.

31434

Ritchie GD, Still KR, Alexander WK, Nordholm AF, et al (2001). A review of the neurotoxicity risk of selected hydrocarbon fuels. Journal of Toxicology & Environmental Health Part B, 4(3) pp 223-312.

31436

Ritchie G, Still K, et al (2003). Biological and health effects of exposure to kerosene-based jet fuels & performance additives. Journal of Toxicology & Environmental Health, Part B., 6(4) pp 357-451

32010

Ku MC, Huang CC, Kuo HC, Yen TC, et al. Diffuse white matter lesions in carbon disulfide intoxication: microangiopathy or demyelination. Eur Neurol, 50(4) pp 220-224.

32017

Struwe G, Knave B, Mindus P (1983). Neuropsychiatric symptoms in workers occupationally exposed to jet fuel--a combined epidemiological and casuistic study. Acta Psychiatr Scand suppl, Vol 303 pp 55-67

of 53

32053 Lilis R, Stanescu D, Muica N, Roventa A (1969). Chronic effects of trichloroethylene exposure. Med Lav, 60(10) pp 595-601.

32092

Elofsson SA, Gamberale F, Hindmarsh T, Iregren A, (1980). Exposure to organic solvents. A cross-sectional epidemiologic investigation on occupationally exposed care and industrial spray painters with special reference to the nervous system. Scand J Work Environ Health, 6(4) pp 239-73

32170

Orbaek P, Risberg J, Rosen I, Haeger-Aronsen B, et al. Effects of long-term exposure to solvents in the paint industry. A cross-sectional epidemiologic study with clinical and laboratory methods. Scand J Work Environ Health, 11(S2) pp 1-28

32791

Department of Defence (2004). Study of Health Outcomes in Aircraft Maintenance Personnel. Volume 5. Report on the General Health and Medical Study. September 2004. Commonwealth of Australia.

32916 Neiman J, Haapaniemi HM, Hillbom M (2000). Neurological complications of drug abuse: pathophysiological mechanisms. Eur J Neurol, 7(6) pp 595-606.

33153 Bromberg MB (2000). Peripheral neurotoxic disorders. Neurol Clin, 18(3): 681-94.

33154 Sawyer RJ, Richmond MN, Hickey JD, Jarrratt JA (2000). Peripheral nerve injuries associated with anaesthesia. Anaesthesia, Vol 55 pp 980-991.

33155

Campbell AW, Thrasher JD, et al (2003). Neural autoantibodies and neurophysiologic abnormalities in patients exposed to molds in water-damaged buildings. Arch Environ Health, 58(8) pp 464-74.

33156 Hilton PJ (2001). [LETTER] Peripheral nerve injuries. Anaesthesia, 56(3) pp 289-90.

33157

Vital C, Vital A, Bouillot-Eimer S, Brechenmacher C, et al (2004). Amyloid neuropathy: a retrospective study of 35 peripheral nerve biopsies. Journal of the Peripheral Nervous System, Vol 9 pp 232-241.

33158

Sanchez-Porro Valades P, Posada de la Paz M, et alI (2003). Toxic oil syndrome: survival in the whole cohort between 1981 and 1995. J Clin Epidemiol, 56(7) pp 701-708.

33159 Shy ME, Garbern JY, Kamholz J (2002). Hereditary motor and sensory neuropathies: a biological perspective. Lancet Neurol, 1(2) pp 110-118.

33160 Peltier AC, Russell JW (2002). Recent advances in drug-induced neuropathies. Curr Opin Neurol, 15(5) pp 633-638.

33161 Rosenbaum R (2001). Neuromuscular complications of connective tissue diseases. Muscle Nerve, 24(2): 154-69.

33162

Murrison AW, Glasspool E, Pethybridge RJ, Francis TJ, Sedgwick EM (1994). Neurophysiological assessment of divers with medical histories of neurological decompression illness. Occup Environ Med, 51(11) pp 730-4.

33163

Bednarik J, Lukas Z, Vondracek P (2003). Critical illness polyneuromyopathy: the electrophysiological components of a complex entity. Intensive Care Med, 29(9) pp 1505-1514.

33164

Ammendola A, Tata MR, Aurilio C, Ciccone G, et al (2001). Peripheral neuropathy in chronic alcoholism: a retrospective cross-sectional study in 76 subjects. Alcoho & Alcoholism, 36(3): 271-5.

33165 Rivera-Zayas J, Arroyo M, Mejias E (2001). Evaluation of Persian Gulf veterans with symptoms of peripheral neuropathy. Mil Med, 166(5) pp 449-51.

33166 Rempel DM, Diao E (2004). Entrapment neuropathies: pathophysiology and pathogenesis. J Electromyogr Kinesiol, 14(1) pp 71-75.

33167 Ratnaike RN (2003). Acute and chronic arsenic toxicity. Postgrad Med J, 79(933) pp 391-396.

33168 Pollard JD (2002). Chronic inflammatory demyelinating polyradiculoneuropathy. Curr Opin Neurol, 15(3) pp 279-83.

33169

Magy L, Chassande B, Maisonobe T, Bouche P, et al (2003). Polyneuropathy associated with IgG/IgA monoclonal gammopathy: a clinical and electrophysiological study of 15 cases. Eur J Neurol, 10(6) pp 677-85.

of 53

33170

Omdal R, Loseth S, Torbergsen T, Koldingsnes W, et al (2001). Peripheral neuropathy in systemic lupus erythematosus--a longitudinal study. Acta Neurol Scand, 103(6) pp 386-91.

33171

Albers JW, Garabrant DH, Schweitzer SJ, Garrison RP, et al (2004). The effects of occupational exposure to chlorpyrifos on the peripheral nervous system: a prospective cohort study. Occup Environ Med, 61(3) pp 201-211.

33172

Bradberry SM, Watt BE, Proudfoot AT, Vale JA (2000). Mechanisms of toxicity, clinical features, and management of acute chlorophenoxy herbicide poisoning: a review. J Toxicol Clin Toxicol, 38(2) pp 111-22.

33173

Bovenzi M, Giannini F, Rossi S (2000). Vibration-induced multifocal neuropathy in forestry workers: electrophysiological findings in relation to vibration exposure and finger circulation. Int Arch Occup Environ Health, 73(8): 519-27.

33174

Delalande S, de Seze J, Fauchais AL, Hachulla E, et al (2004). Neurologic manifestations in primary Sjogren syndrome: a study of 82 patients. Medicine (Baltimore), 83(5) pp 280-291.

33175

Kim DH, Murovic JA, Tiel RL, Kline DG (2004). Penetrating injuries due to gunshot wounds involving the brachial plexus. Neurosurg Focus, 16(5) Article 3.

33176 Burnett MG, Zager EL (2004). Pathophysiology of peripheral nerve injury: a brief review. Neurosurg Focus, 16(5) Article 1.

33177 Burns TM, Shneker BF, Juel VC (2001). Gasoline sniffing multifocal neuropathy. Pediatr Neurol, 25(5) pp 419-421.

33178 Pengiran Tengah DSNA, Wills AJ, Holmes GKT (2002). Neurological complications of coeliac disease. Postgrad Med J, Vol 78 pp 393-398.

33179

Cherry N, Creed F, Silman A, Dunn G, et al (2001). Health and exposures of United Kingdom Gulf war veterans. Part I: The pattern and extent of ill health. Occup Environ Med, 58(5) pp 291-298.

33180

Cherry N, Creed F, Silman A, Dunn G, et al (2001). Health and exposures of United Kingdom Gulf war veterans. Part II: The relation of health to exposure. Occup Environ Med, 58(5) pp 299-306.

33181

Hughes PR (2001). Workshop Report - 79th ENMC International Workshop: multifocal motor neuropathy. 14-15 April 2000, Hilversum, The Netherlands. Neuromuscul Disord, 11(3) pp 309-14.

33182 Fung F, Clark RF (1999). Styrene-induced peripheral neuropathy. J Toxicol Clin Toxicol, 37(1) pp 91-97.

33183 Chan TY, Kwok TC (2001). Chronicity of neurological features in ciguatera fish poisoning. Human & Experimental Toxicology, 20(8) pp 426-428.

33184

Kovacs T, Aranyi Z, Szirmai I, Lantos PL (2002). Creutzfeldt-Jakob disease with amyotrophy and demyelinating polyneuropathy. Arch Neurol, 59(11) pp 1811-1814.

33185

Koike H, Mori K, Misu K, Hattori N,et al (2001). Painful alcoholic polyneuropathy with predominant small-fiber loss and normal thiamine status. Neurology, 56(12) pp 1727-32.

33186

Koike H, Iijima M, Sugiura M, Mori K, et al (2003). Alcoholic neuropathy is clinicopathologically distinct from thiamine-deficiency neuropathy. Ann Neurol, 54(1) pp 19-29.

33187

Kieseier BC, Kiefer R, Gold R, Hemmer B, et al (2004). Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system. Muscle Nerve, 30(2) pp 131-56.

33188 Lotti M (2002). Age-related sensitivity of the nervous system to neurotoxic insults. Toxicol Lett, 127(1-3) pp 183-187.

33189

Laaksonen S, Metsarinne K, Voipio-Pulkki LM, Falck B (2002). Neurophysiologic parameters and symptoms in chronic renal failure. Muscle Nerve, 25(6) pp 884-890.

33190 Kuwabara S (2004). Guillain-Barre syndrome: epidemiology, pathophysiology and management. Drugs, 64(6) pp 597-610.

of 53

33191 Kowalske K, Holavanahalli R, Helm P (2001). Neuropathy after burn injury. J Burn Care Rehabil, 22(5) pp 353-357.

33192

Westerman R, Hocking B (2004). Diseases of modern living: neurological changes associated with mobile phones and radiofrequency radiation in humans. Neurosci Lett, 361(1-3) pp 13-16.

33193

Butera R, Prockop LD, Buonocore M, Locatelli C, et al (2000) Mild ciguatera poisoning: Case reports with neurophysiological evaluations. Muscle Nerve, 23(10) pp 1598-603.

33194

De Martino L, Sampaolo S, Tucci C, et al (2003). Viral RNA in nerve tissues of patients with hepatitis C infection and peripheral neuropathy. Muscle Nerve, 27(1) pp 102-4.

33195

Lahrmann H, Albrecht G, Drlicek M, Oberndorfer S,et al (2001). Acquired neuromyotonia and peripheral neuropathy in a patient with Hodgkin's disease. Muscle Nerve, 24(6) pp 834-8.

33196 Willison HJ, Yuki N (2002). Peripheral neuropathies and anti-glycolipid antibodies. Brain, 125(Pt 12): 2591-625.

33197

Lawlor MW, Richards MP, Fisher MA, Stubbs EB Jr (2001). Sensory nerve conduction deficit in experimental monoclonal gammopathy of undetermined significance (MGUS) neuropathy. Muscle Nerve, 24(6) pp 809-16.

33198 Ahn TB, Cho JW, Jeon BS (2004). Unusual neurological presentations of vitamin B(12) deficiency. Eur J Neurol, 11(5) pp 339-41.

33199

Aichenbaum SR, Ring H (2003). Rehabilitation of a patient with critical illness polyneuropathy (CIP) following acute respiratory failure: a case report and review of literature. Disabil Rehabil, 25(6) pp 273-6.

33200

Albers JW, Garabrant DH, Schweitzer S, Garrison RP, et al (2004). Absence of sensory neuropathy among workers with occupational exposure to chlorpyrifos. Muscle Nerve, 29(5) pp 677-686.

33204 Albers JW, Fink JK (2004). Porphyric neuropathy. Muscle Nerve, 30(4) pp 410-422.

33205 Al-Shekhlee A, Katirji B (2003). Spinal accessory neuropathy, droopy shoulder, and thoracic outlet syndrome. Muscle Nerve, 28(3) pp 383-5.

33206

Boonyapisit K, Katirji B (2002). Severe exacerbation of hepatitis C-associated vasculitic neuropathy following treatment with interferon alpha: a case report and literature review. Muscle Nerve, 25(6) pp 909-13.

33207 Brew BJ (2003). The peripheral nerve complications of human immunodeficiency virus (HIV) infection. Muscle Nerve, 28(5) pp 542-52.

33208 Visovsky C (2003). Chemotherapy-induced peripheral neuropathy. Cancer Invest, 21(3) pp 439-51.

33209

Verstappen CC, Heimans JJ, Hoekman K, Postma TJ (2003). Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management. Drugs, 63(15) pp 1549-1563.

33210

Susuki K, Odaka M, Mori M, Hirata K, Yuki N (2004). Acute motor axonal neuropathy after Mycoplasma infection: Evidence of molecular mimicry. Neurology, 62(6) pp 949-56.

33211 Strauss MB, Borer RC Jr (2001). Diving medicine: contemporary topics and their controversies. Am J Emerg Med, 19(3) pp 232-238.

33212

Susuki K, Odaka M, Mori M, Hirata K and Yuki N (2004). Acute motor axonal neuropathy after mycoplasma infection: evidence of molecular mimicry. Neurology, Vol 62 pp 949-956.

33213 Todd M, Shah GV, Mukherji SK (2004). MR Imaging of brachial plexus. Top Magn Reson Imaging, 15(2) pp 113-25.

33214 Storstein A, Vedeler C (2001). Neuropathy and malignancy: a retrospective survey. J Neurol, 248(4) pp 322-327.

33215 Donaghy M (2004). Genes for peripheral neuropathy and their relevance to clinical practice. J Neurol Neurosurg Psychiatry, 75(10) pp 1371-1372.

of 53

33216 Solomon T, Willison H (2003). Infectious causes of acute flaccid paralysis. Curr Opin Infect Dis, 16(5) pp 375-81.

33217

Stamboulis E, Vlachou N, Drossou-Servou M, Tsaftaridis P, et al (2004). Axonal sensorimotor neuropathy in patients with beta-thalassaemia. J Neurol Neurosurg Psychiatry, 75(10) pp 1483-1486.

33218 Sima AA (2003). New insights into the metabolic and molecular basis for diabetic neuropathy. Cell Mol Life Sci, 60(11) pp 2445-2464.

33219

Wada M, Kurita K, Tajima K, Kawanami T, Kato T (2003). A case of inflammatory demyelinating polyradiculoneuropathy associated with T-cell lymphoma. Acta Neurol Scand, 107(1) pp 62-6.

33220 Willison HJ, Winer JB (2003). Clinical evaluation and investigation of neuropathy. J Neurol Neurosurg Psychiatry, 74 Suppl 2:ii3-ii8.

33224 Winer JB (2001). Guillain Barre syndrome. Mol Pathol, 54(6) pp 381-5.

33225

Zafrir B, Zimmerman M, Fellig Y, Naparstek Y,et al (2004). Small fiber neuropathy due to isolated vasculitis of the peripheral nervous system. Isr Med Assoc J, 6(3) pp 183-184.

33251 Peter JV, Cherian AM (2000). Organic insecticides. Anaesth Intensive Care, 28(1) pp 11-21.

33253 Crawford C; Rajkumar SV, et al (2002). [LETTERS] Thalidomide-induced neuropathy. Mayo Clin Proc, 77(12) pp 1395.

33254 Childs SG (2003). Double crush syndrome. Orthop Nurs, 22(2) pp 117-23.

33255

Chuang HY, Schwartz J, Tsai SY, Lee ML, et al (2000). Vibration perception thresholds in workers with long term exposure to lead. Occup Environ Med, 57(9) pp 588-94.

33256

Coppini DV, Wellmer A, Weng C, Young PJ, et al (2001). The natural history of diabetic peripheral neuropathy determined by a 12 year prospective study using vibration perception thresholds. J Clin Neurosci, 8(6) pp 520-4.

33257 Corallo CE, Paull AE (2002). [LETTER] Linezolid-induced neuropathy. Med J Aust, 177(6) pp 332.

33258 Corbo M, Balmaceda C (2001). Peripheral neuropathy in cancer patients. Cancer Invest, 19(4) pp 369-382.

33259 Costa J, Resende C, de Carvalho M (2003). Motor-axonal polyneuropathy associated with hepatitis C virus. Eur J Neurol, 10(2) pp 183-5.

33260 Katirji B, Preston DC (2003). Vibration-induced median neuropathy. Neurology, 61(7) pp 1011.

33261

Chaudhry V, Chaudhry M, Crawford TO, Simmons-O'Brien E, Griffin JW (2003). Toxic neuropathy in patients with pre-existing neuropathy. Neurology, 60(2) pp 337-40.

33262

Cavaletti G, Beronio A, Reni L, Ghiglione E, et al (2004). Thalidomide sensory neurotoxicity: a clinical and neurophysiologic study. Neurology, 62(12) pp 2291-3.

33263 Apfel SC, Zochodne W (2004). Thalidomide neuropathy: too much or too long? Neurology, 62(12) pp 2158-9.

33264 Chaudhry V, Escolar DM, Cornblath DR ( 2002). Worsening of multifocal motor neuropathy during pregnancy. Neurology, 59(1) pp 139-41.

33265 Chin RL, Sander HW, Brannagan TH, Green PH, et al (2003). Celiac neuropathy. Neurology, 60(10) pp 1581-5.

33266 Cross AH, Golumbek PT (2003). Neurologic manifestations of celiac disease: proven, or just a gut feeling? Neurology, 60(10) pp 1566-8.

33267 Cordes P, Keil R, Bartsch T, Tetzlaff K, et al (2000). Neurologic outcome of controlled compressed-air diving. Neurology, 55(11) pp 1743-5.

33268 Kishi Y, Sasaki H, Yamasaki H, Ogawa K, et al (2001). An epidemic of arsenic neuropathy from a spiked curry. Neurology, 56(10) pp 1417-8.

33269 Sander HW, Latov N (2003). Research criteria for defining patients with CIDP. Neurology, 60(8S3) pp S8-15.

of 53

33270 Koike H, Misu K, Hattori N, Ito S,et al (2001). Postgastrectomy polyneuropathy with thiamine deficiency. J Neurol Neurosurg Psychiatry, 71(3) pp 357-62.

33271 Manji H, Miller R. (2004). The neurology of HIV infection. J Neurol Neurosurg Psychiatry, 75(S1) pp i29-35.

33272 Moretto A, Lotti M (1998). Poisoning by organophosphorus insecticides and sensory neuropathy. J Neurol Neurosurg Psychiatry, 64(4) pp 463-8.

33273

Mori K, Iijima M, Sugiura M, Koike H, et al (2003). Sjogren's syndrome associated painful sensory neuropathy without sensory ataxia. J Neurol Neurosurg Psychiatry, 74(9) pp 1320-1322.

33274

Rubens O, Logina I, Kravale I, Eglite M, Donaghy M (2001). Peripheral neuropathy in chronic occupational inorganic lead exposure: a clinical and electrophysiological study. J Neurol Neurosurg Psychiatry, 71(2) pp 200-4.

33275

Ishibashi S, Yokota T, Shiojiri T, Matunaga T, et al (2003). Reversible acute axonal polyneuropathy associated with Wernicke-Korsakoff syndrome: impaired physiological nerve conduction due to thiamine deficiency? J Neurol Neurosurg Psychiatry, 74(5) pp 674-6.

33276 Kieseier BC, Dalakas MC, Hartung HP (2002). Immune mechanisms in chronic inflammatory demyelinating neuropathy. Neurology, 59(12S6) pp S7-12.

33277

Klein CJ, Dyck PJ, Friedenberg SM, Burns TM, et al (2002). Inflammation and neuropathic attacks in hereditary brachial plexus neuropathy. J Neurol Neurosurg Psychiatry, 73(1) pp 45-50.

33278 Chaudhry V, Cornblath DR, Corse A, et al (2002). Thalidomide-induced neuropathy. Neurology, 59(12) pp 1872-5.

33279

Carmichael J, Conron M, Beynon H, Crow J, Warner TT (2000). [Letter] Churg-Strauss syndrome presenting with visual loss. Rheumatology (Oxford), 39(12) pp 1433-4.

33280 Carulli MT, Davies UM (2002). [letter] Peripheral neuropathy: an unwanted effect of leflunomide? Rheumatology (Oxford), 41(8) pp 952-3.

33281 Bonnel RA, Graham DJ (2004). Peripheral neuropathy in patients treated with leflunomide. Clin Pharmacol Ther, 75(6) pp 580-5.

33282 Griffin MR, Stein CM, Ray WA (2004). Postmarketing surveillance for drug safety: surely we can do better. Clin Pharmacol & Ther, 75(6) pp 491-4.

33283

Bostock H, Walters RJ, Andersen KV, Murray NM,et al (2004). Has potassium been prematurely discarded as a contributing factor to the development of uraemic neuropathy? Nephrol Dial Transplant, 19(5) pp 1054-7.

33284 Brust JC (2002). Neurologic complications of substance abuse. J Acquir Immune Defic Syndr, 31(S2) pp S29-34.

33285

Buchanan D, Jamal GA, Pilkington A, Hansen S (2002). Clinical validation of methods of diagnosis of neuropathy in a field study of United Kingdom sheep dippers. Occup Environ Med, 59(7) pp 442-446.

33286

Busby M, Donaghy M (2003). Chronic dysimmune neuropathy. A subclassification based upon the clinical features of 102 patients. J Neurol, 250(6) pp 714-24.

33287

Camdessanche JP, Antoine JC, Honnorat J, Vial C, et al (2002). Paraneoplastic peripheral neuropathy associated with anti-Hu antibodies: A clinical and electrophysiological study of 20 patients. Brain, 125(Pt 1) pp 166-75.

33288 Honig J; Cardosi RJ, et al (2002). [LETTERS] Postoperative neuropathies after major pelvic surgery. Obstet Gynecol, 100(5 Pt 1) pp 1041-2.

33289

Au WY, Tsang J, Cheng TS, Chow WS, et al (2003). Cough mixture abuse as a novel cause of megaloblastic anaemia and peripheral neuropathy. Br J Haematol, 123(5) pp 956-8.

33290 Allanore Y, Zuber M, Kahan A (2002). Brachial plexopathy associated with systemic sclerosis. Clin Rheumatol, 21(5) pp 401-402.

of 53

33291

Altaha R, Abraham J (2003). Paraneoplastic neurologic syndrome associated with occult breast cancer: a case report and review of literature. Breast J, 9(5) pp 417-9.

33292

Bastuji-Garin S, Ochonisky S, Bouche P, Gherardi RK, et al (2002). Incidence and risk factors for thalidomide neuropathy: a prospective study of 135 dermatologic patients. J Invest Dermatol, 119(5) pp 1020-6.

33293 Beck MA, Levander OA, Handy J (2003). Selenium deficiency and viral infection. J Nutr, 133(5S1) pp 1463S-7S.

33294

Bernit E, Pouget J, Janbon F, Dutronc H, et al (2002). Neurological involvement in acute Q fever: a report of 29 cases and review of the literature. Arch Intern Med, 162(6) pp 693-700.

33295 Bharadwaj A, Haroon N (2004). [LETTER] Peripheral neuropathy in patients on leflunomide. Rheumatology (Oxford), 43(7) pp 934.

33296 Bogucki A et al; Chang AP, et al (1999). [LETTERS] Focal conduction block in n-hexane polyneuropathy. Muscle Nerve, 22(3) pp 425-6.

33297

Kuntzer T, Antoine JC, Steck AJ (2004). Clinical features and pathophysiological basis of sensory neuronopathies (ganglionopathies). Muscle & Nerve, 30(3) pp 255-68.

33298

McDougall AJ, Davies L, McCaughan GW (2003). Autonomic and peripheral neuropathy in endstage liver disease and following liver transplantation. Muscle & Nerve, 28(5) pp 595-600.

33299 Ooi WW, Srinivasan J (2004). Leprosy and the peripheral nervous system: basic and clinical aspects. Muscle & Nerve, 30(4) pp 393-409.

33300 Pastore C, Izura V, Marhuenda D, Prieto MJ,et al (2002). Partial conduction blocks in N-hexane neuropathy. Muscle & Nerve, 26(1) pp 132-5.

33301 Rajabally YA, Varakantam V, Abbott RJ (2004). Disorder resembling Guillain-Barre syndrome on initiation of statin therapy. Muscle Nerve, 30(5) pp 663-6.

33302 Reinhardt F, Wetzel T, Vetten S, Radespiel-Troger M, et al (2000). Peripheral neuropathy in chronic venous insufficiency. Muscle Nerve. 23(6) pp 883-7.

33303 Russell JW, Feldman EL (2001). Impaired glucose tolerance--does it cause neuropathy? Muscle Nerve, 24(9) pp 1109-12.

33304 Singleton JR, Smith AG, Bromberg MB (2001). Painful sensory polyneuropathy associated with impaired glucose tolerance. Muscle Nerve, 24(9) pp 1225-8.

33305 Ang CW, Jacobs BC, Laman JD (2004). The Guillain-Barre syndrome: a true case of molecular mimicry. Trends Immunol, 25(2) pp 61-66.

33306

Aramideh M, Koopmans RP, Koelman JH, Stam J (2001). [LETTER] Rapidly progressing peripheral neuropathy with lactic acidosis and coproporphyria in a patient with HTLV-I associated T-cell leukaemia treated with zidovudine. J Neurol, 248(7) pp 621-2.

33307 Hund E (2001). Neurological complications of sepsis: critical illness polyneuropathy and myopathy. J Neurol, 248(11) pp 929-34.

33308 Ghaus N, Bohlega S, Rezeig M (2001). Neurological complications in liver transplantation. J Neurol, 248(12) pp 1042-8.

33309 Jardim MR, Antunes SL, Santos AR, Nascimento OJ, et al (2003). Criteria for diagnosis of pure neural leprosy. J Neurol, 250(7) pp 806-9.

33310

Karppa M, Syrjala P, Tolonen U, Majamaa K (2003). Peripheral neuropathy in patients with the 3243A>G mutation in mitochondrial DNA. J Neurol, 250(2) pp 216-21.

33311

Krarup C, Crone C (2002). Neurophysiological studies in malignant disease with particular reference to involvement of peripheral nerves. J Neurol, 249(6) pp 651-61.

33312

Kuhlenbaumer G, Young P, Hunermund G, Ringelstein B, Stogbauer F (2002). Clinical features and molecular genetics of hereditary peripheral neuropathies. J Neurol, 249(12) pp 1629-50.

of 53

33313

Leite AC, Silva MT, Alamy AH, Afonso CR, et al (2004). Peripheral neuropathy in HTLV-I infected individuals without tropical spastic paraparesis/HTLV-I-associated myelopathy. J Neurol, 251(7) pp 877-81.

33314 Kaufman M (1995). [LETTER] Triglycerides and neuropathy. Neurology, 45(11) pp 2119.

33315 McManis P, Windebank AJ (1995). [LETTER] Reply from the Author: Triglycerides and Neuropathy. Neurologia, 45(11): 2119-20.

33322 Liu S, Hayden GF (2002). Maladies in musicians. South Med J, 95(7) pp 727-34.

33323

Lopez OL, Becker JT, Dew MA, Caldararo R (2004). Risk modifiers for peripheral sensory neuropathy in HIV infection/AIDS. Eur J Neurol, 11(2) pp 97-102.

33324 Lotti M (2002). Low-level exposures to organophosphorus esters and peripheral nerve function. Muscle Nerve, 25(4) pp 492-504.

33325 Low PA (2002). Autonomic neuropathies. Curr Opin Neurol, 15(5) pp 605-9.

33326

Lucchini R, Calza S, Camerino D, Carta P, et al (2003). Application of a latent variable model for a multicenter study on early effects due to mercury exposure. Neurotoxicology, 24(4-5) pp 605-16.

33327 Mutti A; Lucchini R (2004). [LETTERS] Effects of low-level exposure to inorganic Mercury. Neurotoxicology, 25(4) pp 733-736.

33328

Luostarinen L, Himanen SL, Luostarinen M, Collin P, Pirttila T (2003). Neuromuscular and sensory disturbances in patients with well treated coeliac disease. J Neurol Neurosurg Psychiatry, 74(4) pp 490-4.

33329

Mawrin C, Brunn A, Rocken C, Schroder JM (2003). Peripheral neuropathy in systemic lupus erythematosus: pathomorphological features and distribution pattern of matrix metalloproteinases. Acta Neuropathol (Berl), 105(4) pp 365-72.

33330

McDougall AJ, Davies L, McCaughan GW (2002). Rapid improvement of autonomic and peripheral neuropathy after liver transplantation: a single case report. Liver Transpl, 8(2) pp 164-6.

33331

Leonard GD, Wagner MR, Quinn MG, Grem JL (2004). Severe disabling sensory-motor polyneuropathy during oxaliplatin-based chemotherapy. Anti-Cancer Drugs, 15(7) pp 733-5.

33332 Lacomis D (2002). Small fiber neuropathy. Muscle and Nerve, 26(2) pp 173-188.

33333

Laaksonen S, Voipio-Pulkki L, Erkinjuntti M, Asola M, Falck B (2000). Does dialysis therapy improve autonomic and peripheral nervous system abnormalities in chronic uraemia? J Intern Med, 248(1) pp 21-6.

33334

Lago PM, Guzman MG, Sarmiento L, Perez AB, et al (2001). Mechanism of enterovirus involvement in epidemic neuropathy: hypothesis regarding pathophysiology. Med Hypotheses, 56(3) pp 339-47.

33335 Kleopa KA, Scherer SS (2002). Inherited neuropathies. Neurol Clin, 20(3) pp 679-709.

33336 Rosch PJ; Kashyap AS, et al; England JD et al (2004). [LETTERS] Peripheral neuropathy. Lancet, 364(9446) pp 1663-5.

33337 Katirji B (2002). Electrodiagnostic approach to the patient with suspected mononeuropathy of the lower extremity. Neurol Clin, 20(2) pp 479-501.

33338

Katsimihas M, Hutchinson J, Heath P, Smith E, Travlos J (2002). Delayed transient sciatic nerve palsy after total hip arthroplasty. J Arthroplasty, 17(3) pp 379-81.

33339 Keswani SC, Pardo CA, Cherry CL, Hoke A, McArthur JC (2002). HIV-associated sensory neuropathies. AIDS, 16(16) pp 2105-17.

33340

Kindstrand E, Nilsson BY, Hovmark A, Pirskanen R, Asbrink E (2002). Peripheral neuropathy in acrodermatitis chronica atrophicans - effect of treatment. Acta Neurol Scand, 106(5) pp 253-57.

of 53

33341 Klein CM, Vernino S, Lennon VA, Sandroni P, et al (2003). The spectrum of autoimmune autonomic neuropathies. Ann Neurol, 53(6) pp 752-758.

33342 Klemmer PJ, Harris AA (2000). Carbon disulfide nephropathy. Am J Kidney Dis, 36(3) pp 626-9.

33343 Dueker CW; Baskett P; Varon J, et al (2004). [Comments] Diving emergencies. Resuscitation, 61(2): 239-40. Comments on ID: 41352.

33344

Fletcher SN, Kennedy DD, Ghosh IR, et al (2003). Persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness. Crit Care Med, 31(4) pp 1012-6.

33345 Ferrante MA, Wilbourn AJ (2002). Electrodiagnostic approach to the patient with suspected brachial plexopathy. Neurol Clin, 20(2) pp 423-50.

33346 England JD, Asbury AK (2004). Peripheral neuropathy. Lancet, Vol 363 pp 2151-61.

33347 El-Sabrout RA, Radovancevic B, Ankoma-Sey V et al (2001). Guillain-Barre syndrome after solid organ transplantation. Transplantation, 71(9): 1311-6.

33348

Elesber AA, Kent PD, Jennings CA (2001). Compressive neuropathy of the brachial plexus and long thoracic nerve: a rare complication of heparin anticoagulation. Chest, 120(1) pp 309-11.

33349

Gaist D, Garcia Rodriguez LA, Huerta C, Hallas J, Sindrup SH (2001). Are users of lipid-lowering drugs at increased risk of peripheral neuropathy? Eur J Clin Pharmacol, 56(12) pp 931-3.

33350

Frumkin H, Letz R, Williams PL, Gerr F, et al (2001). Health effects of long-term mercury exposure among chloralkali plant workers. Am J Ind Med, 39(1) pp 1-18.

33351

Miller RF, Bunting S, Sadiq ST, Manji H (2002). Peripheral neuropathy in patients with HIV infection: consider dual pathology. Sex Transm Infect, 78(6) pp 462-3.

33352

Dimopoulos MA, Eleutherakis-Papaiakovou V (2004). Adverse effects of thalidomide administration in patients with neoplastic diseases. Am J Med, 117(7): 508-15.

33353 Diagos P, Bos JA, Verrips A, Booij LH (2003). Giant axonal neuropathy and anaesthesia. Anaesthesia, 58(7) pp 723-4.

33354

Gerard A, Sarrot-Reynauld F, Liozon E, Cathebras P, et al (2002). Neurologic presentation of Whipple disease: report of 12 cases and review of the literature. Medicine (Baltimore), 81(6) pp 443-57.

33355

Gomes C, L'heveder G, Vandhuick O, Mabin D, Saraux A (2003). A case of cutaneous sensory neuropathy associated with Churg-Strauss syndrome. Joint Bone Spine, 70(1) pp 73-6.

33356 Goswami R, Bhatia M, Goyal R et al (2002). Reversible peripheral neuropathy in idiopathic hypoparathyroidism. Acta Neurol Scand, 105(2): 128-31.

33357 Greco F, Pavone P, Falsaperla R, Sorge G (2004). Peripheral neuropathy as first sign of ulcerative colitis in a child. J Clin Gastroenterol, 38(2) pp 115-17.

33358 Hall AH (2002). Chronic arsenic poisoning. Toxicol Lett, 128(1-3) pp 69-72.

33359 Heiser P, et al (2004). [LETTER] Neuropathy due to hypovitaminosis following excessive weight loss. J Am Acad Child Adolesc Psychiatry, 43(8) pp 928-9.

33360

Hoitsma E, Drent M, Verstraete E, Faber CG, et al (2003). Abnormal warm and cold sensation thresholds suggestive of small-fibre neuropathy in sarcoidosis. Clin Neurophysiol, 114(12) pp 2326-33.

33361

Horowitz SH, Stark A, Marshall E, Mauer MP (1999). A multi-modality assessment of peripheral nerve function in organophosphate-pesticide applicators. J Occup Environ Med, 41(5) pp 405-8.

33362 Hug U, Burg D, Baldi SV, Meyer VE (2004). Compression neuropathy of the radial palmar thumb nerve. Chir Main, 23(1) pp 49-51.

33363 Hughes R (2004). Campylobacter jejuni in Guillain-Barre syndrome. Lancet Neurol, 3(11) pp 644.

33364 Hughes R (2002). Peripheral neuropathy. BMJ, Vol 324 pp 466-69.

of 53

33365

Hughes RA, Umapathi T, Gray IA, Gregson NA, et al (2004). A controlled investigation of the cause of chronic idiopathic axonal polyneuropathy. Brain, 127(Pt 8) pp 1723-30.

33366

Hund E, Genzwurker H, Bohrer H, Jakob H,et al (1997). Predominant involvement of motor fibres in patients with critical illness polyneuropathy. Br J Anaesth, 78(3) pp 274-8.

33367

Ichihara G, Li W, Shibata E, Ding X, et al (2004). Neurologic abnormalities in workers of a 1-bromopropane factory. Environ Health Perspect, 112(13) pp 1319-25.

33368

Jamal GA, Hansen S, Julu PO (2002). Low level exposures to organophosphorus esters may cause neurotoxicity. Toxicology, Vol 181-182 pp 23-33.

33369

Jamal GA, Hansen S, Pilkington A, Buchanan D, et al (2002). A clinical neurological, neurophysiological, and neuropsychological study of sheep farmers and dippers exposed to organophosphate pesticides. Occup Environ Med, 59(7) pp 434-41.

33370 Jeppesen U, Gaist D, Smith T, Sindrup SH (1999). Statins and peripheral neuropathy. Eur J Clin Pharmacol, 54(11) pp 835-8.

33371 Kamanyire R, Karalliedde L (2004). Organophosphate toxicity and occupational exposure. Occup Med (Lond), 54(2) pp 69-75.

33372

Jankowski CJ, Keegan MT, Bolton CF, Harrison BA.(2003). Neuropathy following axillary brachial plexus block: is it the tourniquet? Anesthesiology, 99(5) pp 1230-2. Erratum: (2004) Anesthesiology, 100(2) pp 468.

33393 Vinik AI, Mehrabyan A (2004). Diabetic neuropathies. Med Clin North Am. 88(4) pp 947-99.

33394

Wax PM, Thornton CA (2000). Recovery from severe arsenic-induced peripheral neuropathy with 2,3-dimercapto-1-propanesulphonic acid. J Toxicol Clin Toxicol, 38(7) pp 777-80.

33395 Tsang RS (2002). The relationship of Campylobacter jejuni infection and the development of Guillain-Barre syndrome. Curr Opin Infect Dis, 15(3) pp 221-8.

33396 van Mook WN, Hulsewe-Evers RP (2002). Critical illness polyneuropathy. Curr Opin Crit Care, 8(4) pp 302-10.

33397 Siva A (2001). Vasculitis of the nervous system. J Neurol, 248(6) pp 451-68.

33398

Stokes L, Letz R, Gerr F, Kolczak M, et al (1998). Neurotoxicity in young adults 20 years after childhood exposure to lead: the Bunker Hill experience. Occup Environ Med, 55(8) pp 507-16.

33399

Tassler PL, Schwartz BS, Coresh J, Stewart WF, Todd AC (2001) Associations of tibia lead, DMSA-chelatable lead, and blood lead with measures of peripheral nervous system function in former organolead manufacturing workers. Am J Ind Med, 39(3) pp 254-61.

33400

Simpson DM, Haidich AB, Schifitto G, et al (2002). Severity of HIV-associated neuropathy is associated with plasma HIV-1 RNA levels. AIDS, 16(3) pp 407-412.

33401

Sharma AN, Nelson LS, Hoffman RS (2004). Cerebrospinal fluid analysis in fatal thallium poisoning: evidence for delayed distribution into the central nervous system. Am J Forensic Med Pathol, 25(2) pp 156-8.

33402

Sharma KR, Cross J, Santiago F, Ayyar DR, Burke G 3rd. (2002). Incidence of acute femoral neuropathy following renal transplantation. Arch Neurol, 59(4) pp 541-5.

33403

Saiz Hervas E, Martin Llorens M, Lopez Alvarez J (2000). [LETTER] Peripheral neuropathy as the first manifestation of Madelung's disease. Br J Dermatol, 143(3) pp 684-6.

33404

Said G, Lacroix C, Plante-Bordeneuve V, Le Page L, et al (2002). Nerve granulomas and vasculitis in sarcoid peripheral neuropathy: a clinicopathological study of 11 patients. Brain, 125(Pt 2) pp 264-75.

of 53

33405

Saif MW, Wilson RH, Harold N, Keith B, et al (2001). Peripheral neuropathy associated with weekly oral 5-fluorouracil, leucovorin and eniluracil. Anticancer Drugs, 12(6) pp 525-31.

33406 Wein TH, Albers JW (2002). Electrodiagnostic approach to the patient with suspected peripheral polyneuropathy. Neurol Clin, 20(2) pp 503-26.

33407

Ryan MM, Tilton A, De Girolami U, Darras BT, Jones HR Jr (2003). Paediatric mononeuritis multiplex: a report of three cases and review of the literature. Neuromuscul Disord, 13(9) pp 751-56.

33408

Rubin DI, Schomberg PJ, Shepherd RF, Panneton JM (2001). Arteritis and brachial plexus neuropathy as delayed complications of radiation therapy. Mayo Clin Proc, 76(8) pp 849-52.

33409 Rusyniak DE, Furbee RB, Kirk MA (2002). Thallium and arsenic poisoning in a small midwestern town. Ann Emerg Med, 39(3) pp 307-11.

33410 Roy MJ, May EF, Jabbari B (2002). Life-threatening polyneuropathy heralding renal cell carcinoma. Mil Med, 167(12) pp 986-9.

33411 Richardson JK (2002). The clinical identification of peripheral neuropathy among older persons. Arch Phys Med Rehabil, 83(11) pp 1553-8.

33412 Ring D, Chin K, Jupiter JB (2004). Radial nerve palsy associated with high-energy humeral shaft fractures. J Hand Surg [Am], 29(1) pp 144-7.

33413 Quasthoff S, Hartung HP (2002). Chemotherapy-induced peripheral neuropathy. J Neurol, 249(1) pp 9-17.

33414

Prielipp RC, Morell RC, Butterworth J (2002). Ulnar nerve injury and perioperative arm positioning. Anesthesiol Clin North America, 20(3) pp 589-603.

33415

Rawal A, Ratnam KR, Yin Q, Sinopidis C, Frostick SP (2004). Compression neuropathy of common peroneal nerve caused by an extraneural ganglion: a report of two cases. Microsurgery, 24(1) pp 63-6.

33416

Rehn B, Nilsson T, Jarvholm B (2004). Neuromusculoskeletal disorders in the neck and upper extremities among drivers of all-terrain vehicles--a case series. BMC Musculoskelet Disord, 13(5) pp 1.

33417

Rezaiguia-Delclaux S, Lefaucheur JP, Zakkouri M, Duvoux C, et al (2002). Severe acute polyneuropathy complicating orthotopic liver allograft failure. Transplantation, 74(6) pp 880-2.

33418 Poncelet AN (2003). Diabetic polyneuropathy. Risk factors, patterns of presentation, diagnosis, and treatment. Geriatrics, 58(6) pp 16-8, 24-5, 30.

33419

Pilkington A, Buchanan D, Jamal GA, Gillham R, et al (2001). An epidemiological study of the relations between exposure to organophosphate pesticides and indices of chronic peripheral neuropathy and neuropsychological abnormalities in sheep farmers and dippers. Occup Environ Med, 58(11) pp 702-10.

33420 Plotkin SR, Wen PY (2003). Neurologic complications of cancer therapy. Neurol Clin, 21(1) pp 279-318.

33424

Pego-Reigosa R, Branas-Fernandez F, Garcia-Porrua C, Gonzalez-Gay MA (2003). [LETTER] Sciatic nerve palsy as presenting sign of a perianal abscess. Joint Bone Spine, 70(1) pp 85-6.

33425 Palmer CA (2002). Neurologic manifestations of renal disease. Neurol Clin, 20(1) pp 23-34.

33426

Page EH, Pajeau AK, Arnold TC, Fincher AR, Goddard MJ (2001). Peripheral neuropathy in workers exposed to nitromethane. Am J Ind Med, 40(1) pp 107-13.

33427

Niewiadomska M, Kulczycki J, Wochnik-Dyjas D, Szpak GM, et al (2002). Impairment of the peripheral nervous system in Creutzfeldt-Jakob disease. Arch Neurol, 59(9) pp 1430-6.

33428

Nilsson T (2002). Neurological diagnosis: aspects of bedside and electrodiagnostic examinations in relation to hand-arm vibration syndrome. Int Arch Occup Environ Health, 75(1-2) pp 55-67.

of 53

33429 Nobile-Orazio E, Carpo M (2001). Neuropathy and monoclonal gammopathy. Curr Opin Neurol, 14(5) pp 615-20.

33430 Nobile-Orazio E (2001). Multifocal motor neuropathy. J Neuroimmunol, 115(1-2) pp 4-18.

33431 Melli G, Chaudhry V, Dorman T, Cornblath DR (2002). Perioperative bilateral median neuropathy. Anesthesiology, 97(6) pp 1632-4.

33432

Milanov I, Kolev P (2001). Clinical and electromyographic examinations of patients with tremor after chronic occupational lead exposure. Occup Med (Lond), 51(3) pp 157-62.

33433

Miranda J, McConnell R, Wesseling C, Cuadra R, et al (2004). Muscular strength and vibration thresholds during two years after acute poisoning with organophosphate insecticides.Occup Environ Med, 61(1) pp e4.

33434

Moshe S, Bitchatchi E, Goshen J, Attias J (2002). Neuropathy in an artist exposed to organic solvents in paints: a case study. Arch Environ Health, 57(2) pp 127-9.

33435

Murrison AW, Glasspool E, Pethybridge RJ, Francis TJ, Sedgwick EM (1994). Neurophysiological assessment of divers with medical histories of neurological decompression illness. Occup Environ Med, 51(11) pp 730-4.

33444

Nagashima T, Cao B, Takeuchi N, Chuma T, Mano Y, Fujimoto M, Nunomura M, Oshikiri T, Miyazaki K, Dohke M, Kashimura N, Shinohara T, Orba Y, Ishizawa S, Nagashima K (2002). Clinicopathological studies of peripheral neuropathy in Churg-Strauss syndrome. Neuropathology. 22(4) pp 299-307.

33445

Nakagawa-Yagi Y, Choi DK, Ogane N, Shimada S, Seya M, Momoi T, Ito T, Sakaki Y. (2001). Discovery of a novel compound: insight into mechanisms for acrylamide-induced axonopathy and colchicine-induced apoptotic neuronal cell death. Brain Res. 909(1-2) pp 8-19.

33446

McFarlane VJ, Clein GP, Cole J, Cowley N, Illidge TM (2002). Cervical neuropathy following mantle radiotherapy. Clin Oncol (R Coll Radiol). 14(6) pp 468-71.

33447 Meggs WJ (2003). Permanent paralysis at sites of dermal exposure to chlorpyrifos. J Toxicol Clin Toxicol. 41(6) pp 883-6.

33448 Chakravarty A, Chatterjee SK (2003). Sepsis and neurology. J Assoc Physicians India. 51:385-90.

33502

Triebig G, Nasterlack M, Hacke W, Frank KH, Schmittner H (2000). Neuropsychiatric symptoms in active construction painters with chronic solvent exposure. Neurotoxicology, 21(5) pp 791-4.

33505 Flanagan RJ, Ives RJ (1994). Volatile substance abuse. Bull Narc, 46(2) pp 49-78.

33507

Shubhakaran, Sharma CM (2003). Acute inflammatory demyelinating polyneuropathy with P. falciparum malaria. J Assoc Physicians India, 51 pp 223-4.

33508

Murrison A, Glasspool E, Francis J, Sedgwick M (1995). Somatosensory evoked potentials in acute neurological decompression illness. J Neurol, 242(10) pp 669-76.

33509

Mehndiratta MM, Sen K, Tatke M, Bajaj BK ( 2004). IgA monoclonal gammopathy of undetermined significance with peripheral neuropathy. J Neurol Sci, 221(1-2) pp 99-104.

33510

Ozcakar L, Aknc A, Aksoy DY, Cetinkaya Y, Aydnl M. (2004). Peroneal neuropathy due to a popliteal aneurysm in a patient with infectious endocarditis. Ann Vasc Surg, 18(1) pp 115-7.

33518 Mohseni S (2001). Hypoglycemic neuropathy. Acta Neuropathol (Berl), 102(5) pp 413-21.

33519

Lo YL, Leoh TH, Loh LM, Tan CE (2003). Statin therapy and small fibre neuropathy: a serial electrophysiological study. J Neurol Sci, 208(1-2) pp 105-8.

of 53

33520 Saraf SK, Singh OP, Singh VP (2003). Peripheral nerve complications in hemophilia. J Assoc Physicians India, Vol 51 pp 167-9.

33521

Santos NQ, Azoubel AC, Lopes AA, Costa G, Bacellar A (2004). Guillain-Barre syndrome in the course of dengue: case report. Arq Neuropsiquiatr, 62(1) pp 144-6.

33522 Bradberry SM, Proudfoot AT, Vale JA (2004). Poisoning due to chlorophenoxy herbicides. Toxicol Rev, 23(2) pp 65-73.

33523

Churn M, Clough V, Slater A (2000). Early onset of bilateral brachial plexopathy during mantle radiotherapy for Hodgkin's disease. Clin Oncol (R Coll Radiol), 12(5) pp 289-91.

33524 Burton JM, Kern RZ, Halliday W, Mikulis D, et al (2004). Neurological manifestations of West Nile virus infection. Can J Neurol Sci, 31(2) pp 185-93.

33525 Power C, van Marle G (2004). The emergence of West Nile Virus in Canada. Can J Neurol Sci, 31(2) pp 135-7.

33526

Ghezzi A, Zaffaroni M (2001). Neurological manifestations of gastrointestinal disorders, with particular reference to the differential diagnosis of multiple sclerosis. Neurol Sci, 22(S 2) pp S117-22.

33527 Birol A, Ulkatan S, Kocak M, Erkek E (2004). Peripheral neuropathy in Behcet's disease. J Dermatol, 31(6) pp 455-9.

33528 Brannagan TH 3rd, Zhou Y (2003). HIV-associated Guillain-Barre syndrome. J Neurol Sci, 208(1-2) pp 39-42.

33529

Font J, Ramos-Casals M, de la Red G, Pou A, Casanova A, Garcia-Carrasco M, Cervera R, Molina JA, Valet al (2003). Pure sensory neuropathy in primary Sjogren's syndrome. Longterm prospective followup and review of the literature. J Rheumatol, 30(7) pp 1552-7.

33530 England JD, Ferguson MA, Hiatt WR, Regensteiner JG (1995). Progression of neuropathy in peripheral arterial disease. Muscle Nerve, 18(4) pp 380-7.

33531

De Haro L, Gastaut JL, Jouglard J, Renacco E (1997). Central and peripheral neurotoxic effects of chronic methyl bromide intoxication. J Toxicol Clin Toxicol, 35(1) pp 29-34.

33532 Elliott DH (1989). Long-term sequelae of diving. J R Soc Med, 82(2) pp 79-80.

33533

Borman H, Akinbingol G, Maral T, Sozay S (2002). [LETTER] Entrapment neuropathy of the upper extremity in hemodialysis patients. Plast Reconstr Surg, 109(7) pp 2598-9.

33534 Chowdhry IA, Sinha J, Barland P (2002). Brachial plexopathy as a presenting symptom of giant cell arteritis. J Rheumatol, 29(12) pp 2653-7.

33535 Chu CC, Huang CC, Ryu SJ, Wu TN (1998). Chronic inorganic mercury induced peripheral neuropathy. Acta Neurol Scand, 98(6) pp 461-5.

33536 Cornblath DR; Kjuus H, et al (2004). [LETTERS] Neuropathy in grout workers. Scand J Work Environ Health, 30(3) pp 253-254.

33537

Kapoor K, Chandra M, Nag D, Paliwal JK, et al (1999). Evaluation of metronidazole toxicity: a prospective study. Int J Clin Pharmacol Res,19(3) pp 83-8.

33538

Oh BC, Lim YM, Kwon YM, Khang SK, Kim KK (2004). A case of Hodgkin's lymphoma associated with sensory neuropathy. J Korean Med Sci, 19(1) pp 130-3.

33539 Fukuda K, Yamamoto H (2001). Dialysis-related amyloidosis. Semin Musculoskelet Radiol, 5(2) pp 113-119.

33540 Anand P (2004). Neurotrophic factors and their receptors in human sensory neuropathies. Prog Brain Res, Vol 146 pp 477-92.

33541 Kucera P, Balaz M, Varsik P, Kurca E (2002). Pathogenesis of alcoholic neuropathy. Bratisl Lek Listy, 103(1) pp 26-9.

33542

Lee HC, Kim HD, Park WK, Rhee HD, Kim KJ (2003). Radial nerve paralysis due to Kent retractor during upper abdominal operation. Yonsei Med J, 44(6) pp 1106-1109.

of 53

33543

Mahadevan A, Gayathri N, Taly AB, Santosh V, et al (2001). Vasculitic neuropathy in HIV infection: a clinicopathological study. Neurol India, 49(3) pp 277-83.

33544 Choi IS (2001). Carbon monoxide poisoning: systemic manifestations and complications. J Korean Med Sci, 16(3) pp 253-261.

33545

Garcia Gasalla M, Yebra Bango M, Vargas Nunez JA, et al (2001). Giant cell arteritis associated with demyelinating polyradiculoneuropathy. Ann Rheum Dis, 60(8) pp 812-3.

33546

Bove L, Picardo M, Maresca V, Jandolo B, Pace A (2001). A pilot study on the relation between cisplatin neuropathy and vitamin E. J Exp Clin Cancer Res, 20(2) pp 277-80.

33547 Highleyman L (2002). Peripheral neuropathy. BETA, 15(1) pp 11-8.

33548

Hassan K, Simri W, Rubenchik I, Manelis J, et al (2003). Effect of erythropoietin therapy on polyneuropathy in predialytic patients. J Nephrol, 16(1) pp 121-5.

33556

Wang JD, Chen JD (1993). Acute and chronic neurological symptoms among paint workers exposed to mixtures of organic solvents. Environ Res, 61(1) pp 107-16.

33562

Reinhardt F, Drexler H, Bickel A, Claus D, et al (1997). Neurotoxicity of long-term low-level exposure to carbon disulphide: results of questionnaire, clinical neurological examination and neuropsychological testing. Int Arch Occup Environ Health, 69(5) pp 332-338.

33571 Kanda T (2003). Chronic hepatitis C infection and peripheral neuropathy; is mixed cryoglobulinemia really important? Intern Med, 42(5) pp 377-8.

33572

Ijichi T, Muranishi M, Shimura K, Inaba T, et al (2003). Idiopathic thrombocytopenic purpura and mononeuropathy multiplex. Acta Haematol, 110(1) pp 33-5.

33573

Rodolico C, Toscano A, De Luca G, Mazzeo A, et al (2001). Peripheral neuropathy as the presenting feature of multiple system atrophy. Clin Auton Res, 11(2) pp 119-21.

33574 Sander HW (1999). Mononeuropathy of the medial branch of the deep peroneal nerve in a scuba diver. J Peripher Nerv Syst, 4(2) pp 134-7.

33575

Nobile-Orazio E, Casellato C, Di Troia A (2002). Neuropathies associated with IgG and IgA monoclonal gammopathy. Rev Neurol (Paris), 158(10 Pt 1) pp 979-87.

33576

Paoletti V, Donnarumma L, De Matteis A, Mammarella A, et al (2000). Peripheral neuropathy without cryoglobulinemia in patients with hepatitis C virus infection. Panminerva Med, 42(3) pp 175-8.

33577

Ono S, Oishi M, Takasu T (1999). Central and peripheral motor conduction time in chronic alcoholics with polyneuropathy and/or spasticity. Funct Neurol, 14(1) pp 29-36.

33578

Pantalone D, Muscas GC, Tings T, Paolucci R, et al (2002). Peripheral paraneoplastic neuropathy, an uncommon clinical onset of sigmoid cancer. Case report and review of the literature.Tumori, 88(4) pp 347-9.

33579

Mukherjee SC, Rahman MM, Chowdhury UK, Sengupta MK, et al (2003). Neuropathy in arsenic toxicity from groundwater arsenic contamination in West Bengal, India. J Environ Sci Health Part A Tox Hazard Subst Environ Eng, 38(1) pp 165-83.

33580

Letz R, Gerr F, Cragle D, Green RC, et al (2000). Residual neurologic deficits 30 years after occupational exposure to elemental mercury. Neurotoxicology, 21(4) pp 459-74.

33588 Authier FJ, Gheradi RK (2003). Peripheral neuropathies in HIV-infected patients in the era of HAART. Brain Pathol, 13(2) pp 223-8.

33589

Ball R, Auker CR, Ford GC, Lawrence D (1998) Decompression sickness presenting as forearm swelling and peripheral neuropathy: a case report. Aviat Space Environ Med, 69(7) pp 690-2.

of 53

33590 Antoine JC (2000). Immunological mechanisms in paraneoplastic peripheral neuropathy. Clin Rev Allergy Immunol, 19(1) pp 61-72.

33591

Anlar O, Tombul T, Kisli M (2003) Peripheral sensory and motor abnormalities in patients with multiple sclerosis. Electromyogr Clin Neurophysiol, 43(6) pp 349-51.

33592

Bouillot S, Martin-Negrier ML, Vital A, Ferrer X, et al (2002) Peripheral neuropathy associated with mitochondrial disorders: 8 cases and review of the literature.J Peripher Nerv Syst , 7(4) pp 213-20.

33593

Moriwaki K, Kanno Y, Nakamoto H, Okada H, Suzuki H (2000). Vitamin B6 deficiency in elderly patients on chronic peritoneal dialysis. Adv Perit Dial, Vol 16 pp 308-12.

33594

Kiwaki T, Umehara F, Arimura Y, Izumo S, et al (2003). The clinical and pathological features of peripheral neuropathy accompanied with HTLV-I associated myelopathy. J Neurol Sci, 206(1) pp 17-21.

33595 Klein C (2004). Pathology and molecular genetics of inherited neuropathy. Journal of the Neurological Sciences, Vol 220 pp 141-143.

33596

Taylor DM, O'Toole KS, Ryan CM (2003). Experienced scuba divers in Australia and the United States suffer considerable injury and morbidity. Wilderness Environ Med, 14(2): 83-8.

33597

Keresztes K, Istenes I, Folhoffer A, Lakatos PL, et al (2004). Autonomic and sensory nerve dysfunction in primary biliary cirrhosis. World J Gastroenterol, 10(20) pp 3039-43.

33598

Jokanovic M, Stukalov PV, Kosanovic M (2002). Organophosphate induced delayed polyneuropathy. Curr Drug Targets CNS Neurol Disord, 1(6) pp 593-602.

33599 Hagiwara H, Sunada Y (2004). Mechanism of taxane neurotoxicity. Breast Cancer, 11(1) pp 82-85.

33600 De Letter MA (2000). Acute polyneuropathies encountered in the intensive care unit. Suppl Clin Neurophysiol, Vol 53 pp 53-60.

33601 Ohsumi S, Sunada Y (2004). Techniques for the neurological examination of taxane-induced neuropathy. Breast Cancer, 11(1) pp 86-91.

33602 Spira A (1999). Diving and marine medicine review part II: diving diseases. J Travel Med, 6(3) pp 180-98.

33603 Stewart JD, Shantz SH (2003). Perioperative ulnar neuropathies: a medicolegal review. Can J Neurol Sci, 30(1) pp 15-9.

33604

Soysal A, Atay T, Ozu T, Arpaci B (2004). Electrophysiological evaluation of peripheral and autonomic involvement in leprosy. Can J Neurol Sci, 31(3) pp 357-62.

33605 Kidd D, Beynon HL (2003). The neurological complications of systemic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 20(2) pp 85-94.

33606 Visovsky C, Daly BJ (2004). Clinical evaluation and patterns of chemotherapy-induced peripheral neuropathy. J Am Acad Nurse Pract, 16(8) pp 353-9.

33607

Singh S, Reddy SR, Sud A, Wanchu A, et al (2002). Subacute arsenical neuropathy leading to Gullian-Barre-like syndrome and respiratory failure. J Assoc Physicians India, Vol 50 pp 853-854.

33608 Vincent AM, Feldman EL (2004). New insights into the mechanisms of diabetic neuropathy. Rev Endocr Metab Disord, 5(3) pp 227-36.

33609

Sevim S, Aktekin M, Dogu O, Ozturk H, Ertas M (2003). Late onset polyneuropathy due to organophosphate (DDVP) intoxication. Can J Neurol Sci, 30(1) pp 75-8.

33610 Quattrini A, Previtali SC, Kieseier BC, Kiefer R, et al (2003). Autoimmunity in the peripheral nervous system. Crit Rev Neurobiol, 15(1) pp 1-39.

33617 Obrosova IG (2003). Update on the pathogenesis of diabetic neuropathy. Curr Diab Rep, Vol 3(6) pp 439-45.

of 53

33618

Micco A, Nobile-Orazio E, Baron P, Conti G, et al (2003). Severe chronic sensory-motor polyneuropathy: coexistence of 3 unrelated etiologies in a type 1 diabetic patient. A case report and review of the literature. J Peripher Nerv Syst, Vol 8(1) pp 23-8.

33619 Menon NK (2001). Neuropathy associated with Norplant. J Fam Plann Reprod Health Care, 27(4) pp 241.

33620 Rankine JJ (2004). Adult traumatic brachial plexus injury. Clin Radiol, 59(9) pp 767-74.

33621 Eg Dimeff RJ (2003). Entrapment neuropathies of the upper extremity. Curr Sports Med Rep, 2(5) pp 255-61.

33622

Ayers DE, Mercer SJ, Glover M (2003). Common medical disorders related to diving--prevention, diagnosis and fundamentals of treatment. Part 1: Diving disorders that do not require recompression. J R Army Med Corps, 149(1): 15-22.

33623

Bowen BC, Pattany PM, Saraf-Lavi E, Maravilla KR (2004). The brachial plexus: normal anatomy, pathology, and MR imaging. Neuroimaging Clinics of North America, 14(1) pp 59-85, vii-viii.

33624

Hirata M, Taoda K, Ono-Ogasawara M, Takaya M, Hisanaga N (1998). A probable case of chronic occupational thallium poisoning in a glass factory. Ind Health, 36(3) pp 300-3.

33625

Schilling C (2000). Effects of exposure to very high frequency radiofrequency radiation on six antenna engineers in two separate incidents. Occup Med, Vol 50 pp 49-56.

33626

Holliday R; Schilling C (2000). [Letters] Effects of exposure to very high frequency radiofrequency radiation on six antenna engineers in two separate incidents. Occup Med (Lond), 50(8) pp 616.

33627 Beric A (2002). Peripheral nerve disorders. Adv Neurol, Vol 90 pp 227-40.

33628

Kayacan O, Beder S, Deda G, Karnak D (2001). Neurophysiological changes in COPD patients with chronic respiratory insufficiency. Acta Neurol Belg, 101(3) pp 160-65.

33629

Seijo-Martinez M, Castro del Rio M, Fontoira E, Fontoira M (2003). Acute femoral neuropathy secondary to an iliacus muscle hematoma. J Neurol Sciences, 209(1-2) pp 119-22.

33630 Schmidt RE (2002). Neuropathology and pathogenesis of diabetic autonomic neuropathy. Int Rev Neurobiology, Vol 50 pp 257-92.

33631

Allen RK, Sellars RE, Sandstrom PA (2003). A prospective study of 32 patients with neurosarcoidosis. Sarcoidosis Vasc Diffuse Lung Diseases, 20(2) pp 118-25.

33632

Ijichi T, Kono I, Mori S, Nakajima K, et al (2003). Peripheral neuropathy in Japanese patients with hepatitis C virus infection. Intern Medicine, 42(5) pp 394-9.

33633

Simpson DM (2002). Selected peripheral neuropathies associated with human immunodeficiency virus infection and antiretroviral therapy. J Neurovirol, 8(S2) pp 33-41.

33634

Kochar DK, Shubhakaran, Kumawat BL, Kochar SK, et al (2002). Cerebral malaria in Indian adults: a prospective study of 441 patients from Bikaner, north-west India. J Assoc Physicians India, Vol 50 pp 234-41.

33635

McFall TL, Richards JS, Matthews G (1998). Rehabilitation in an individual with chronic arsenic poisoning: medical, psychological, and social implications. J Spinal Cord Med, 21(2) pp 142-7.

33636 De Smet L (2002). Median and ulnar nerve compression at the wrist caused by anomalous muscles Acta Orthop Belg, 68(5) pp 431-8.

33637

Sacktor N (2002). The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J Neurovirol, 8(S 2) pp 115-21.

of 53

33638 Wenning GK, Diem A (2001). Is peripheral neuropathy a feature of multiple system atrophy? Clin Auton Res, 11(2) pp 63.

33639 Hirose CB, McGarvey WC (2004). Peripheral nerve entrapments. Foot Ankle Clin N Am, 9(2) pp 255-69.

33640 Auer-Grumbach M (2004). Hereditary sensory neuropathies. Drugs Today (Barc), 40(5) pp 385-94.

33641

Weintraub MI, Cole SP (2004). Pulsed magnetic field therapy in refractory neuropathic pain secondary to peripheral neuropathy: electrodiagnostic parameters--pilot study. Neurorehabil Neural Repair, 18(1) pp 42-46.

33642 Craig AS, Richardson JK (2003). Acquired peripheral neuropathy. Phys Med Rehabil Clin N Am, 14(2) pp 365-86.

33643

Nagale SV, Bosch EP (2003). Multifocal motor neuropathy with conduction block: current issues in diagnosis and treatment. Semin Neurol, 23(3) pp 325-33.

33644

Ivanaj A, Pautier P, Rixe O, Duvillard P, Dubard T (2003). Peripheral neuropathy in association with an ovarian dysgerminoma. Gynecol Oncol, 89(1) pp 168-70.

33645

Coert JH, Meek MF, Gibeault D, Dellon AL (2004). Documentation of posttraumatic nerve compression in patients with normal electrodiagnostic studies. J Trauma, 56(2) pp 339-44.

33646 Anonymous (2000). Peripheral neuropathy due to statins. Prescrire Int, 9(48) pp 115.

33647 Reeves GI (2000). Review of extensive workups of 34 patients overexposed to radiofrequency radiation. Aviat Space Environ Med, Vol 71 pp 206-215.

33648 Hocking B; Reeves GI (2001). [LETTERS] Radiofrequency radiation overexposure. Aviat Space Environ Med, 72(6) pp 590-1.

33649 Rajabally YA, Mortimer N (2004). Acute neuropathy and erythromelalgia following topical exposure to isopropanol. Vet Hum Toxicol, 46(1) pp 24-5.

33650

Barats MS, Gonick HC, Rothenberg S, Balabanian M, Manton WI (2000). Severe lead-induced peripheral neuropathy in a dialysis patient. Am J Kidney Dis, 35(5) pp 963-8.

33651

Nafe R, Trollmann R, Schlote W (2001). The giant axonal neuropathy--clinical and histological aspects, differential diagnosis and a new case. Clin Neuropathol, 20(5): 200-11.

33652 Forman AD (2004). Peripheral neuropathy and cancer. Curr Oncol Rep, 6(1) pp 20-5.

33653 Romeo AA, Rotenberg DD, Bach BR Jr (1999). Suprascapular neuropathy. J Am Acad Orthop Surg, 7(6) pp 358-67.

33654 Pendergrass TL, Moore JH (2004). Saphenous neuropathy following medial knee trauma. J Orthop Sports Phys Ther, 34(6) pp 328-34.

33655 Barratt DM, Van Meter K (2004). Decompression sickness in Miskito Indian lobster divers: review of 229 cases. Aviat Space Environ Med, 75(4) pp 350-3.

33656 Moloff AL (1993). Delayed onset arterial gas embolism. Aviat Space Environ Med, 64(11) pp 1040-3.

33657

Cervera R, Font J, Ramos-Casals M, Garcia-Carrasco M, et al (2000). Primary Sjogren's syndrome in men: clinical and immunological characteristics. Lupus, 9(1) pp 61-4.

33658 Kim JS, Lim HS, Cho SI et al (2003). Impact of Agent Orange exposure among Korean Vietnam veterans. Ind Health, 41(3): 149-57.

33659 Klemmer PJ, Harris AA (2000). Carbon disulfide nephropathy. Am J Kidney Dis, 36(3) pp 626-9.

33660 Wedeen RP (2000). [LETTER] Occupational renal diseases. Am J Kidney Dis, 36(3) pp 644-5.

33661 Holstege CP, Baer AB (2004). Insecticides. Curr Treat Options Neurol, 6(1) pp 17-23.

of 53

33680

Suneetha S, Arunthathi S, Kurian N, Chacko CJ (2000-2001). Histological changes in the nerve, skin and nasal mucosa of patients with primary neuritic leprosy. Acta Leprol, 12(1) pp 11-18.

33681 Karamagi C, Owino E, Katabira ET (2001). Hydroquinone neuropathy following use of skin bleaching creams: case report. East Afr Med J, 78(4) pp 223-4.

33684 Yoshikawa H, Abe T, Oda T (1999). Extremely acute phenytoin-inducted peripheral neuropathy. Epilepsia, 40(4) pp 528-9.

33690 Vital A (2001). Paraproteinemic neuropathies. Brain Pathol, 11(4) pp 399-407.

33691

Ramadan W, Mourad B, Fadel W, Ghoraba E (2001). Clinical, electrophysiological, and immunopathological study of peripheral nerves in Hansen's disease. Lepr Rev, 72(1) pp 35-49.

33692 Gordon N (2004). Giant axonal neuropathy. Dev Med Child Neurol, 46(10) pp 717-9.

33693

Dahlin LB, Lundborg G (2001) Vibration-induced hand problems: role of the peripheral nerves in the pathophysiology. Scand J Plast Reconstr Surg Hand Surg, 35(3) pp 225-32.

33694

Shin SS, Hyson AM, Castaneda C, Sanchez E, et al (2003). Peripheral neuropathy associated with treatment for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis, 7(4) pp 347-53.

33695

Saperstein DS, Barohn RJ (2003). Current concepts and controversy in chronic inflammatory demyelinating polyneuropathy. Curr Neurol Neurosci Rep, 3(1) pp 57-63.

33696

Vaernes RJ, Bergan T, Warncke M (1988). HPNS effects among 18 divers during compression to 360 msw on heliox. Undersea Biomed Res, 15(4) pp 241-55.

33697 Vaernes RJ, Klove H, Ellertsen B (1989). Neuropsychologic effects of saturation diving. Undersea Biomed Res, 16(3) pp 233-51.

33698

Todnem K, Nyland H, Riise T, Kambestad BK, et al (1990). Analysis of neurologic symptoms in deep diving: implications for selection of divers. Undersea Biomed Res, 17(2) pp 95-107.

33699 Taylor GN (2000). Cases from the aerospace medicine residents' teaching file. Decompression sickness. Aviat Space Environ Med, 71(12) pp 1252-3.

33700

Todnem K, Knudsen G, Riise T, Nyland H, Aarli JA (1989). Nerve conduction velocity in man during deep diving to 360 msw. Undersea Biomed Res 16(1) pp 31-40.

33701

Cavalleri F, Galassi G, Ferrari S, Merelli E, et al (1995). Methyl bromide induced neuropathy: a clinical, neurophysiological, and morphological study. J Neurol Neurosurg Psychiatry, Vol 58(3) pp 383.

33702 Weintraub E, Gandhi D, Robinson C (2000). Medical complications due to mothball abuse. South Med J, 93(4) pp 427-9.

33703

Chaudhry V, Corse AM, O'Brian R, Cornblath DR, et al (1999). Autonomic and peripheral (sensorimotor) neuropathy in chronic liver disease: a clinical and electrophysiologic study. Hepatology, 29(6) pp 1698-703.

33704 Griffin JW (2001). Vasculitic neuropathies. Rheum Dis Clin North America, 27(4) pp 751-60.

33705

Hattori N, Mori K, Misu K, Koike H, et al (2002). Mortality and morbidity in peripheral neuropathy associated Churg-Strauss syndrome and microscopic polyangiitis. J Rheumatology, 29(7) pp 1408-1414.

33706

Jardim MR, Chimelli L, Faria SC, Fernandes PV, et al (2004). Clinical, electroneuromyographic and morphological studies of pure neural leprosy in a Brazilian referral centre. Leprosy Rev, 75(3) pp 242-53.

33707

Kjuus H, Goffeng LO, Heier MS, Sjoholm H, et al (2004). Effects on the peripheral nervous system of tunnel workers exposed to acrylamide and N-methylolacrylamide. Scand J Work Environ Health, 30(1) pp 21-9.

33708 Cornblath, DR; Kjuus H, et al (2004). [LETTERS] Neuropathy in grout workers. Scan J Work Environ Health, 30(3) pp 253-254.

of 53

33709 Peters BH, Levin HS, Kelly PJ (1977). Neurologic and psychologic manifestations of decompression illness in divers. Neurology, 27(2) pp 125-7.

33710 Todnem K, Nyland H, Dick AP, Lind O, et al (1989). Immediate neurological effects of diving to a depth of 360 metres. Acta Neurol Scand, 80(4) pp 333-40.

33711

Thomke F, Jung D, Besser R, Roder R, et al (1999). Increased risk of sensory neuropathy in workers with chloracne after exposure to 2,3,7,8-polychlorinated dioxins and furans. Acta Neurol Scand, 100(1) pp 1-5.

33712 Lee DH, Claussen GC, Oh S (2004). Clinical nerve conduction and needle electromyography studies. J Am Acad Orthop Surg, 12(4) pp 276-87.

33713

Rostain JC, Gardette-Chauffour MC, Lemaire C, Naquet R (1988). Effects of a H2-He-O2 mixture on the HPNS up to 450 msw. Undersea Biomed Res, 15(4) pp 257-70.

33714 Bishop RA (2000). Approach to the patient with polyneuropathy. Lippincotts Prim Care Pract, 4(6) pp 563-79.

33719 Rom WN (Ed) (1998). Environmental and Occupational Medicine, Third Edition,. Lippincott-Raven, Philadelphia.

33731 Handevidt F (2001). Peripheral neuropathy in persons with diabetes. Clin Excell Nurse Pract, 5(1) pp 17-20.

33732

Wilson JL, Sokol DK, Smith LH, Snook RJ, et al (2003). Acute painful neuropathy (insulin neuritis) in a boy following rapid glycemic control for type 1 diabetes mellitus. J Child Neurol, 18(5) pp 365-7.

33733

Duby JJ, Campbell RK, Setter SM, White JR, Rasmussen KA (2004). Diabetic neuropathy: an intensive review. Am J Health Syst Pharm, 61(2) pp 160-73; quiz 175-6.

33734 Shah R et al; Duby JJ (2004). [LETTERS] Am J Health Syst Pharm, 61(14) pp 1446-7.

33753

Chariot P, Ragot F, Authier FJ, Questel F, Diamant-Berger O (2001). Focal neurological complications of handcuff application. J Forensic Science, Vol 46(5) pp 1124-5.

33754

Moudgil SS, Riggs JE (2000). Fulminant peripheral neuropathy with severe quadriparesis associated with vincristine therapy. Ann Pharmacotherapy, 34(10) pp 1136-8.

33755 Tillotson GS (2001). [Comment] Peripheral neuropathy syndrome and fluoroquinolones. Ann Pharmacotherapy, 35(12) pp 1673-4.

33756 Spencer PS, Kim MS, Sabri MI (2002). Aromatic as well as aliphatic hydrocarbon solvent axonopathy. Int J Hyg Environ Health, 205(1-2) pp 131-6.

33757

Muellner T, Ganko A, Bugge W, Engebretsen L (2001). Isolated femoral mononeuropathy in the athlete. Anatomic considerations and report of two cases. Am J Sports Medicine, 29(6) pp 814-7.

33758

Drory VE, Groozman GB, Rubinstein A, Korczyn AD (1999). Hypertriglyceridemia may cause a subclinical peripheral neuropathy. Electromyogr Clin Neurophysiology, 39(1) pp 39-41.

33759 Backes JM, Howard PA (2003). Association of HMG-CoA reductase inhibitors with neuropathy. Ann Pharmacotherapy, 37(2) pp 274-8.

33760

Misra UK, Kalita J, Das A (2003). Vitamin B12 deficiency neurological syndromes: a clinical, MRI and electrodiagnostic study. Electromyogr Clin Neurophysiology, 43(1) pp 57-64.

33761

Kalita J, Misra UK, Rajani M, Kumar A (2004) Central sensory motor pathways are less affected than peripheral in chronic renal failure. Electromyogr Clin Neurophysiology, 44(1) pp 7-10.

33762 Cohen JS (2001). Peripheral neuropathy associated with fluoroquinolones. Ann Pharmacotherapy, 35(12) pp 1540-1547.

33763

McQueen D, Kent G, Murrison A (1994). Self-reported long-term effects of diving and decompression illness in recreational scuba divers. Br J Sports Medicine, 28(2) pp 101-4.

of 53

33764 Ng AB, Borhan J, Ashton HR, Misra AN, Redfern DR (2003). Radial nerve palsy in an elite bodybuilder. Br J Sports Medicine, Vol 37(2) pp 185-6.

33777

Lacson AG, Gieron-Korthals M, Mueller OT (2001). Peripheral neuropathy in the first 2 years of life: diagnostic evaluation including molecular genetics. Adv Pediatr, Vol 48 pp 213-43.

33778 Weimer LH (2003). Medication-induced peripheral neuropathy. Curr Neurol Neurosci Rep, 3(1) pp 86-92.

33781

Todnem K, Nyland H, Kambestad BK, Aarli JA (1990). Influence of occupational diving upon the nervous system: an epidemiological study. Br J Industrial Medicine, 47(10) pp 708-14.

33782 Todnem K, Nyland H, Skeidsvoll H, Svihus R, et al (1991). Neurological long term consequences of deep diving. Br J Industrial Medicine, 48(4) pp 258-66.

33816

Spring PJ, Sharpe DM, Hayes MW (2001). Nitrofurantoin and peripheral neuropathy: a forgotten problem? Medical Journal of Australia, 174(3) pp 153-4.

33817 Wu PBJ, Kingery WS, Date ES (1995). An EMG case report of lead neuropathy 19 years after a shotgun injury. Muscle & Nerve, 18(3) pp 326-9.

33894 Adams D (2001). Hereditary and acquired amyloid neuropathies. Journal of Neurology, 248(8) pp 647-57.

33895 McManis PG, Windebank AJ, Kiziltan M (1994). [COMMENT] Neuropathy associated with hyperlipidemia. Neurology, 45(11) pp 2119-20.

33906 Patel HR, Albehussi S, Arya M, Miller RA (2002). Can oxybutynin cause peripheral neuropathy? J Urology, 168(2) pp 646.

33907 Poncelet AN, Connolly MK (2003). Peripheral neuropathy in scleroderma. Muscle Nerve, 28(3) pp 330-35.

33908

Sadoh DR, Sharief MK, Howard RS (1999). Occupational exposure to methyl methacrylate monomer induces generalised neuropathy in a dental technician. Br Dent Journal, 186(8) pp 380-1.

33909 Swerdloff MA, Tarras SC (2000). Amantadine-induced peripheral neuropathy. Neurology, 55(3) pp 456-7.

33910 Kuroi K, Shimozuma K (2004). Neurotoxicity of taxanes: symptoms and quality of life assessment. Breast Cancer, 11(1) pp 92-9.

33929

Tsambaos D, Sakkis T, Chroni E, Koniavitou K, et al (2003). Peripheral sensory neuropathy associated with short-term oral acitretin therapy. Skin Pharmacol Appl Skin Physiology, 16(1) pp 46-9.

33930 McManis PG, Windebank AJ, Kiziltan M (1994). Neuropathy associated with hyperlipidemia. Neurology, 44(11) pp 2185-6.

33933 Makino H (2004). Treatment and care of neurotoxicity from taxane anticancer agents. Breast Cancer, 11(1) pp 100-4.

33938

Zarrell MM, Amoruso L, Beghi E, Apollo F, et al (2001). Arterial hypertension as a risk factor for chronic symmetric polyneuropathy. Journal of Epidemilogy and Biostatistics, 6(5): 409-13.

33939

Chong PH, Boskovich A, Stevkovic N, Bartt RE (2004). Statin-Associated Peripheral Neuropathy: Review of the Literature. Pharmacotherapy, 24(9) pp 1194 - 1203.

33940 Ambler Z (2000). Guillain-Barre syndrome: an overview of current concepts. Suppl Clin Neurophysiology, Vol 53 pp 388-95.

33941 Borgeat A, Ekatodramis G (2001). Nerve injury associated with regional anesthesia. Curr Top Med Chem, 1(3) pp 199-203.

33942 Comenzo RL (2000). Primary systemic amyloidosis. Curr Treat Options Oncology, 1(1) pp 83-9.

33943 Baker WC (2003). HIV-associated neuropathies: Not a necessary consequence of HIV infection. Adv Nurse Pract, 11(11) pp 83-6, 89-90.

33944 Gertz MA, Rajkumar SV (2002) Primary systemic amyloidosis.Curr Treat Options Oncol, 3(3) pp 261-71.

of 53

33945 Huang CC (2004). Carbon disulfide neurotoxicity: Taiwan experience. Acta Neurol Taiwan, 13(1) pp 3-9.

33946

Mansouri B, Adybeig B, Rayegani M, Yasami S, Behshad V (2001). Uremic neuropathy and the analysis of electrophysiological changes. Electromyogr Clin Neurophysiol, vol 41 pp 107-115.

33947

Gamelin E, Gamelin L, Bossi L, Quasthoff S (2002). Clinical Aspects and Molecular Basis of Oxaliplatin Neurotoxicity: Current Management and Development of Preventive Measures. Seminars in Oncology, 29(5 S 15) pp 21 - 33.

33949 Wilson JR, Stittsworth JD, Fisher MA (2001). Electrodiagnostic patterns in MGUS Neuropathy. Electromyogr Clin Neurophysiol, Vol 41 pp 409 - 418.

33950

Integrated Risk Information System (EPA) (IRIS), a database of the National Library of Medicine's TOXNET system (http://toxnet.nlm.nih.gov) accessed on April 14, 2004 for - METHYL ISOBUTYL KETONE (MIBK).

34043 Rutchik JS, Wittman RI (2004). Neurologic issues with solvents. Clin Occup Environ Med, 4(4) pp 621-656.

34044 Verma A (2001). Epidemiology and clinical features of HIV-1 associated neuropathies. J Peripher Nerv Syst, 6(1) pp 8-13.

34045 Stein RH, Phelps RG, Sapadin AN (2001). Cutaneous polyarteritis nodosa after streptococcal necrotizing fasciitis. Mt Sinai J Med, 68(4-5) pp 336-8.

34046

Hirata M, Sakakibara H, Abe M (2002). Reduced sensory nerve conduction velocity of the distal part of the radial nerve among patients with vibration syndrome. Electromyogr Clin Neurophysiol, 42(2) pp 113-8.

34047

Ozge A, Atis S, Sevim S (2001). Subclinical peripheral neuropathy associated with chronic obstructive pulmonary disease. Electromyogr Clin Neurophysiol, 41(3) pp 185-91.

34051 Grothey A (2003). Oxaliplatin-safety profile: neurotoxicity. Semin Oncol, 30(4 S 15) pp 5-13.

34052 Rushing EJ, Bouffard JP (2004). Basic pathology of the peripheral nerve. Neuroimaging Clin N Am, 14(1) pp 43-53.

34122 Marlowe SN, Lockwood DN (2001). Update on leprosy. Hosp Med, 62(8) pp 471-6.

34340 Juntunen J (1993). Neurotoxic syndromes and occupational exposure to solvents. Environ Res, 60(1) pp 98-111.

34341

Kilburn KH (2002). Do duration of exposure, proximity to electronic manufacturing plants, and involvement in a lawsuit affect chlorinated solvent toxicity? Arch Environ Health, 57(2) pp 121-126.

34342

Kuriwaka R, Mitsui T, Fujiwara S, Nishida Y, Matsumoto T (2002). Loss of postural reflexes in long-term occupational solvent exposure. Eur Neurol, 47(2) pp 85-7.

34343

Maruff P, Burns CB, Tyler P, Currie BJ, Currie J (1998). Neurological and cognitive abnormalities associated with chronic petrol sniffing. Brain, 121(10) pp 1903-1917.

34344 Miller NS, Gold MS (1991) Organic solvent and aerosol abuse. Am Fam Physician, 44(1) pp 183-9.

34350

Rodriguez V, Kuehnle I, Heslop HE et al (2002). Guillain-Barre syndrome after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant, 29(6): 515-7.

34391 Polydefkis MJ (2002). Peripheral neuropathy and HIV. Hopkins HIV Rep, 14(4) pp 6-7.

34392

Yang YW, Liu CH, Tsai CH, Lee CC, Jou SB (2004). Multifocal acquired demyelinating sensory and motor neuropathy: report of a case and review of the literature. Acta Neurol Taiwan, 13(1) pp 24-8.

34422

Rodriguez V, Kuehnle I, Heslop HE, Khan S, Krance RA (2002). Guillain-Barre syndrome after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant, 29(6) pp 515-7.

of 53

34447 Lolin Y (1989). Chronic neurological toxicity associated with exposure to volatile substances. Hum Toxicol, 8(4) pp 293-300.

34477 Linden CH (1990). Volatile substances of abuse. Emerg Med Clin North Am, 8(3) pp 559-78.

34488 Podwall D, Gooch C (2004). Diabetic neuropathy: clinical features, etiology, and therapy. Curr Neurol Neurosci Rep, 4(1) pp 55-61.

34489

van Laarhoven HW, Verstappen CC, Beex LV, Kappelle AC, Punt CJ (2003). 5-FU-induced peripheral neuropathy: a rare complication of a well-known drug. Anticancer Res, 23(1B) pp 647-8.

34742 Skeen MB (2002). Neurologic manifestations of gastrointestinal disease. Neurol Clinics, 20(1) pp 195-225.

35397 Lotti M (1991). The pathogenesis of organophosphate polyneuropathy. Crit Rev Toxicol, 21(6) pp 465-87.

35398

Buiatti E, Cecchini S, Ronchi O et al (1978). Relationship between clinical and electromyographic findings and exposure to solvents, in shoe and leather workers. British Journal of Industrial Med, 35: 168-73.

35399 Langman JM (1994). Xylene: Its Toxicity, measurement of exposure levels, absorption, metabolism and clearance. Pathology, vol 26 pp 301-309.

35400

Maizlish NA, Langolf GD, Whitehead LW, Fine LJ, et al (1985). Behavioural evaluation of workers exposed to mixtures of organic solvents. British Journal of Industrial Medicine, vol 42 pp 579-590.

35401

Maizlish NA, Fine LJ, Albers JW, Whitehead L, Langolf GD (1987). A neurological evaluation of workers exposed to mixtures of organic solvents. British Journal of Industrial Medicine, 44(1) pp 14-25.

35402 Dickoff DJ, Gerber O, Turovsky Z (1987). Delayed neurotoxicity after ingestion of carbamate pesticide. Neurology, vol 37 pp 1229-1231.

35403

House RA, Liss GM, Wills MC (1994). Peripheral sensory neuropathy associated with 1,1,1-trichloroethane. Archives of Environmental Health, 49(3) pp196 -199.

35474

Ames RG, Steenland K, Jenkins B, Chrislip D, Russo J (1995). Chronic neurologic sequelae to cholinesterase inhibition among agricultural pesticide applicators. Archives of Environmental Health, 50(6) pp 440-444.

35475

Auger N, Kofman O, Kosatsky T, Armstrong B (2005). Low-level methylmercury exposure as a risk factor for neurologic abnormalities in adults. NeuroToxicology, Vol 26 pp 149-157.

35476 Bajaj BK, Agrarwal, Ram BK (2003). Autonomic neuropathy in patients with hepatic cirrhosis. Postgrad Med Journal, 79: 408-11.

35477

Barrett DH, Morris RD, Akhtar FZ, Michalek JE (2001). Serum dioxin and cognitive functioning among veterans of Operation Ranch Hand. NeuroToxicology, Vol 22 pp 491-502.

35478

Brashear A, Unverzagt FW, Farber MO et al (1996). Ethylene oxide neurotoxicity: a cluster of 12 nurses with peripheral and central nervous system toxicity. Neurology, 46(4): 992-98.

35479 Briani C, Zara G, Negrin P (2002). [Letter] Disopyramide-induced neuropathy. Neurology, Vol 58 pp 663.

35480 Choi SSL, Chan KF, Ng HK, Mak WP (1999). Colchicine-induced myopathy and neuropathy. Hong Kong Med Journal, Vol 5 pp 204-207.

35481

Cheery N, Creed F, Silman A, Dunn G, et al (2001). Health and exposures of United Kingdom Gulf war veterans. Part I: the pattern and extent of ill health. Occup Environ Med, Vol 58 pp 291-298.

35482

Cheery N, Creed F, Silman A, Dunn G, et al (2001). Health and exposures of United Kingdom Gulf war veterans. Part II: The relation of health to exposure. Occup Environ Med, Vol 58 pp 299-306.

35483

Cherry CL, McArthur JC, Hoy JF, Wesselingh SL (2003). Nucleoside analogues and neuropathy in the era of HAART. Journal of Clinical Virology, Vol 26 pp 195-207.

of 53

35484

Clark RF, Williams SR, Fung F, Schneir AB, et al (2004). [Letter] A reassessment of tropical organic phosphorus insecticide exposures and permanent paralysis. Journal of Toxicology, 42(7) pp 991-992.

35485 Corbo M, Balmaceda C (2001). Peripheral neuropathy in cancer patients. Cancer Investigation, 19(4) pp 369-382.

35486 Cross NE, Glantz MJ (2003). Neurologic complications of radiation therapy. Neurologic Clinics of North America, Vol 21 pp 249-277.

35487 Diamond I, Messing RO (1994). Neurologic effects of alcoholism. The Western Journal of Medicine, 161(3) pp 279-287.

35488 Encke J, Uhl W, Stremmel W et al (2004). Immunosuppression and modulation in liver transplantation. Nephrol Dial Transplant, 19(S4): iv22-iv25.

35489

Farahat TM, Abdelrasoul GM, Amr MM, Shebl MM, et al (2003). Neurobehavioural effects among workers occupationally exposed to organophosphorous pesticides. Occup Environ Med, Vol 60 pp 279-286.

35490

Gondim FAA, Brannagan TH, Sander HW, Chin RL, Latov N (2005). Peripheral neuropathy in patients with inflammatory bowel disease. Brain, Vol 128 pp 867-879.

35491 Grogan PM, Katz JS (2005). Toxic neuropathies. Neurol Clin, Vol 23 pp 377-396.

35492

Haveman J, Van Der Zee J, Wondergem J, Hoogeveen JF, Hulshof MCCM (2004). Effects of hyperthermia on the peripheral nervous system: a review. Int J Hyperthermia, 20(4) pp 371-391.

35493

Herbert R, Gerr F, Luo J, Harris-Abbott D, Landrigan PJ (1995). Peripheral neurologic abnormalities among roofing workers: sentinel case and clinical screening. Archives of Environmental Health, 50(5) pp 349-354.

35494 Hoffman RS (2003). Thallium toxicity and the role of Prussian Blue in therapy. Toxicol Rev, 22(1) pp 29-40.

35495

House R, Liss G, Wills MC, Holness DL (1996). [LETTER] Paresthesias and sensory neuropathy due to 1,1,1-trichloroethane. The Journal of Occupational and Environment Medicine, 38(2) pp 123-124.

35496 Jaffee MS (2005). The neurology of aviation, underwater, and space environments. Neurologic Clinics, Vol 23 pp 541-552.

35497

Jovanovic JM, Jovanovuc MM, Spasic MJ, Lukic SR (2004). Peripheral nerve conduction study in workers exposed to a mixture of organic solvents in paint and lacquer industry. Croatian Medical Journal, 45(6) pp 769-774.

35498

Jamal GA, Hansen S, Ecne FA, Ecne AP, et al (2001). Peripheral nerve dysfunction in farmers using organophosphate sheep dip. Journal of Nutritional & Environmental Medicine, Vol 11 pp 9-22.

35499

Jenkins PJ, Sohaib SA, Akker S, Phillips RR, et al (2000). The pathology of median neuropathy in acromegaly. Annals of Internal Medicine, Vol 130 pp 197-201.

35500

Kelsall H, Macdonell R, Sim M, Forbes A, et al (2005). Neurological status of Australian veterans of the 1991 Gulf War and the effect of medical and chemical exposures. Int J Epidemiol, 34: 810-9.

35506

Kingman A, Albers JW, Arezzo JC, Garabrant DH, Michalek JE (2005). Amalgam exposure and neurological function. NeuroToxicology, Vol 26 pp 241-255.

35507

Kovala T, Matikainen E, Mannelin T, Erkkila J, et al (1997). Effects of low level exposure to lead on neurophysiological functions among lead battery workers. Occupational & Environmental Medicine, 54(7) pp 487-493.

35508 Legout L, et al (2004). [LETTER] Linezolid-induced neuropathy. Clinical Infectious Diseases, Vol 38 pp 767-768.

35509

Lifshitz M, Gavrilov V (2000). Central nervous system toxicity and early peripheral neuropathy following dermal exposure to methyl bromide. Clinical Toxicology, 38(7) pp 799-801.

of 53

35510

Maguiness S, Guenther L, Shum D (2002). Coma blisters, peripheral neuropathy, and amitriptyline overdose: a brief report. Journal of Cutaneous Medicine and Surgery, pp 438-441, DOI: 10.1007/s10227-001-0132-8

35511

Michalek JE, Akhtar FZ, Arezzo JC, Garabrant DH, Albers JW (2001). Serum dioxin and peripheral neuropathy in veterans of Operation Ranch Hand. NeuroToxicology, Vol 22 pp 479-490.

35512

Mitsui Y, Kusunoki S, Hiruma S, Akamatsu M, et al (1999). Sensorimotor polyneuropathy associated with chronic lymphocytic leukemia, IgM antigangliosides antibody and human t-cell leukemia virus 1 infection. Muscle & Nerve, Vol 22 pp 1461-1465.

35513 Moretto A (1998). Experimental and clinical toxicology of anticholinesterase agents. Toxicology Letters, 102-103 pp 509-513.

35514

Nemni R, Sanvito L, Quattrini A et al (2003). Peripheral neuropathy in hepatitis C virus infection with and without cryoglobulinaemia. Journal of Neurology, Neurosurgery & Psychiatry, 74(9): 1267-71.

35515 Newmark J (2005). Nerve agents. Neurologic Clinics, Vol 23 pp 623-641.

35516

Okuda M, Kunitsugu I, Kobayakawa S, Hobara T (2001). Inhibitory effect of 1,1,1-trichloroethane on calcium channels of neurons. The Journal of Toxicological Sciences, 26(3) pp 169-176.

35517

Openshaw H, Beamon K, Synold TW, Longmate J, et al (2004). Neurophysiological study of peripheral neuropathy after high-dose paclitaxel: lack of neuroprotective effect of amifostine. Clinical Cancer Research, Vol 10 pp 461-467.

35518 Murakami T, Shibazaki K, Kurokawa K, Ichikawa Y, et al (2003). Conduction block of varicella zoster virus neuropathy. Neurology, 61(8) pp 1153-1154.

35519 Swerdloff MA, Seth T (2000). [LETTER] Amantadine-induced peripheral neuropathy. Neurology, 55(3) p 456.

35520 Pagnoux C, Guillevin L (2005). Peripheral neuropathy in systemic vasculitides. Current Opinion in Rheumatology, Vol 17 pp 41-48.

35521

Pelclova D, Fenclova Z, Preiss J, Prochazka B, et al (2002). Lipid metabolism and neuropsychological follow-up study of workers exposed to 2,3,7,8-tetrachlordibenzo-p-dioxin. Int Arch Occup Environ Health, 75(suppl) pp S60-S66.

35522 Ray DE, Richards PP (2001). The potential for toxic effects of chronic, low-dose exposure to organophosphates. Toxicology Letters, Vol 120 pp 343-351.

35523 Recht L, Mrugala M (2003). Neurologic complications of hematologic neoplasms. Neurologic Clinics of North America, Vol 21 pp 87-105.

35524

Ridgway P, Nixon TE, Leach JP (2003). Occupational exposure to organic solvents and long-term nervous system damage detectable by brain imaging, neurophysiology or histopathology. Food and Chemical Toxicology, Vol 41 pp 153-187.

35525

Rodriguez-Landa JF, Contreras CM (2003). A review of clinical and experimental observations about antidepressant actions and side effects produced by Hypericum perforatum extracts. Phytomedicine, 10(8) pp 688-699.

35526

Salvi RM, Lara DR, Ghisolfi ES, Portela LV, et al (2003). Neuropsychiatric evaluation in subjects chronically exposed to organophosphate pesticides. Toxicological Sciences, Vol 72 pp 267-271.

35527

Simpson DM (2002). Selected peripheral neuropathies associated with human immunodeficiency virus infection and antiretroviral therapy. Journal of NeuroVirology, 8(S 2) pp 33-41.

35528

Spencer PS, Kim MS, Sabri MI (2002). Aromatic as well as aliphatic hydrocarbon solvent axonopathy. Int J Hyg Environ Health, Vol 205 pp 131-136.

35529 Tsai SY, Chen JD (1996). Neurobehavioral effects of occupational exposure to low-level styrene. Neurotoxicology and Teratology, 18(4) pp 463-469.

of 53

35530 Yang PY, Tsao TCY, Lin JL, Lyu RK, Chiang PC (2000). Carbofuran-induced delayed neuropathy. Clinical Toxicology, 38(1) pp 43-46.

35843

Barendregt PJ, van den Bent MJ, van Raaij-van den Aarssen VJ, et al (2001). Involvement of the peripheral nervous system in primary Sjogren's syndrome. Ann Rheum Dis, 60(9) pp 876-81.

35844

Caniello M, Baxter P, Lino AM, Lima LG, Pinto WP (2002). Confluent peripheral multiple mononeuropathy associated to acute hepatitis B: a case report. Rev Inst Med Trop Sao Paulo, 44(3) pp 171-73.

35889

Gray MR, Thrasher JD, Crago R, Madison RA, et al (2003). Mixed mold mycotoxicosis: immunological changes in humans following exposure in water-damaged buildings. Arch Environ Health, 58(7) pp 410-20.

35890

Goswami R, Bhatia M, Goyal R, Kochupillai N (2002). Reversible peripheral neuropathy in idiopathic hypoparathyroidism. Acta Neurol Scand, 105(2) pp 128-31.

35908

Dyck P, Windebank AJ (2002). Diabetic and nondiabetic lumbosacral radiculoplexus neuropathies: New insights into pathophysiology and treatment. Muscle and Nerve, 25(4) pp 477-91.

35909 Hadjivassiliou M, et al (2002). Gluten sensitivity as a neurological illness. Journal of Neurology Neurosurgery and Psychiatry, Vol 72 pp 560-63.

35910 Krantz A, Dorevitch S (2004). Metal Exposure and Common Chronic Diseases: A guide for the Clinician. Dis Mon, Vol 50 pp 220-262.

35911

Lidove O, Cacoub P, Maisonobe T, Servan J, et al (2001). Hepatitis C virus infection with peripheral neuropathy is not always associated with cryoglobulinaemia. Ann Rheum Dis, 60(3) pp 290-292.

35913

Anon (2001). n-Hexane-related peripheral neuropathy among automotive technicians--California, 1999-2000. MMWR Morb Mortal Wkly Rep, 50(45) pp 1011-13.

35918

Lefaucheur JP, Gregson NA, Gray I, von Raison F, et al (2003). A variant of multifocal motor neuropathy with acute, generalised presentation and persistent conduction blocks. J Neurol Neurosurg Psychiatry, 74(11) pp 1555-61.

35919 Pearn J (2001). Neurology of ciguatera. J Neurol Neurosurg Psychiatry, 70(1) pp 4-8.

35920

Ogura T, Makinodan A, Kubo T, Hayashida T, Hirasawa Y (2001). Electrophysiological course of uraemic neuropathy in haemodialysis patients. Postgrad Med J, 77(909) pp 451-4.

35928 Hund E (2001). Critical illness polyneuropathy. Curr Opin Neurol, 14(5) pp 649-53.

35929 Hocking B, Westerman R (2003). Neurological effects of radiofrequency radiation. Occup Med (Lond), 53(2) pp 123-27.

35931 Bressler AM, Zimmer SM, Gilmore JL, Somani J (2004). Peripheral neuropathy associated with prolonged use of linezolid. Lancet Infect Dis, 4(8) pp 528-31.

35939 Fauci AS, Braunwald E, Isselbacher KJ, et al (Eds.)(1998). Harrison’s Principles of Internal Medicine 14th Edition, Vol 2. McGraw-Hill, New York.

36021 Rho JP,Sia IG, Crum BA, Dekutoski MB and Trousdale RT (2004). Linezolid-associated peripheral neuropathy. Mayo Clinic Proceedings, 79(7) pp 927-930.

38065 Younger DS (2004). Vasculitis of the nervous system. Curr Opin Neurol, Vol 17 pp 317-336.

50902 Posada de la Paz M, Philen RM, Borda IA (2001). Toxic oil syndrome: The perspective after 20 years. Epidemiol Rev, 23(2): 231-47.

57092

Committee on Gulf War and Health (2010). Update of health effects of serving in the Gulf War. Gulf War and Health, Vol 8. National Academy Press - Washington, DC.

60969

Berenson JR, Anderson KC, Audell RA, Boccia RV, et al (2010). Monoclonal gammopathy of undetermined significance: a consensus statement. Br J Haematol, 150: 28-38.

of 53

64717

Ferguson JS, Franco J, Pollack J, Rumbolo P, Smock M (2010). Compression neuropathy: a late finding in the postburn population: a four-year institutional review. J Burn Care Res, 31: 458-61.

65582

Ravaglia S, Marchioni E, Costa A et al (2004). Erectile dysfunction as a sentinel symptom of cardiovascular autonomic neuropathy in heavy drinkers. J Peripher Nerv Syst, 9(4): 209-14.

66975 Koike H, Tanaka F, Sobue G (2011). Paraneoplastic neuropathy: wide-ranging clinicopathological manifestations. Curr Opin Neurol, 24(5): 504-10.

67394 Kelly JJ, Karcher DS (2005). Lymphoma and peripheral neuropathy: a clinical review. Muscle Nerve, 31(3): 301-13.

67871 Arbogast SD (2012). Autonomic neuropathy. . Retrieved 24 May 2013, from http://emedicine.medscape.com/article/1173756-overview#aw2aab6b2b4

68441 Lotti M, Moretto A (2005). Organophosphate-induced delayed polyneuropathy. Toxicol Rev, 24(1): 37-49.

68603 Ng K, Lin CS, Murray NM et al (2007). Conduction and excitability properties of peripheral nerves in end-stage liver disease. Muscle Nerve, 35(6): 730-8.

68604

Shehab D, Al-Jarallah K, Mojiminiyi OA et al (2012). Does Vitamin D deficiency play a role in peripheral neuropathy in Type 2 diabetes? Diabet Med, 29(1): 43-9.

68605

Wolf S, Barton D, Kottschade L et al (2008). Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies. Eur J Cancer, 44(11): 1507-15.

68606 Labate A, Morelli M, Palamara G et al (2010). Tacrolimus-induced polyneuropathy after heart transplantation. Clin Neuropharmacol, 33(3): 161-2.

68607

Bilodeau M, Hassoun Z, Brunet D (2008). Demyelinating sensorimotor polyneuropathy associated with the use of sirolimus: a case report. Transplant Proc, 40(5): 1545-7.

68608 Stubgen JP (2011). Neuromuscular disorders associated with hepatitis B virus infection. J Clin Neuromuscul Dis, 13(1): 26-37.

68609

Scarpato S, Tirri E, Naclerio C et al (2007). Plasmapheresis in cryoglobulinemic neuropathy: a clinical study. Dig Liver Dis, 39(Suppl 1): s136-7.

68610

Agmon-Levin N, Kivity S, Tzioufas AG et al (2012). Low levels of vitamin-D are associated with neuropathy and lymphoma among patients with Sjögren's syndrome. J Autoimmun, 39(3): 234-9.

68611

Koike H, Hama T, Kawagashira Y et al (2012). The significance of folate deficiency in alcoholic and nutritional neuropathies: analysis of a case. Nutrition, 28(7-8): 821-4.

68612

Echaniz-Laguna A, de Séze J, Chanson JB (2012). Chronic inflammatory demyelinating polyradiculoneuropathy in solid organ transplant recipients: a prospective study. J Neurol Neurosurg Psychiatry, 83(7): 699-705.

68613

Zambelis T, Karandreas N, Tzavellas E et al (2005). Large and small fiber neuropathy in chronic alcohol-dependent subjects. J Peripher Nerv Syst, 10(4): 375-81.

68614

Cacoub P, Saadoun D, Limal N et al (2005). Hepatitis C virus infection and mixed cryoglobulinaemia vasculitis: a review of neurological complications. AIDS, 19(Suppl 3): s128-34.

68615 Sene D, Limal N, Cacoub P (2004). Hepatitis C virus-associated extrahepatic manifestations: a review. Metab Brain Dis, 19(3-4): 357-81.

68643 Krishnan AV, Kiernan MC (2007). Uremic neuropathy: clinical features and new pathophysiological insights. Muscle Nerve, 35(3): 273-90.

68644 Brouns R, De Deyn PP (2004). Neurological complications in renal failure: a review. Clin Neurol Neurosurg, 107(1): 1-16.

68645

O'Regan J, Walsh R, Kelly D et al (2012). Neuropathy in the hemodialysis population: a review of neurophysiology referrals in a tertiary center. Ren Fail, 34(4): 538-41.

of 53

68646 Vernino S, Wolfe GI (2007). Antibody testing in peripheral neuropathies. Neurol Clin, 25(1): 29-46.

68647 Hernandez L, Green PH (2006). Extraintestinal manifestations of celiac disease. Curr Gastroenterol Rep, 8(5): 383-9.

68648

Lionetti E, Francavilla R, Pavone P et al (2010). The neurology of coeliac disease in childhood: what is the evidence? A systematic review and meta-analysis. Dev Med Child Neurol, 52(8): 700-7.

68649

Tesfaye S, Selvarajah D (2012). Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. Diabetes Metab Res Rev, 28(Suppl 1): 8-14.

68650

Zois CD, Katsanos KH, Kosmidou M et al (2010). Neurologic manifestations in inflammatory bowel diseases: current knowledge and novel insights. J Crohns Colitis, 4(2): 115-24.

68651 Scheid R, Teich N (2007). Neurologic manifestations of ulcerative colitis. Eur J Neurol, 14(5): 483-93.

68652

Ariatti A, Ficarra G, Girolami F et al (2009). Chronic inflammatory demyelinating polyradiculoneuropathy associated with inflammatory bowel diseases: questioning the autoimmunity hypothesis. Int J Colorectal Dis, 24(5): 603-4.

68653 Gascon-Bayarri J, Mana J, Martinez-Yelamos S et al (2011). Neurosarcoidosis: report of 30 cases and a literature survey. Eur J Intern Med, 22(6): e125-32.

68654 Vargas DL, Stern BJ (2010). Neurosarcoidosis: diagnosis and management. Semin Respir Crit Care Med, 31(4): 419-27.

68655 Grantz M (2010). Unusual peripheral neuropathies. Part II: intrinsic reactive causes. Semin Neurol, 30(4): 396-404.

68668 Grantz M, Huan MC (2010). Unusual peripheral neuropathies. Part I: extrinsic causes. Semin Neurol, 30(4): 387-95.

68669 Grantz M (2010). Unusual peripheral neuropathies. Part III: intrinsic inherited causes. Semin Neurol, 30(4): 405-15.

68670

Vital A, Lagueny A, Ferrer X et al (2008). Sarcoid neuropathy: clinico-pathological study of 4 new cases and review of the literature. Clin Neuropathol, 27(2): 96-105.

68736 Mistry N, Wass J, Turner MR (2009). When to consider thyroid dysfunction in the neurology clinic. Pract Neurol, 9(3): 145-56.

68737

Hordon LD (2012). Rheumatic and bone disorders associated with acromegaly [updated 29/8/12]. . Retrieved 26 July 2013, from http://www.uptodate.com/contents/rheumatic-and-bone-disorders-associated-with-acromegaly

68738

Chapman IM (2007). Gigantism and acromegaly. . Retrieved 26 July 2013, from http://www.merckmanuals.com/professional/endocrine_and_metabolic_disorders/pituitary_disorders/gigantism_and_acromegaly.html

68739

Ropper AH, Samuels MA (2009). Intracranial neoplasms and paraneoplastic disorders. Adams and Victor's Principles of Neurology, Chapter 31: 612-666. McGraw Hill.

68740

Ropper AH, Samuels MA (2009). Diseases of the nervous system caused by nutritional deficiency. Adams and Victor's Principles of Neurology, Chapter 41: 1108-30. McGraw Hill.

68742

Ropper AH, Samuels MA (2009). Disorders of the nervous system caused by drugs, toxins, and other chemical agents. Adams and Victor's Principles of Neurology, Chapter 43: 1145-80. McGraw Hill.

68743 Ropper AH, Samuels MA (2009). Diseases of the peripheral nerves. Adams and Victor's Principles of Neurology, Chapter 46: 1251-325. McGraw Hill.

68745

Gerke AK, Hunninghake GW (2012). Hypersensitivity pneumonitis and pulmonary infiltrates with eosinophilia. Harrison's Principles of Internal Medicine, 18th Edition, Chapter 255: 2116-21. .

of 53

68746 Powers AC (2012). Diabetes mellitus. Chronic complications of DM. Harrison's Principles of Internal Medicine, 18th Edition, Chapter 344: 2980-9. .

68747 Amato AA, Barohn RJ (2012). Peripheral neuropathy. Harrison's Principles of Internal Medicine, 18th Edition, Chapter 384: 3448-72. .

68752

Carlson K, Ocean AJ (2011). Peripheral neuropathy with microtubule-targeting agents: occurrence and management approach. Clin Breast Cancer, 11(2): 73-81.

68753 Cavaletti G, Marmiroli P (2010). Chemotherapy-induced peripheral neurotoxicity. Nat Rev Neurol, 6(12): 657-66.

68754

Delforge M, Blade J, Dimopoulos MA et al (2010). Treatment-related peripheral neuropathy in multiple myeloma: the challenge continues. Lancet Oncol, 11(11): 1086-95.

68755

Cavaletti G, Jakubowiak AJ (2010). Peripheral neuropathy during bortezomib treatment of multiple myeloma: a review of recent studies. Leuk Lymphoma, 51(7): 1178-87.

68756

Braik T, Evans AT, Telfer M et al (2010). Paraneoplastic neurological syndromes: unusual presentations of cancer. A practical review. Am J Med Sci, 340(4): 301-8.

68760 Kelly JJ (2004). The evaluation of peripheral neuropathy. Part I: clinical and laboratory evidence. Rev Neurol Dis, 1(3): 133-40.

68761 Kelly JJ (2004). The evaluation of peripheral neuropathy. Part II: Identifying common clinical syndromes. Rev Neurol Dis, 1(4): 190-201.

68762 Kelly JJ (2005). Evaluation of peripheral neuropathy. Part III: vasculitic, infectious, inherited, and idiopathic neuropathies. Rev Neurol Dis, 2(2): 70-9.

68818

Anderson KC, Alsina M, Bensinger W et al (2012). Waldenstrom's macroglobulinemia/lymphoplasmacytic lymphoma, version 2.2013. J Natl Compr Canc Netw, 10(10): 1211-9.

68819 Giglio P, Gilbert MR (2006). Neurologic complications of non-Hodgkin's lymphoma. Curr Hematol Malig Rep, 1(4): 214-9.

68820 Baehring JM, Batchelor TT (2012). Diagnosis and management of neurolymphomatosis. Cancer J, 8(5): 463-8.

68821 Li J, Zhou DB (2013). New advances in the diagnosis and treatment of POEMS syndrome. Br J Haematol, 161(3): 303-15.

68822 Scarlato M, Previtali SC (2011). POEMS syndrome: the matter-of-fact approach. Curr Opin Neurol, 24(5): 491-6.

68823 Dispenzieri A (2011). POEMS syndrome: 2011 update on diagnosis, risk-stratification, and management. Am J Hematol, 86(7): 591-601.

68824

Pavlakis PP, Alexopoulos H, Kosmidis ML et al (2012). Peripheral neuropathies in Sjogren's syndrome: a critical update on clinical features and pathogenetic mechanisms. J Autoimmun, 39(1-2): 27-33.

68825 Ramchandren S, Lewis RA (2012). An update on monoclonal gammopathy and neuropathy. Curr Neurol Neurosci Rep, 12(1): 102-10.

68826 Kelly JJ (2008). Peripheral neuropathies associated with monoclonal gammopathies of undetermined significance. Rev Neurol Dis, 5(1): 14-22.

68827 Lozeron P, Adams D (2007). Monoclonal gammopathy and neuropathy. Curr Opin Neurol, 20(5): 536-41.

68829 Rajabally YA (2011). Neuropathy and paraproteins: review of a complex association. Eur J Neurol, 18(11): 1291-8.

68830 Zivkovic SA, Lacomis D, Lentzsch S (2009). Paraproteinemic neuropathy. Leuk Lymphoma, 50(9): 1422-33.

68831 Kwan JY (2007). Paraproteinemic neuropathy. Neurol Clin, 25(1): 47-69.

68832 Acharya JN, Pacheco VH (2008). Neurologic complications of hepatitis C. Neurologist, 14(3): 151-6.

68833 Silberman J (2008). Review of peripheral neuropathy in plasma cell disorders. Hematological Oncology, 26(2): 55-65.

of 53

68834 Drappatz J, Batchelor T (2004). Neurologic complications of plasma cell disorders. Clinical Lymphoma, 5(3): 163-71.

68835 Blade J, Rosinol L (2007). Complications of multiple myeloma. Hematology/oncology Clinics of North America, 21(6): 1231-46.

68836

Richardson PG, Delforge M, Beksac M, et al (2012). Management of treatment-emergent peripheral neuropathy in multiple myeloma. Leukemia, 26(4): 595-608.

68837

Badros A, Goloubeva O, Dalal JS, et al (2007). Neurotoxicity of bortezomib therapy in multiple myeloma: a single-center experience and review of the literature. Cancer, 110(5): 1042-9.

68848 Behin A, Psimaras D, Hoang-Xuan K, et al (2008). Neuropathies in the context of malignancies. Current Opinion in Neurology, 21(5): 534-39.

68849 Antoine JC, Camdessanche JP (2007). Peripheral nervous system involvement in patients with cancer. Lancet Neurology, 6(1): 75-86.

68850

Dumcke CW, Moller S (2008). Autonomic dysfunction in cirrhosis and portal hypertension. Scandinavian Journal of Clinical and Laboratory Investigation, 68(6): 437-47.

68851

Hojs-Fabjan T, Hojs R (2006). Polyneuropathy in hemodialysis patients: the most sensitive electrophysiological parameters and dialysis adequacy. Wien Klin Wochenschr, 118(Suppl 2): 29-34.

68852

Briani C, Zara G, Alaedini A, et al (2008). Neurological complications of celiac disease and autoimmune mechanisms: a prospective study. Journal of Neuroimmunology, 195(1-2): 171-5.

68853

Green PH, Alaedini A, Sander HW, et al (2005). Mechanisms underlying celiac disease and its neurologic manifestations. Cellular & Molecular Life Sciences: CMLS, 62(7-8): 791-9.

68981 Misiunas A, Niepomniszcze H, Ravera B, et al (1995). Peripheral neuropathy in subclinical hypothyroidism. Thyroid, 5(4): 283-6.

68982 Sahni V, Gupta N, Anuradha S, et al (2007). Thyrotoxic neuropathy- an under diagnosed condition. The Medical Journal of Malaysia, 62(1): 76-7.

68989

Franca MC Jr, de Castro R, de Oliveira MF, et al (2004). Long-standing idiopathic hypoparathyroidism masking coexistent chronic inflammatory demyelinating polyneuropathy. Journal of the Peripheral Nervous System, 9(4): 196-7.

68990

Dionisi-Vici C, Garavaglia B, Burlina AB, et al (1996). Hypoparathyroidism in mitochondrial trifunctional protein deficiency. The Journal of Pediatrics, 129(1): 159-62.

68991

Oliveira GR, Teles BC, Brasil EF, et al (2008). Peripheral neuropathy and neurological disorders in an unselected Brazilian population-based cohort of IBD patients. Inflammatory Bowel Disease, 14(3): 389-95.

68992

Sassi SB, Kallel L, Ben Romdhane S, et al (2009). Peripheral neuropathy in inflammatory bowel disease patients: a prospective cohort study. Scandinavian Journal of Gastroenterology, 44(10): 1268-9.

68993

Shen TC, Lebwohl B, Verma H, et al (2012). Peripheral neuropathic symptoms in celiac disease and inflammatory bowel disease. Journal of Clinical Neuromuscular Disease, 13(3): 137-45.

69021

Figueroa JJ, Loftus EV Jr, Harmsen WS, et al (2013). Peripheral neuropathy incidence in inflammatory bowel disease: a population-based study. Neurology, 80(18): 1693-7.

69022 Hobson-Webb LD, Donofrio PD (2005). Inflammatory neuropathies: an update on evaluation and treatment. Curr Rheumatol Rep, 7(5): 348-55.

69119 Volta U, De Giorgio R, Granito A, et al (2006). Anti-ganglioside antibodies in coeliac disease with neurological disorders. Dig Liver Dis, 38(3): 183-7.

69132 Chen YH, Lin HJ, Chen KT (2009). Rare presentations of hyperthyroidism--Basedow's paraplegia and pancytopenia. Am J Emerg Med, 27(2): 258.e1-e2.

of 53

69133 Pandit L, Shankar SK, Gayathri N, et al (1998). Acute thyrotoxic neuropathy--Basedow's paraplegia revisited. J Neurol Sci, 155(2): 211-4.

69193 Kolson DL, Gonzalez-Scarano F (2001). HIV-associated neuropathies: role of HIV-1, CMV, and other viruses. J Peripher Nerv Syst, 6(1): 2-7.

69265 Kelly JJ (2008). Peripheral neuropathies associated with monoclonal gammopathies of undetermined significance. Rev Neurol Dis., 5(1): 14-22.

69266

Sugie K, Umehara F, Kataoka H, et al (2012). Chronic severe axonal polyneuropathy associated with hyperthyroidism and multivitamin deficiency. Neuro Endocrinol Lett, 33(8): 757-60.

69267 Sozay S, Gokce-Kutsal Y, Celiker R, et al (1994). Neuroelectrophysiological evaluation of untreated hyperthyroid patients. Thyroidology, 6(2): 55-9.

69269

Zezos P, Mpoumponaris A, Koutsopetras P, et al (2007). Acute motor sensory polyneuropathy (AMSAN) complicating active ulcerative colitis with a patchy distribution. Acta Gastroenterol Belg, 70(2): 226-30.

69288 Kung AW (2007). Neuromuscular complications of thyrotoxicosis. Clin Endocrinol, 67(5): 645-50.

69791

Boylu E, Togrol E, Dogan T, et al (2010). Crohn disease and chronic inflammatory demyelinating polyneuropathy; a case report. Electromyogr Clin Neurophysiol, 50(3-4): 181-5.

69792 Glass J (2006). Neurologic complications of lymphoma and leukemia. Semin Oncol, 33(3): 342-7.

69971

Malas FU, Ozcakar L, Fìrat F, et al (2007). Drop foot in Crohn's disease: reported nadir incidence of peroneal neuropathy. Inflamm Bowel Dis, 13(12): 1586-7.

70049 Said G, Lacroix C (2005). Primary and secondary vasculitic neuropathy. J Neurol, 252(6): 633-41.

70051 Vrancken AF, Said G (2013). Vasculitic neuropathy. Handb Clin Neurol, 115: 463-83.

70052 Burns TM, Schaublin GA, Dyck PJ (2007). Vasculitic neuropathies. Neurol Clin, 25(1): 89-113.

70130 Poza JJ, Cobo AM, Marti-Masso JF (1996). Peripheral neuropathy associated with polycythemia vera. Neurologia, 11(8): 276-9.

70197 de Freitas MR (2007). Infectious neuropathy. Curr Opin Neurol, 20(5): 548-52. 70198 Said G (2007). Infectious neuropathies. Neurol Clin, 25(1): 115-37.

70199

Langford CA, Fauci AS (2013). Chapter 236: The Vasculitis Syndromes. Harrison’s Internal Medicine Online. . Retrieved 21 November 2013, from http://accessmedicine.com/content.aspx?aid=9138083

70210

Filosto M, Cavallaro T, Pasolini G, et al (2009). Idiopathic hypocomplementemic urticarial vasculitis-linked neuropathy. J Neurol Sci, 284(1-2): 179-81.

70211 Manji H (2011). Toxic neuropathy. Curr Opin Neurol, 24(5): 484-90.

70212 Weimer LH, Sachdev N (2009). Update on medication-induced peripheral neuropathy. Curr Neurol Neurosci Rep, 9(1): 69-75.

70272 Morrison B, Chaudhry V (2012). Medication, toxic, and vitamin-related neuropathies. Continuum (Minneap Minn), 18(1): 139-60.

70280 Kumar N (2010). Neurologic presentations of nutritional deficiencies. Neurol Clin, 28(1): 107-70.

70296

Corssmit EP, Leverstein-van Hall MA, Portegies P, et al (1997). Severe neurological complications in association with Epstein-Barr virus infection. J NeuroVirol, 3: 460-464.

71044 Lui CH, Huang CY, Huang CC (2012). Occupational Neurotoxic Diseases in Taiwan. Safety and Health at Work, 3(4): 257-267.

71045

Becker DA, Balcer LJ, Galetta SL (2012). The Neurological Complications of Nutritional Deficiency following Bariatric Surgery. J Obes, 2012(Article ID 608534): Epub.

of 53

71046 Koffman BM, Greenfield LJ, Ali II, et al (2006). Neurologic complications after surgery for obesity. Muscle & Nerve, 33(2): 166-76.

71047

Karami-Mohajeri S, Nikfar S, Abdollahi M (2014). A systematic review on the nerve-muscle electrophysiology in human organophosphorus pesticide exposure. Hum Exp Toxicol, 33(1): 92-201.

71048

Husain K, Ansari RA, Ferder L (2010). Pharmacological agents in the prophylaxis/treatment of organophosphorous pesticide intoxication. Indian J Exp Biol, 48(7): 642-50.

71049 Colovic MB, Krstic DZ, Lazarevic-Pasti TD, et al (2013). Acetylcholinesterase inhibitors: pharmacology and toxicology. Curr Neuropharmacol, 11(3): 315-35.

71050

Rubin M (2012). Peripheral Neuropathy. The Merck Manual for healthcare professionals. . Retrieved 26 February 2014, from http://www.merckmanuals.com/professional/neurologic_disorders/peripheral_nervous_system_and_motor_unit_disorders/peripheral_neuropathy.html#v6570077

71051

Rubin M (2012). Nerve Root Disorders. The Merck Manual for Healthcare professionals. . Retrieved 26 February 2014, from http://www.merckmanuals.com/professional/neurologic_disorders/peripheral_nervous_system_and_motor_unit_disorders/nerve_root_disorders.html

71052

Ben Slamia L, Harzallah S, Lamouchi T, et al (2006). [Peripheral neuropathy induced by acute methyl bromide skin exposure: a case report]. Rev Neurol (Paris), 162(12): 1257-9. [Abstract]

71152 Kuo HC, Huang CC, Chu CC, et al (2006). Axonal polyneuropathy after acute dimethylamine borane intoxication. Arch Neurol, 63(7): 1009-12.

71371

Yi SW, Ohrr H, Hong JS, et al (2013). Agent Orange exposure and prevalence of self-reported diseases in Korean Vietnam veterans. J Prev Med Public Health, 46: 213-25.

71395 Douvoyiannis M, Litman N, Goldman DL (2009). Neurologic manifestations associated with parvovirus B19 infection. Clin Infect Dis, 48(12): 1713-23.

71396

Tubone MQ, Escobar GF, Peruzzu J et al (2013). Livedoid vasculopathy associated with peripheral neuropathy: a report of two cases. An Bras Dermatol, 88(6 (Suppl 1)): 227-9.

71397 Kim JE, Park SY,Sinn DI et al (2011). Ischemic neuropathy associated with livedoid vasculitis. journal of clinical neurology, 7(4): 233-6.

71398

Sinkovic A, Smolle-Juettner FM, Krunic B, et al (2006). Severe carbon monoxide poisoning treated by hyperbaric oxygen therapy - a case report. Inhal Toxicol, 18(3): 211-4.

71399

Bennetto L, Powter L, Scolding NJ (2008). Accidental carbon monoxide poisoning presenting without a history of exposure: a case report. J Med Case Rep, 2: 118.

71400

Lahbabi M, Ghissassi M, Belahcen F, et al (2012). Acute inflammatory demyelinating polyneuropathy after treatment with pegylated interferon alfa-2a in a patient with chronic hepatitis. Journal of Medical Case Reports, 6(1): 278.

71401

Khiani V, Kelly T, Shibli A et al (2008). Acute inflammatory demyelinating polyneuropathy associated with pegylated interferon alpha 2a therapy for chronic hepatitis C virus infection. World J Gastroenterol, 14(2): 318-21.

71402 Chester AC, Sandroni P (2011). Case report: Peripheral polyneuropathy and mefloquine prophylaxis. Am J Trop Med Hyg, 85(6): 1008-9.

71403

Gabriel V, Kowalske KJ, Holavanahalli RK (2009). Assessment of recovery from burn-related neuropathy by electrodiagnostic testing. J Burn Care Res, 30(4): 668-74.

71404 Tamam Y, Tamam C, Tamam B,et al (2013). Peripheral neuropathy after burn injury. Eur Rev Med Pharmacol Sci, 17(Suppl 1): 107-11.

71405 Tsan YT, Peng KY, Hung DZ et al (2005). Case report: the clinical toxicity of dimethylamine borane. Environ Health Perspect, 113(12): 1784-6.

of 53

71406 Ostwal P, Dabadghao VS, Sharma SK et al (2013). Chlorpyrifos toxicity causing delayed myeloneuropathy. Ann Indian Acad Neurol, 16(4): 736.

71407

Garzoni L, Vanoni F, Rizzi M et al (2009). Nervous system dysfunction in Henoch-Schonlein syndrome: systematic review of the literature. Rheumatology ( Oxford), 48(12): 1524-9.

71408 Kushlaf HA (2011). Emerging toxic neuropathies and myopathies. Neurol Clin, 29(3): 679-87.

71409

Diezi M, Buclin T, Kuntzer T (2013). Toxic and drug induced peripheral neuropathies: updates on causes, mechanisms and management. Curr Opin Neurol, 26(5): 481-8.

71410

Brass SD, Helfgott SM (2014). Clinical manifestations of vasculitic neuropathy. . Retrieved 30 April 2014, from http://www.uptodate.com/contents/clinical-manifestations-of-vasculitic-neuropathy?source=see_link

71411 Young AL, Cecil PF Sr (2011). Agent Orange exposure and attributed health effects in Vietnam veterans. Mil Med, 176(7 Suppl): 29-34.

71412 de la Monte SM, Kril JJ (2014). Human alcohol-related neuropathology. Acta Neuropathol, 127(1): 71-90.

71413

Nardin R, Freeman R (2014). Epidemiology, pathogenesis and clinical features of HIV-associated neuropathies. . Retrieved 30 April 2014, from http://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-features-of-hiv-associated- neuropathies?source=search_result&search=epidemiology+pathogenesis+and+clinical+features+of+the+hiv+associated+neuropathies&selectedTitle=1%7E5

71414

Nardin RA, Freeman R (2014). Diagnosis, treatment and prognosis of HIV-associated neuropathies. . Retrieved 30 April 2014, from http://www.uptodate.com/contents/diagnosis-treatment-and-prognosis-of-hiv-associated-neuropathies?

71415 McKeown NJ (2013). Toluene toxicity. . Retrieved 30 April 2014, from http://emedicine.medscape.com/article/818939-overview

71416 Rutchik JS (2014). Toxic neuropathy clinical presentation. . Retrieved 30 April 2014, from http://emedicine.medscape.com/article/1175276-clinical#showall

71417

Bird S (2013). Organophosphate and carbamate poisoning. . Retrieved 30 April 2014, from http://www.uptodate.com/contents/organophosphate-and-carbamate-poisoning

71418 Laker SR (2013). Alcoholic neuropathy. . Retrieved 30 April 2014, from http://emedicine.medscape.com/article/315159-clinical#showall

71419 Kedlaya D (2014). Mononeuritis multiplex. . Retrieved 30 April 2014, from http://emedicine.medscape.com/article/316024-overview#showall

71420

Dedeoglu F, Kim S, Sundel R (2014). Clinical manifestations and diagnosis of Henoch-Schonlein purpura (IgA vasculitis). . Retrieved 30 April 2014, from http://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-henoch-schonlein-purpura-iga-vasculitis?source=see_link

71421 Lee MY, Liu G, Kowlowitz JH et al (2009). Causative factors affecting peripheral neuropathy in burn patients. Burns, 35(3): 412-6.

71422

Garcia A, Maestro I (2005). Reversible motor and sensory peripheral neuropathy in a patient following acute carbon monoxide intoxication. Electromyogr Clin Neurophysiol, 45(1): 19-21.

71423

Lenglet T, Haroche J, Schnuriger A et al (2011). Mononeuropathy multiplex associated with acute parvovirus B19 infection: characteristics, treatment and outcome. J Neurol, 258(7): 1321-6.

71424 Shi X, Yu S (2013). Trichloropropane and dichlorohydrin associated with painful peripheral neurotoxicity. J Clin Neurosci, 20(10): 1387 - 9.

71425

Osada S, Kimura Y, Kawana S (2010). Case of livedoid vasculopathy with peripheral neuropathy successfully treated with low-dose warfarin. J Dermatol, 37(1): 98-101.

of 53

71426

Jha S, Kumar R, Kumar R (2006). Mefloquine toxicity presenting with polyneuropathy - a report of two cases in India. Trans R Soc Trop Med Hyg, 100(6): 594-6.

71427

Thivakaran T, Gamage R, Gunarathne KS et al (2012). Chlorpyrifos-induced delayed myelopathy and pure motor neuropathy: a case report. Neurologist, 18(4): 226-8.

71438 Qureshi A, Ali R, Yaqoob MY et al (2007). Organophosphate induced delayed polyneuropathy. J Coll Physicians Surg Pak, 17(7): 441-3.

71457

McKenney JM, Davidson MH, Jacobson TA et al (2006). Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force. Am J Cardio, 97(8A): 89C- 94C.

71458 Iguchi Y, Mori K, Koike H et al (2009). Hypophosphataemic neuropathy during total parental nutrition. BMJ Care Rep, 2009: pii:bcr08.2008.0718.

71460

Grisold W, Cavaletti G, Windebank AJ (2012). Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment and prevention. Neuro Oncol, 14: Supp 4;iv45-54 doi:10.1093.

71461

Lahbabi M, Ghissassi M, Belahcen F et al (2012). Acute inflammatory demyelinating polyneuropathy after treatment with pegylated interferon alfa-2a in a patient with chronic hepatitis C virus infection: a case report. J Med Case Rep, 6(1): 278.

71475 Kumar N (2007). Obesity surgery: a word of neurological caution. Neurology, 68(21): E36 - E38.

71477

Juhasz-Pocsine K, Rudnicki SA, Archer RL et al (2007). Neurologic complications of gastric bypass surgery for morbid obesity. Neurology, 68(21): 1843 - 1850.

71479 Guest M, Attia JR, D'este CA et al (2011). Peripheral neuropathy in military aircraft maintenance workers in Australia. J Occup Environ Med, 53(4): 381-7.

71480

Roshanzamir S, Dabbaghmanesh A, Ashraf A (2013). Predicting post-electrical injury autonomic dysfunction symptom occurrence by a simple test. Elsevier, 40: 624-9.

71481 Watson DF, Griffin JW (1987). Vacor neuropathy: ultrastructural and axonal transport studies. J Neuropathol Exp Neurol, 46(1): 96-108.

71482

Gable KL,Afshari Z, Sufit RL et al (2013). Distal acquired demyelinating symmetric neuropathy after vaccination. J Clin Neuromuscul Dis, 14(3): 117-22.

71483

Brass SD, Helfgott SM (2014). Clinical manifestations of vasculitic neuropathy. . Retrieved 9 May 2014, from http://www.uptodate.com/contents/clinical-manifestations-of-vasculitic-neuropathy#H20

71484 Rudnicki SA (2010). Prevention and treatment of peripheral neuropathy after bariatric surgery. Curr Treat Options Neurol, 12(1): 29-36.

71485

De Weerdt A, Claeys KG, De Jonghe P et al (2008). Tacrolimus-related polyneuropathy: case report and review of literature. Clin Neurol Neurosurg, 110(3): 291-294.

71486

Lacomis D (2014). Neuromuscular weakness related to critical illness. . Retrieved 9 May 2014, from http://www.uptodate.com/contents/neuromuscular-weakness-related-to-critical-illness

71505 Hasbani MJ, Sansing LH, Perrone J (2005). Encephalopathy and peripheral neuropathy following diethylene glycol ingestion. Neurology, 64(7): 1273-5.

71516 Daubert GP, Katiyar A, Wilson J et al (2006). Encephalopathy and peripheral neuropathy following diethylene glycol ingestion. Neurology, 66(5): 782 - 3.

71522 Brannagan TH, Weimer LH (2010). Acquired neuropathies. Merritt's Neurology, 12th, 134: 823-838. Lippincott Williams & Wilkins, (Philadelphia).

71523 Stubgen JP (2009). Interferon alpha and neuromuscular disorders. Journal of Neuroimmunology, 207(1-2): 3-17.

of 53

71524

Bhagavati S, Maccabee P, Muntean E et al (2007). Chronic sensorimotor polyneuropathy associated with tacrolimus immunosuppression in renal transplant patients: case reports. Transplantation Proceedings, 39(10): 3465 - 3467.

71548

Ropper AH, Samuels MA (2009). Disorders of the nervous system caused by drugs, toxins and other chemical agents. Phosphorus and organophosphate poisoning. Adams and Victor's Principles of Neurology, 43, : 1169.

71549 Misra UK, Kalita J (2009). Toxic neuropathies. Neurol India, 57(6): 697-705.

71589

Hansen RA, Gartlehner G, Powell GE et al (2007). Serious adverse events with infliximab: analysis of spontaneously reported adverse events. Clin Gastroenterol Hepatol, 5(6): 729 - 36.

71590

Rollins YD, Filley CM, McNutt JT et al (2002). Fulminant ascending paralysis as a delayed sequela of diethylene (Sterno) ingestion. Neurology, 59(9): 1460 -3.

71638 Finsterer J (2009). Systemic and systemic vasculitis affecting the peripheral nerves. Acta Neurol Belg, (109): 100 - 13.

71639 Rahman SS, Kadakia S, Balsam L et al (2012). Autonomic dysfunction as a delayed sequelae of acute ethylene glycol ingestion. J Med Toxicol, (8): 124-9.

71640

Foreman AD, Meyers CA, Levin VA (2009). Neurotoxic effects of pharmaceutical agents IV:cancer chemotherapeutic agents. Ed MR Dobbs. Clinical Neurotoxicity: syndromes, substances, environments, 33: 372 - 381. .

71649

Ryan M (2009). Neurotoxic effects of pharmaceutical agents 1: Anti-infectives Ed MR Dobbs. Clinical Neurotoxicity: syndromes, substances environments, 30: 338 - 347. Elsevier Saunders.

71653

Ryan M, Kennedy KA (2009). Neurotoxic effects of pharmaceutical agents V: Miscellaneous agents ( Ed MR Dobbs). Clinical Neurotoxicity: syndromes, substances, environments, 34: 382 - 400. Elsevier Saunders.

71656

Gospe SM jr (2009). Other organic chemicals (Ed MR Dobbs). Clinical neurotoxicity: syndromes, substances, environments, 36: 415 - 20. Elsevier Saunders.

71660 Firestone JA, Gospe SM jr (2009). Organic solvents ( Ed MR Dobbs). Clinical neurotoxicity: syndromes, substances, environments, 35: 401 - 14. .

71673

Baldwin F, Sran H (2010). Delayed ethylene glycol poisoning presenting with abdominal pain and multiple cranial and peripheral neuropathies: a case report. J Med Case Rep, 4(220): 1-4.

71674

Campbell JR, Estey MP (2013). Metal release from hip prostheses: cobalt and chromium toxicity and the role of the clinical laboratory. Clin Chem Lab Med, 51(1): 213-20.

71675

Kim JM, Lee TH, Lee MC et al (2002). Endoneurial microangiopathy of sural nerve in experimental vacor-induced diabetes. Ultrastruct Pathol, 26(6): 393-401.

71676

Pazzaglia UE, Apostoli P, Congiu T et al (2011). Cobalt, chromium and molybdenum ions kinetics in the human body: data gained from a total hip replacement with massive third body wear of the head and neuropathy by cobalt intoxication. Arch Orthop Trauma Surg, 131(9): 1299-308.

71677

Reddy NJ, Sudini M, Lewis LD (2010). Delayed neurological sequelae from ethylene glycol, diethylene glycol and methanol poisonings. Clinical Toxicology, 48(10): 967 - 73.

71694

Institute of Medicine (2013). Chronic peripheral system disorders. Veterans and Agent Orange update 2012 (prepublication copy), : 660 - 3. National Academies Press - Washington, DC.

71696

Institute of Medicine (2013). Early-onset peripheral neuropathy. Veterans and Agent Orange: Update 2012, : 793 - 795. National Academies Press - Washington, DC.

71701 Ikeda T, Takahashi K, Kabata T et al (2010). Polyneuropathy caused by cobalt-chromium metallosis after total hip replacement. Muscle & Nerve, 42(1): 140-3.

of 53

71702

Alzouebi M, Sarrigiannis PG, Hadjivassiliou M, (2008). Acute polyradiculoneuropathy with renal failure: mind the anion gap. Journal of Neurology, Neurosurgery & Psychiatry, 79(7): 842 - 4.

71703

Biswas HH, Engstrom JW, Kaidarova Z et al (2009). Neurological abnormalities in HTLV-I - and HTLV - II- infected individuals without overt myelopathy. Neurology, (73): 781 - 789.

71705 Amato AA, Dumitru D (2002). Acquired neuropathies. Elsevier, Chapter 23: 937 - 1041. .

71708

Azhary H, Farooq MU, Bhanushali M et al (2010). Peripheral neuropathy:Differential diagnosis and management. American Family Physician, 81(7): 887 - 892.

71711

Duyff RF, Van den Bosch J, Laman DM (2000). Neuromuscular findings in thyroid dysfunction: a prospective clinical and electrodiagnostic study. J Neur, Neurosurg & Psych, (68): 750 - 5.

71718 European Medicines Agency (2008). Risk of peripheral neuropathy with Sebivo (telbivudine). Post-Authorisation Evaluation of Medicines for Human Use, : .

71719

Fujii N, Tabira T, Shibasaki H et al (1982). Acute autonomic and sensory neuropathy associated with elevated Epstein-Barr virus antibody titre. Journal of Neurology, Neurosurgery & Psychiatry, : 1-3.

71720 Gavin C, Langan Y, Hutchinson M (1997). Cranial and peripheral neuropathy due to Epstein-Barr virus infection. Postgrad Med J, : 1-2.

71721 Gay JDL, Grimes JD (1972). Idiopathic hypoparathyroidism with impaired vitamin B12 absorption and neuropathy. CMA Journal, 107: 54-7.

71722

Grauer O, Wolff D, Bertz H et al (2010). Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease in chronic graft-versus-host disease. Journal of Neurology, : 1-14.

71723

Gujral N, Freeman HJ, Thomson ABR (2012). Celiac disease:Prevalence, diagnosis, pathogenesis and treatment. World Journal of Gastroenterology, 18(42): 6036 - 6059.

71724

Hadjivassiliou M, Grunewald RA, Kandler RH et al (2006). Neuropathy associated with gluten sensitivity. J Neurol Neurosurg & Psychiatry, (77): 1262 - 1266.

71725 Liu CH, Huang CY, Huang CC (2012). Occupational neurotoxic diseases in Taiwan. Safety and Health at Work, (3): 257 - 67.

71726

Mihalj M, Titlic M, Bonacin D et al (2013). Sensomotor axonal peripheral neuropathy as a first complication of polycythemia rubra vera: A report of 3 cases. American Journal of Case reports, (14): 385 - 7.

71727 Pelosof LC, Gerber DE (2010). Paraneoplastic Syndromes: an approach to diagnosis and treatment. Mayo Clin Proc, 85(9): 838 - 54.

71728

Senanayake N (1981). Tri-cresyl phosphate neuropathy in Sri Lanka: a clinical and neurophysiological study with a three year follow up. Journal of Neurology, Neurosurgery & Psychiatry, (44): 775 - 80.

71731 Department of Veterans Affairs (2010). Information for health care/medical providers. F-111 SHOAMP health care scheme, : 1-2.

71737 Villa-Forte A, Mandell BF (2014). Systemic vasculitis syndromes. Scientific American Medicine, : 1-16.

71752 Adams D, Lozeron P, Lacroix C (2012). Amyloid neuropathies. Curr Opin Neurol, (25): 564-572.

of 53

71753 Head J, Johnston S (2004). New targets for therapy in breast cancer. Breast Cancer Res, 6(6): 262-268.

71754 Leikin JB,Karydes HC, Whiteley PM et al (2013). Outpatient toxicology clinic experience of patients with hip implants. Clin Toxicol, 51(4): 230-6.

71755

Gdynia HJ, Muller T, Sperfeld AD et al (2008). Severe sensorimotor neuropathy after intake of highest dosages of vitamin B6. Neuromuscular Disorders, 18(2): 156-8.

71756

US Food and Drug Administration (2013). Metal-on-metal hip implants:FDA Safety Communication. . Retrieved 11 June 2014, from http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm335775.htm

71757 Various authors (2014). Pyriminil. . Retrieved 11 June 2014, from http://toxnet.nlm.nih.gov/cgi-bin/sis/search

71758 Catalani S, Rizzetti MC, Padovani A et al (2012). Neurotoxicity of cobalt. Hum Exp Toxicol, 31(5): 421 - 37.

71777

Hernandez C (2013). Dermatologic manifestations of Churg-Struss syndrome (allergic granulomatosis). . Retrieved 13 June 2014, from http://emedicine.medscape.com/article/1083013-overview

71778 Quan D, Lin H (2012). Diabetic neuropathy. . Retrieved 13 June 2014, from http://emedicine.medscape.com/article/1170337-overview

71779 Dorlands online medical dictionary (2013). Polyneuropathy. . Retrieved 13 June 2014, from http://www.dorlands.com/def.jsp?id=100085057

71780

Goebel SU (2013). Celiac Sprue treatment and management. . Retrieved 13 June 2014, from http://emedicine.medscape.com/article/171805-treatment#01130

71781

O'Malley GF, O'Malley R (2013). Lead poisoning. . Retrieved 13 June 2014, from http://www.merckmanuals.com/professional/injuries_poisoning/poisoning/lead_poisoning.html

71782

Ludvigsson J, Olsson T, Ekbom A et al (2007). A population- based study of coeliac disease, neurodegenerative and neuroinflammatory diseases. Aliment Pharmacol Ther, (25): 1317-1327.

71783

Committee on Blue Water Navy Vietnam Veterans and Agent Orange Exposure (2011). Summary, and chapter 3 - selected chemicals used during the Vietnam War. Blue Water Navy Vietnam Veterans and Agent Orange Exposure, : 1, 53-55, 110. The National Academic Press, Washington DC.

71784

O'Malley GF (2013). Organophosphate and Carbamate poisoning. . Retrieved 13 June 2014, from http://www.merckmanuals.com/professional/injuries_poisoning/poisoning/organophosphate_and_carbamate_poisoning.html

71785 Perez-Ruixo J, Chen W, Zhang S et al (2011). Exposure- toxicity relationships for tipifarnib in cancer patients. Br J Clin Pharmacol, 64(2): 219-232.

71786 Dienstag JL (2014). Principles of Internal medicine - Chronic hepatitis. Harrison’s Internal Medicine, 18th Edition, 2 Chapter 306: 2567-88. .

71787

Unknown authors (2013). Amphotericin B Aspen ( amphotericin B) product information. . Retrieved 16 June 2014, from www.aspenpharma.com.au/product_info/pi/PI_Amphotericin_B_Aspen.pdf

71793 Rashtak S, Marietta E, Murray JA (2009). Celiac sprue: a unique autoimmune disorder. Expert Rev Clin Immunol, 5(5): 593-604.

71794 Roufosse F, Goldman M, Cogan E (2007). Hypereosinophilic syndromes. Orphanet J Rare Dis, 2: 37.

71797 Shani V, Gupta N, Anuradha S et al (2007). Thyrotoxic neuropathy - an under diagnosed condition. Med J Malaysia, 62(1): 76-7.

71798

Yamamoto S, Geiyjo F (2005). Historical background and clinical treatment of dialysis-related amyloidosis - Abstract only. Biochimica et Biophysica Acta, 1753(1): 4-10. [Abstract]

of 53

71801

Kaye K (2013). Infectious mononucleosis. . Retrieved 16 June 2014, from www.merckmanuals.com/professional/infectious_diseases/herpesviruses/infectious_mononucleosis.html

71806 Akhter K (2013). Cytomegalovirus. . Retrieved 16 June 2014, from http://emedicine.medscape.com/article/215702-overview

71807

Scheinfeld NS, Jones EL, Arnold JL et al (2013). Henoch-Schonlein purpura. . Retrieved 16 June 2014, from http://emedicine.medscape.com/article/984105-overview

71812 Mehdi A, Beydoun SR, (2012). Vasculitic neuropathy. . Retrieved 16 June 2014, from http://emedicine.medscape.com/article/1172488-overview#showall

71818

Pyrsopoulos N, Reddy KR, Talavera F et al (2013). Hepatitis B clinical presentation. . Retrieved 16 June 2014, from http://emedicine.medscape.com/article/177632-clinical

71819

Chawla J, Recht LD, Sewell RA (2013). Nutritional neuropathy. . Retrieved 16 June 2014, from http://emedicine.medscape.com/article/1171558-overview#showall

71820 Thomas F (2013). HIV associated multiple mononeuropathies. . Retrieved 17 June 2014, from http://emedicine.medscape.com/article/1167942-overview#a1

71823

Yesilova Z, Naharci I, Uygun A et al (2006). Motor axonal polyneuropathy in the course of ulcerative colitis: A case report. Turk J Gastroenterol, 17(1): 58-61.

71824

FDA drug and safety communication (2013). FDA drug safety communication: FDA requires label changes to warn of risk for possibly permanent nerve damage from antibacterial fluroquinolone drugs taken by mouth or by injection. . Retrieved 17 June 2014, from http://www.fda.gov/Drugs/DrugSafety/ucm365050.htm

71825

US Food and Drug Administration (2011). Tyzeka (telbivudine) labelling updates re:use with pegylated interferon alfa-2a. . Retrieved 17 June 2014, from http://www.fda.gov/ForConsumers/ByAudience/ForPAtientAdvocates/ucm285056.htm

71831

Wu G, Weng FL, Balaraman V (2013). Tacrolimus-induced encephalopathy and polyneuropathy in a renal transplant recipient. BMJ Case Reports, : doi:10.1136/bcr-2013-201099.

71882 Ramachandran T (2012). Metabolic neuropathy. . Retrieved 19 June 2014, from http://emedicine.medscape.com/article/1171051-overview#showall

71894

Author Unknown (2014). Amphotericin B Aspen ( amphotericin B) product information. : 1-6. Retrieved 20 June 2014, from http://www.aspenpharma.com.au/product_info/pi/PI_Amphotericin_B_Aspen.pdf

71896

Committee to review the health effects in Vietnam veterans of exposure to herbicides (2010). Veterans & Agent Orange: Update 2010, : pp7-10, 360-4. The National Academic Press, Washington DC.

71897 Wu G, Weng FL, Balaraman V (2013). Tacrolimus-induced encephalopathy and polyneuropathy in a renal transplant recipient. BMJ Case Reports, : 1-4.

72196 Rizzo MA, Frediani F, Granata A et al (2012). Neurological complications of hemodialysis: state of the art (2012). Journal of Nephrology, 25(2): 170-82.

72197

American Gastroenterological Association (2001). American Gastroenterological Association medical position statement: Celiac sprue. Gastroenterology, 120(6): 1522-25.

72207 Singerman J, Gomez M, Fish JS (2008). Long-term sequelae of low-voltage electrical injury. J Burn Care Res, 29(5): 773-7.

72218 Ratnayake B, Emmanuel ER, Walker CC (1996). Neurological sequlae following a high voltage electrical burn. Burns, 22(7): 574-7.

72219 Wesner ML, Hickie J (2013). Long-term sequelae of electrical injury. Can Fam Physician, 59(9): 935-9.

of 53

72220

Bailey B, Gaudreault P, Thivierge RL (2008). Neurologic and neuropsychological symptoms during the first year after an electric shock: results of a prospective multicenter study. Am J Emerg Med, 26(4): 413-8.

72221

Baqain E, Haertsch P, Kennedy P (2004). Complete recovery following a high voltage electrical injury associated with delayed onset of quadriplegia and multiple cranial nerves dysfunction. Burns, 30: 603-5.

72222

Duff, K McCaffrey RJ (2001). Electrical injury and lightning injury: a review of their mechanisms and neuropsychological, psychiatric and neurological sequelae. Neuropsychol Rev, 11: 101-16.

72223 Silversides J (1964). The neurological sequelae of electrical injury. Canadian Medical Association Journal, 91: 195-204.

72224 Grube BJ, Heimbach DM, Engrav LH et al (1990). Neurologic consequences of electrical burns. J Trauma, 30(3): 254-8.

72230

World Health Organization Drug Information (2005). Statins and peripheral neuropathy. 19 (2): 1-98. Retrieved 17 July 2014, from http://apps.who.int/medicinedocs/en/d/Js7917e/2.15.html

72232

Morse MS, Berg JS, Ten Wolde RL (2004). Diffuse electrical injury: a study of 89 subjects reporting long-term symptomatology that is remote to the theoretical current pathway. IEEE Transactions on Biomedical Engineering, 51: 1449-59.

72233

Morse MS (2009). A study of long term symptomatology reported in non-head-involved low voltage electrical contacts. IEEE Transactions on Biomedical Engineering, 2009: 6522-5.

Reference list concerning peripheral neuropathy · 19238 Herron LD, Kissel P, Smilovitz D (1997)....

Documents

Transcript of Reference list concerning peripheral neuropathy · 19238 Herron LD, Kissel P, Smilovitz D (1997)....